<!DOCTYPE html><html lang="en" class="bg-surface-base antialiased"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width, initial-scale=1, interactive-widget=resizes-content"/><link rel="stylesheet" href="/_next/static/css/62c4caba71dfda84.css" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/eb3d87f98fe1565f.css" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/1b5e561215938d4d.css" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/0227d069a630d414.css" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/f87fff2ab93d05a7.css" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh" data-precedence="next"/><link rel="preload" as="script" fetchPriority="low" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh" href="/_next/static/chunks/webpack-e121ed42680f327e.js"/><script src="/_next/static/chunks/78a669d9-e7993486b22c4915.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/40c4a5a7-abdabb07419d1cfc.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/2230-f7c87dc9fa57c408.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/main-app-536d4b8fca62396a.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/63f0ec43-8ee6a76d70472249.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/7670-7326298c9856172b.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/282-691fffb366e24ca5.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/7515-336759ef5dad2b52.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/927-34e2a6da3e15e26b.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/5855-243eeca8f0e4cabd.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/4393-1c8dff25ec904469.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/2225-454cf9f44775e7ce.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/7618-43536a8fb0dd3bfe.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/7720-3a1e7e411adba2d3.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/7086-1f1c4891d766e04f.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/app/global-error-4d07d20223cd4b4c.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/8208b75a-a48e5a4507a0de91.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/5497-ab85ef3ea59dd353.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/6281-c6e84786dade3614.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/2660-d983a7f287e89f18.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/5002-9735c25beda556ba.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/3655-6717081f7512305a.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/8945-e4e3cf487f5e27c7.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/9214-a10614844a67ba31.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/4789-2080f6497f78b5b6.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/app/layout-226f2bd71acf9f9e.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/24cf1b50-159cca90b09285e0.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/9ffa21ba-c069766d809bd4c7.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/600-9a9fcafaaa6c1c4c.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/5448-2a3cfd853d899c9a.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/8-8ca70ca619d8e099.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/app/error-4a29e9399afba038.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><script src="/_next/static/chunks/app/not-found-dd95690acf732f18.js" async="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script><meta name="next-size-adjust" content=""/><title>Grokipedia</title><meta name="description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><link rel="icon" type="image/x-icon" href="/favicon.ico" sizes="48x48"/><link rel="icon" href="/images/icon-dark.png" media="(prefers-color-scheme: light)" type="image/png"/><link rel="icon" href="/images/icon-light.png" media="(prefers-color-scheme: dark)" type="image/png"/><link rel="apple-touch-icon" href="/icon-192x192.png"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><meta property="og:title" content="Grokipedia"/><meta property="og:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta property="og:url" content="https://grokipedia.com"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en_US"/><meta property="og:type" content="website"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="Grokipedia"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="Grokipedia"/><meta name="twitter:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><title>Bariatrics</title><meta name="description" content="Bariatrics is the branch of medicine dedicated to the prevention, diagnosis, treatment, and management of obesity and its associated comorbidities, encompassing both nonsurgical interventions and surgical procedures aimed at inducing sustained weight loss through alterations in gastrointestinal anatomy or function. The field addresses obesity primarily as a chronic condition driven by caloric surplus relative to expenditure, with treatments prioritizing empirical evidence of efficacy over..."/><meta name="author" content="system"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><link rel="canonical" href="https://grokipedia.com/page/Bariatrics"/><meta property="og:title" content="Bariatrics"/><meta property="og:description" content="Bariatrics is the branch of medicine dedicated to the prevention, diagnosis, treatment, and management of obesity and its associated comorbidities, encompassing both nonsurgical interventions and surgical procedures aimed at inducing sustained weight loss through alterations in gastrointestinal anatomy or function. The field addresses obesity primarily as a chronic condition driven by caloric surplus relative to expenditure, with treatments prioritizing empirical evidence of efficacy over..."/><meta property="og:url" content="https://grokipedia.com/page/Bariatrics"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="Bariatrics"/><meta property="og:type" content="article"/><meta property="article:modified_time" content="1970-01-21T09:19:44.245Z"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="Bariatrics"/><meta name="twitter:description" content="Bariatrics is the branch of medicine dedicated to the prevention, diagnosis, treatment, and management of obesity and its associated comorbidities, encompassing both nonsurgical interventions and surgical procedures aimed at inducing sustained weight loss through alterations in gastrointestinal anatomy or function. The field addresses obesity primarily as a chronic condition driven by caloric surplus relative to expenditure, with treatments prioritizing empirical evidence of efficacy over..."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><link rel="icon" href="/favicon.ico" type="image/x-icon" sizes="16x16"/><meta name="sentry-trace" content="5d4ae2b2d4a23541234fe55512962bca-02a5cc4ef24a8741-1"/><meta name="baggage" content="sentry-environment=production,sentry-public_key=5f2258f71198ee26a355127af230c3a6,sentry-trace_id=5d4ae2b2d4a23541234fe55512962bca,sentry-org_id=4508179396558848,sentry-transaction=GET%20%2Fpage%2F%5Bslug%5D,sentry-sampled=true,sentry-sample_rand=0.42144350438763034,sentry-sample_rate=1"/><script src="/_next/static/chunks/polyfills-42372ed130431b0a.js" noModule="" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh"></script></head><body class="flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b"><div hidden=""><!--$--><!--/$--></div><script nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh">((a,b,c,d,e,f,g,h)=>{let i=document.documentElement,j=["light","dark"];function k(b){var c;(Array.isArray(a)?a:[a]).forEach(a=>{let c="class"===a,d=c&&f?e.map(a=>f[a]||a):e;c?(i.classList.remove(...d),i.classList.add(f&&f[b]?f[b]:b)):i.setAttribute(a,b)}),c=b,h&&j.includes(c)&&(i.style.colorScheme=c)}if(d)k(d);else try{let a=localStorage.getItem(b)||c,d=g&&"system"===a?window.matchMedia("(prefers-color-scheme: dark)").matches?"dark":"light":a;k(d)}catch(a){}})("class","theme","dark",null,["light","dark"],null,true,true)</script><header class="h-16 bg-surface-base fixed top-0 z-50 w-full"><div class="hidden h-full grid-cols-[1fr_3fr_1fr] items-center gap-4 !py-0 md:grid max-w-full py-6 px-4 w-full mx-auto"><div class="-ml-2 justify-self-start"><a class="cursor-pointer" href="/"><svg width="200" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="mx-auto flex w-full"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full px-3 shadow-none sm:w-80 focus-visible:z-1 mx-auto h-full w-full rounded-full bg-surface-l1" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>âŒ˜</span><span class="text-xs">K</span></div></span></div></button></div><div class="flex items-center gap-2 justify-self-end"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0" type="button" id="radix-_R_7apfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button></div></div><div class="flex h-full items-center md:hidden justify-between max-w-full py-6 px-4 w-full mx-auto pt-8"><div class="flex items-center"><div class="-ml-2"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button" aria-label="Toggle table of contents"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-list h-6 w-6"><path d="M3 12h.01"></path><path d="M3 18h.01"></path><path d="M3 6h.01"></path><path d="M8 12h13"></path><path d="M8 18h13"></path><path d="M8 6h13"></path></svg></button></div><a class="cursor-pointer" href="/"><svg width="160" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="flex items-center gap-1"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0 [&amp;_svg]:!w-5" type="button" id="radix-_R_aipfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-search h-5 w-5"><circle cx="11" cy="11" r="8"></circle><path d="m21 21-4.3-4.3"></path></svg></button></div></div></header><div class="bg-surface-base fixed right-0 top-16 z-50 h-[calc(100vh-4rem)] w-full transform border-l transition-transform duration-300 ease-in-out sm:w-1/2 md:hidden translate-x-full"><div class="flex flex-col gap-4 p-4"><div class="flex flex-row gap-2"><button class="focus-visible:ring-ring inline-flex items-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full shadow-none sm:w-80 h-10 w-full justify-start rounded-full bg-surface-l1 px-4" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>âŒ˜</span><span class="text-xs">K</span></div></span></div></button></div></div></div><div><div class="min-[1350px]:grid min-[1350px]:grid-cols-[1fr_3fr_1fr]"><nav class="bg-surface-base hidden h-[calc(100vh-4rem)] overflow-y-auto px-6 pb-32 min-[1350px]:sticky min-[1350px]:top-16 min-[1350px]:block scrollbar-none [-ms-overflow-style:none] [scrollbar-width:none] [&amp;::-webkit-scrollbar]:hidden [overscroll-behavior:contain] pt-8"><ul class="space-y-2 text-sm"><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#bariatrics" class="transition-opacity hover:opacity-100 opacity-50">Bariatrics</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#definition-and-scope" class="transition-opacity hover:opacity-100 opacity-50">Definition and Scope</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#etymology-and-terminology" class="transition-opacity hover:opacity-100 opacity-50">Etymology and Terminology</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#distinction-from-general-obesity-management" class="transition-opacity hover:opacity-100 opacity-50">Distinction from General Obesity Management</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#historical-development" class="transition-opacity hover:opacity-100 opacity-50">Historical Development</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#pre-20th-century-approaches" class="transition-opacity hover:opacity-100 opacity-50">Pre-20th Century Approaches</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#emergence-of-surgical-techniques-20th-century" class="transition-opacity hover:opacity-100 opacity-50">Emergence of Surgical Techniques (20th Century)</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#pharmacological-and-metabolic-advances-21st-century" class="transition-opacity hover:opacity-100 opacity-50">Pharmacological and Metabolic Advances (21st Century)</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#etiology-of-obesity-addressed-in-bariatrics" class="transition-opacity hover:opacity-100 opacity-50">Etiology of Obesity Addressed in Bariatrics</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#physiological-mechanisms-of-weight-gain" class="transition-opacity hover:opacity-100 opacity-50">Physiological Mechanisms of Weight Gain</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#genetic-and-metabolic-factors" class="transition-opacity hover:opacity-100 opacity-50">Genetic and Metabolic Factors</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#behavioral-and-environmental-influences" class="transition-opacity hover:opacity-100 opacity-50">Behavioral and Environmental Influences</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#patient-characteristics-and-selection" class="transition-opacity hover:opacity-100 opacity-50">Patient Characteristics and Selection</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#eligibility-criteria-for-interventions" class="transition-opacity hover:opacity-100 opacity-50">Eligibility Criteria for Interventions</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#associated-comorbidities-and-risk-profiling" class="transition-opacity hover:opacity-100 opacity-50">Associated Comorbidities and Risk Profiling</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#treatment-modalities" class="transition-opacity hover:opacity-100 opacity-50">Treatment Modalities</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#non-invasive-and-lifestyle-based-methods" class="transition-opacity hover:opacity-100 opacity-50">Non-Invasive and Lifestyle-Based Methods</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#pharmacological-treatments" class="transition-opacity hover:opacity-100 opacity-50">Pharmacological Treatments</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#surgical-procedures" class="transition-opacity hover:opacity-100 opacity-50">Surgical Procedures</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#integrated-and-emerging-approaches" class="transition-opacity hover:opacity-100 opacity-50">Integrated and Emerging Approaches</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#efficacy-and-long-term-outcomes" class="transition-opacity hover:opacity-100 opacity-50">Efficacy and Long-Term Outcomes</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#weight-loss-metrics-and-remission-rates" class="transition-opacity hover:opacity-100 opacity-50">Weight Loss Metrics and Remission Rates</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#effects-on-comorbidities-and-mortality" class="transition-opacity hover:opacity-100 opacity-50">Effects on Comorbidities and Mortality</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#factors-influencing-durability-of-results" class="transition-opacity hover:opacity-100 opacity-50">Factors Influencing Durability of Results</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#risks-complications-and-criticisms" class="transition-opacity hover:opacity-100 opacity-50">Risks, Complications, and Criticisms</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#perioperative-and-surgical-complications" class="transition-opacity hover:opacity-100 opacity-50">Perioperative and Surgical Complications</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#adverse-effects-of-pharmacotherapies" class="transition-opacity hover:opacity-100 opacity-50">Adverse Effects of Pharmacotherapies</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#debates-on-personal-responsibility-and-over-medicalization" class="transition-opacity hover:opacity-100 opacity-50">Debates on Personal Responsibility and Over-Medicalization</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#societal-and-economic-dimensions" class="transition-opacity hover:opacity-100 opacity-50">Societal and Economic Dimensions</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#public-health-implications-of-obesity" class="transition-opacity hover:opacity-100 opacity-50">Public Health Implications of Obesity</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#cost-benefit-analyses-of-bariatric-interventions" class="transition-opacity hover:opacity-100 opacity-50">Cost-Benefit Analyses of Bariatric Interventions</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#references" class="transition-opacity hover:opacity-100 opacity-50">References</a></li></ul></nav><div class="relative top-16 pb-32 pt-8 px-4 md:px-8"><div class="mx-auto max-w-[850px]"><button data-state="closed" type="button" class="flex items-center"><div class="text-fg-tertiary mb-2 flex cursor-help items-center gap-2 text-sm"><span class="inline-flex items-center justify-center p-0 m-0" data-namespace="@xai/icons" data-slot="icon" style="height:16px;width:16px"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 33 33" aria-hidden="true" class="" focusable="false" style="fill:currentColor;height:16px;width:16px"><path fill="currentColor" d="m13.237 21.04 11.082-8.19c.543-.4 1.32-.244 1.578.38 1.363 3.288.754 7.241-1.957 9.955-2.71 2.714-6.482 3.31-9.93 1.954l-3.765 1.745c5.401 3.697 11.96 2.782 16.059-1.324 3.251-3.255 4.258-7.692 3.317-11.693l.008.009c-1.365-5.878.336-8.227 3.82-13.031q.123-.17.247-.345l-4.585 4.59v-.014L13.234 21.044M10.95 23.031c-3.877-3.707-3.208-9.446.1-12.755 2.446-2.449 6.454-3.448 9.952-1.979L24.76 6.56c-.677-.49-1.545-1.017-2.54-1.387A12.465 12.465 0 0 0 8.675 7.901c-3.519 3.523-4.625 8.94-2.725 13.561 1.42 3.454-.907 5.898-3.251 8.364-.83.874-1.664 1.749-2.335 2.674l10.583-9.466"></path></svg></span><span>Fact-checked by Grok<!-- --> <!-- -->4 days ago</span></div></button><article class="text-[16px]"><h1 id="bariatrics" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Bariatrics<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<span class="mb-4 block break-words text-[1em] leading-7">Bariatrics is the branch of medicine dedicated to the prevention, diagnosis, treatment, and management of obesity and its associated comorbidities, encompassing both nonsurgical interventions and surgical procedures aimed at inducing sustained weight loss through alterations in gastrointestinal anatomy or function.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_40qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The field addresses obesity primarily as a chronic condition driven by caloric surplus relative to expenditure, with treatments prioritizing empirical evidence of efficacy over unsubstantiated environmental or genetic determinism alone. Nonsurgical approaches include behavioral modifications, pharmacotherapy, and very-low-calorie diets, though these often yield modest, less durable results compared to surgery in severe cases (body mass index â‰¥40 kg/mÂ² or â‰¥35 kg/mÂ² with comorbidities).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_41abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> Bariatric surgery, the cornerstone of advanced intervention, modifies digestive processes to restrict intake, reduce absorption, or both, with procedures like Roux-en-Y gastric bypass (first performed in 1967) and vertical sleeve gastrectomy achieving average excess weight loss of 50-70% at 5-10 years post-operation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_81abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Significant achievements include marked remission rates for type 2 diabetes (up to 70% in some cohorts) and reductions in cardiovascular risk factors, outperforming medical management in randomized trials.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_41qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup> Controversies persist regarding long-term durability, with weight regain in 20-30% of patients after 10 years necessitating revisions, alongside operative risks like anastomotic leaks (1-2%), venous thromboembolism, and lifelong micronutrient supplementation to mitigate deficiencies in iron, vitamin B12, and calcium.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_81qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup> Emerging data also highlight debated associations, such as potential shifts in colorectal cancer incidence post-surgery, underscoring the need for rigorous, extended surveillance beyond initial benefits.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c1qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup> Despite these challenges, bariatrics has evolved from experimental intestinal bypasses in the 1950s to standardized, laparoscopically refined techniques, reflecting causal emphasis on mechanical restriction and hormonal modulation over palliative measures.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g1qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup></span>
<h2 id="definition-and-scope" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Definition and Scope<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="etymology-and-terminology" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Etymology and Terminology<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">The term <em>bariatrics</em> derives from the Ancient Greek <em>baros</em> (Î²Î¬ÏÎ¿Ï‚), meaning &quot;weight&quot; or &quot;pressure,&quot; combined with <em>-iatrics</em>, from <em>iatros</em> (á¼°Î±Ï„ÏÏŒÏ‚), denoting a physician or healer, thus signifying the branch of medicine focused on the treatment of weight disorders, especially obesity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_k3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup> The suffix <em>-iatric</em> reflects therapeutic practices, distinguishing bariatrics as a specialized medical discipline rather than mere descriptive physiology.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_s3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The word <em>bariatrics</em> first appeared in English in the early 1960s, with documented usage by 1963, and is attributed to physician Raymond E. Dietz, who coined it in 1961 to describe obesity management strategies.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_83qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[8]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a3qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup> In modern contexts, <em>bariatric</em> adjectives apply to equipment, procedures, or facilities adapted for obese patients, such as bariatric beds or ambulances designed to accommodate higher body weights.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i3qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Key terminology in bariatrics includes <em>morbid obesity</em>, clinically defined as a body mass index (BMI) of 40 kg/mÂ² or greater, or 35 kg/mÂ² or greater with obesity-related comorbidities like type 2 diabetes or hypertension, indicating severe health risks warranting intervention.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_84abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[10]</sup> <em>Bariatric surgery</em> refers to procedures like gastric bypass or sleeve gastrectomy that induce weight loss by altering gastrointestinal anatomy, often termed <em>metabolic surgery</em> to emphasize improvements in insulin resistance and other metabolic parameters beyond mere weight reduction.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_k4abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[11]</sup> These terms underscore bariatrics&#x27; emphasis on interventional therapies for sustained outcomes in severe cases, distinct from conservative measures like diet or pharmacotherapy.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_o4abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[12]</sup></span>
<h3 id="distinction-from-general-obesity-management" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Distinction from General Obesity Management<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Bariatrics primarily addresses severe obesity through specialized interventions, including metabolic and bariatric surgery, that modify the gastrointestinal tract to induce weight loss and metabolic improvements, in contrast to general obesity management, which emphasizes non-invasive strategies like caloric restriction, increased physical activity, behavioral counseling, and pharmacotherapy for a broader spectrum of body mass index (BMI) levels.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_45abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[13]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_65abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup> While general management aims for modest, often temporary weight reductions of 5-10% via lifestyle changes, bariatric procedures such as Roux-en-Y gastric bypass or sleeve gastrectomy typically yield 20-30% total body weight loss sustained over years, particularly in patients unresponsive to conservative therapies.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a5abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[15]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c5abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The distinction is evident in patient selection criteria: bariatric surgery is indicated for individuals with BMI â‰¥40 kg/mÂ² (or â‰¥35 kg/mÂ² with comorbidities like type 2 diabetes or hypertension) only after documented failure of intensive non-surgical efforts, whereas general management serves as the initial approach for overweight (BMI 25-29.9 kg/mÂ²) and class I-II obesity (BMI 30-39.9 kg/mÂ²) without mandating prior interventions for milder cases.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_45qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_65qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[18]</sup> This threshold reflects empirical evidence that non-surgical methods rarely achieve durable remission of obesity-related conditions in severe cases, with randomized trials showing bariatric surgery superior for long-term glycemic control (e.g., hemoglobin A1c reductions of 1.4% greater at 7 years) and cardiovascular risk reduction compared to medical/lifestyle therapy.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a5qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[19]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c5qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Furthermore, bariatrics incorporates multidisciplinary preoperative optimization and postoperative monitoring to mitigate surgical risks, diverging from the less intensive follow-up in general programs, which often rely on primary care or self-directed efforts.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_46abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[21]</sup> Long-term data from cohort studies confirm bariatric approaches reduce obesity-associated mortality by up to 30-50% in eligible patients, outcomes not replicated in conservative cohorts despite equivalent initial BMI.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_86abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[22]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a6abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[23]</sup> This separation underscores bariatrics&#x27; focus on causal disruption of overeating and malabsorption via anatomical changes, rather than solely addressing behavioral or environmental drivers central to general management.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_e6abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[24]</sup></span>
<h2 id="historical-development" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Historical Development<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="pre-20th-century-approaches" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Pre-20th Century Approaches<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Early recognition of obesity as a medical concern dates to ancient civilizations, where treatments emphasized humoral balance through dietary restraint, physical exertion, and purgative measures. Hippocrates (c. 460â€“377 BCE) identified health risks such as sudden death from overabundant flesh and prescribed reduced food intake, walking, running, and the use of emetics like hellebore or cathartics such as scammony juice to counteract excess.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_47qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[25]</sup> Galen (c. 129â€“200 CE) extended these principles, advocating strenuous running, warm baths, light meals, and manual labor to diminish fat accumulation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_87qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[26]</sup> In parallel Eastern traditions, Sushruta (c. 500 BCE) linked obesity to overeating and diabetes-like conditions, recommending fasting, vigorous exercise, and depletory therapies, while Hindu practices included massage with pea flour or wolf flesh compresses.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[26]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_e7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[27]</sup> Soranus of Ephesus (2nd century CE) further detailed Greco-Roman methods, employing laxatives, heat applications, massage, induced vomiting via hyssop mixtures, and vinegar as a drying agent to restore bodily equilibrium.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[27]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Medieval Islamic medicine built upon these foundations, integrating lifestyle modifications with pharmacological aids. Avicenna (980â€“1037 CE) promoted bulky, low-nutrient foods to slow digestion, pre-meal baths, and exercise to manage corpulence.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_48abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[27]</sup> A notable case involved Hasdai ibn Shaprut treating King Sancho I of LeÃ³n (958 CE) with theriacaâ€”a compound of opium, ginger, and other substancesâ€”which facilitated sufficient weight loss for the king to resume his throne.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_88abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[27]</sup> In Europe, obesity was often framed morally as gluttony, with remedies like fasting persisting from religious practices, though medical texts retained Greco-Roman emphases on diet and activity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c8abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[25]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">By the 17th to 19th centuries, European approaches incorporated emerging substances alongside traditional methods, reflecting a shift toward viewing excess weight as a treatable affliction amid changing social ideals. Physicians like Tobias Venner (1620s) suggested mineral springs for purging, while ThÃ©ophile Bonet (17th century) endorsed vinegar, rhubarb purgatives, aloes, and tobacco to reduce fat.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_48qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[26]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_68qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[27]</sup> Thomas Short (1727) and Malcolm Flemyng (1760) stressed exercise, caloric restriction, and even soap applications to eliminate oils.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a8qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[27]</sup> A landmark non-pharmacological intervention came in 1863 with William Banting&#x27;s &quot;Letter on Corpulence,&quot; detailing a low-carbohydrate regimen avoiding bread, beer, milk, sugar, and potatoes in favor of meats, greens, and dry wine; Banting, initially 202 pounds at 5 feet 5 inches, lost 35 pounds within a year under physician William Harvey&#x27;s guidance, popularizing structured dieting.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_e8qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[28]</sup> These efforts laid groundwork for bariatrics by prioritizing empirical observation over humoral theory, though efficacy varied and risks from purgatives were unrecognized.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i8qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[27]</sup></span>
<h3 id="emergence-of-surgical-techniques-20th-century" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Emergence of Surgical Techniques (20th Century)<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">The first surgical interventions specifically aimed at weight reduction in morbidly obese patients emerged in the mid-20th century, initially focusing on malabsorptive techniques to bypass portions of the small intestine and induce nutrient malabsorption. In 1954, Kremen, Linner, and Nelson at the University of Minnesota performed the inaugural jejunoileal bypass (JIB) in animal models, adapting it for human use shortly thereafter to shorten the intestinal absorptive surface and promote caloric restriction through diarrhea and malabsorption.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_49qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[29]</sup> This procedure gained traction in the 1960s, with Payne and DeWind refining jejunoileostomy in 1969 by anastomosing the proximal jejunum to the distal ileum, leaving only about 35-45 cm of functional small bowel, which achieved substantial weight loss averaging 40-50% excess body weight but at the cost of severe complications including electrolyte imbalances, liver failure, and bacterial overgrowth.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_89qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[30]</sup> By the 1970s, JIB&#x27;s high morbidityâ€”reported in up to 20-30% of cases with life-threatening issuesâ€”led to its decline and near abandonment by the early 1980s, prompting a paradigm shift toward safer, primarily restrictive gastric procedures.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c9qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[31]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">A pivotal advancement occurred in 1967 when Edward E. Mason and Chikashi Ito introduced gastric bypass surgery, marking the transition to operations that limited stomach capacity while preserving intestinal absorption. Performed at the University of Iowa, this technique involved partitioning the stomach to create a small proximal pouch (approximately 15-30 ml) connected via a loop gastrojejunostomy, restricting food intake and inducing early satiety without extensive malabsorption; initial outcomes in over 100 patients demonstrated 30-50% excess weight loss with reduced complication rates compared to intestinal bypasses.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4aabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[32]</sup> Mason&#x27;s innovation stemmed from observations in ulcer surgeries where partial gastrectomies inadvertently led to weight loss, emphasizing gastric restriction as a more physiological and reversible approach; refinements, such as the Roux-en-Y configuration to prevent reflux, followed in subsequent decades.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8aabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[33]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Further refinements in restrictive surgery appeared in the 1980s with the development of gastroplasty variants. In 1980, Mason pioneered vertical banded gastroplasty (VBG), which stapled the stomach vertically to form a 15-30 ml pouch reinforced by a prosthetic band at the outlet to maintain a fixed 10-12 mm stoma, aiming for pure restriction without bypass; early series reported 40-60% excess weight loss in 200+ patients with lower operative risks than malabsorptive methods.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4aqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[34]</sup> These techniques, while effective for short-term weight control, revealed limitations like staple-line disruptions and pouch dilation over time, influencing later hybrid procedures; by the late 20th century, gastric bypass and gastroplasties had established bariatric surgery as a viable option for patients with BMI exceeding 40 kg/mÂ² unresponsive to conservative measures, with cumulative data from thousands of cases validating their role in comorbidity resolution such as diabetes and hypertension.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8aqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[35]</sup></span>
<h3 id="pharmacological-and-metabolic-advances-21st-century" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Pharmacological and Metabolic Advances (21st Century)<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">The 21st century has seen the emergence of glucagon-like peptide-1 (GLP-1) receptor agonists as a major pharmacological advance in obesity management within bariatrics, targeting incretin hormones to suppress appetite, slow gastric emptying, and enhance insulin secretion. These agents address obesity as a chronic metabolic disorder by mimicking physiological pathways disrupted in severe cases, offering non-surgical alternatives or adjuncts to bariatric procedures. Initial approvals focused on diabetes but expanded to weight management, with clinical trials demonstrating sustained reductions in body weight when combined with lifestyle interventions.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4bqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[36]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8bqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[37]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Liraglutide, approved by the FDA as Saxenda for chronic weight management in adults on December 23, 2014, represents the first GLP-1 agonist specifically indicated for obesity. In the SCALE trial, a 56-week randomized controlled study, liraglutide 3.0 mg daily led to a mean weight loss of 8.0% versus 2.6% with placebo, with 63.2% of participants achieving at least 5% weight reduction compared to 27.1% in the placebo group. Efficacy persisted at two years in follow-up analyses, outperforming orlistat, though gastrointestinal side effects like nausea affected up to 39% of users. Real-world data confirm approximately 8% average weight loss, positioning it as a foundational therapy before more potent successors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4cabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[38]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8cabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[39]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ccabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[40]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gcabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[41]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Semaglutide, a longer-acting GLP-1 analog, advanced this class with FDA approval of Wegovy for weight loss on June 4, 2021. The STEP 1 trial, a 68-week study in adults with obesity, reported mean weight reductions of 14.9% at 2.4 mg weekly versus 2.4% with placebo, with 86.4% achieving â‰¥5% loss. Long-term data from the SELECT trial at 208 weeks showed sustained benefits, including cardiovascular risk reduction independent of weight loss extent. Higher investigational doses, such as 7.2 mg, yielded up to 21% loss in non-diabetic patients, though discontinuation leads to substantial regain, underscoring the need for ongoing therapy. These outcomes have correlated with an 8.7% decline in bariatric surgeries from 2022 to 2023 amid rising prescriptions.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4cqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[42]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8cqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[43]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ccqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[44]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gcqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[45]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_kcqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[46]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Tirzepatide, a dual GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) agonist, further refined metabolic targeting, gaining FDA approval as Zepbound for obesity on November 8, 2023. In the SURMOUNT-1 trial over 72 weeks, doses of 5 mg, 10 mg, or 15 mg weekly produced mean weight losses of 15.0%, 19.5%, and 20.9%, respectively, versus 3.1% with placebo, with 89% achieving â‰¥5% reduction at the highest dose. Head-to-head comparison in SURMOUNT-5 showed 20.2% loss with tirzepatide versus 13.7% with semaglutide at 72 weeks. Withdrawal in extension studies resulted in near-complete regain, affirming its role in maintenance rather than cure, while enhancing glycemic control and lipid profiles through dual incretin modulation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4dabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[47]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8dabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[48]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cdabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[49]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gdabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[50]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Metabolic insights from these pharmacotherapies have illuminated bariatrics&#x27; focus on enteroendocrine signaling and gut-brain axes, revealing how GLP-1/GIP activation recalibrates energy homeostasis akin to post-bariatric surgery remodeling. Unlike earlier agents like orlistat, which primarily inhibit fat absorption with modest 5-10% efficacy, incretin mimetics yield superior, dose-dependent outcomes but require monitoring for pancreatitis risk and muscle loss. Ongoing trials explore combinations and next-generation multi-agonists, potentially integrating with surgical outcomes for personalized metabolic restoration.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4dqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[51]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8dqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[52]</sup></span>
<h2 id="etiology-of-obesity-addressed-in-bariatrics" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Etiology of Obesity Addressed in Bariatrics<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="physiological-mechanisms-of-weight-gain" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Physiological Mechanisms of Weight Gain<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Weight gain occurs through a sustained positive energy balance, where caloric intake chronically exceeds energy expenditure, resulting in the storage of excess energy primarily as triglycerides in adipose tissue.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4fabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[53]</sup> This process adheres to the first law of thermodynamics, with adipose tissue serving as the principal reservoir for surplus energy; even a modest daily imbalance of 1-3% can lead to substantial fat accumulation over years, as evidenced by average adult weight gains exceeding 10 kg over 3-4 decades in U.S. populations.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8fabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[53]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_afabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[54]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Central nervous system regulation, particularly via the hypothalamus, integrates peripheral signals to maintain energy homeostasis, but dysregulation favors overconsumption and reduced expenditure. The arcuate nucleus processes inputs from hormones such as ghrelin, which rises preprandially to stimulate appetite through activation of orexigenic neurons like AgRP/NPY, promoting feeding and decreasing energy use.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4fqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[55]</sup> In contrast, satiety is mediated by anorexigenic signals including leptin from adipocytes and insulin from pancreatic beta cells, which activate POMC/CART neurons to suppress intake; however, in obesity, <strong>leptin resistance</strong> impairs hypothalamic responsiveness, allowing elevated circulating leptin levels to fail in curbing hyperphagia despite increased fat mass.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cfqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[53]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_efqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[55]</sup> Insulin further promotes lipogenesis by enhancing lipoprotein lipase activity in adipocytes, facilitating fatty acid uptake and storage while inhibiting lipolysis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ifqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[54]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Adipose tissue expands via <strong>hypertrophy</strong> (increased adipocyte size) and, to a lesser extent, <strong>hyperplasia</strong> (new cell formation) in response to caloric surplus, but impaired expansion in obesity leads to ectopic lipid deposition in non-adipose organs like liver and muscle, exacerbating metabolic dysfunction.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cgabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[56]</sup> This expansion triggers local inflammation and altered adipokine secretion, including reduced adiponectin, which normally enhances insulin sensitivity and fatty acid oxidation, thereby perpetuating a cycle of insulin resistance and further fat accrual.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ggabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[56]</sup> Overall, these mechanisms defend an elevated &quot;set point&quot; of adiposity in obese individuals, resisting weight reduction through adaptive increases in hunger and decreases in resting metabolic rate.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_kgabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[53]</sup></span>
<h3 id="genetic-and-metabolic-factors" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Genetic and Metabolic Factors<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Obesity exhibits substantial genetic heritability, with twin and family studies estimating that genetic factors account for 40% to 70% of variation in body mass index (BMI) and adiposity across populations.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4habav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[57]</sup> This heritability arises from both rare monogenic mutations and common polygenic variants, though environmental influences modulate expression, as evidenced by rising obesity rates despite stable genetic pools. Monogenic forms, while rare (affecting &lt;5% of severe cases), provide causal insights; for instance, mutations in the melanocortin-4 receptor (<em>MC4R</em>) gene, located on chromosome 18, are the most prevalent, contributing to approximately 4% of childhood-onset severe obesity by impairing hypothalamic signaling that regulates appetite and energy expenditure.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_chabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[58]</sup> Similarly, variants in the fat mass and obesity-associated (<em>FTO</em>) gene, such as rs9939609, correlate with increased BMI by influencing DNA demethylation and hypothalamic gene expression, raising obesity risk by 20-30% per risk allele in meta-analyses of diverse cohorts.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_khabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[59]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Polygenic risk scores (PRS), aggregating hundreds of common variants identified via genome-wide association studies (GWAS), better capture population-level genetic predisposition, explaining up to 6-10% of BMI variance in recent multi-ancestry models. A 2025 study across UK Biobank and other cohorts demonstrated that PRS predicts BMI trajectories from childhood through adulthood, with high-risk individuals showing 2-5 kg/mÂ² higher BMI by age 40, though this accounts for only about one-third of total genetic heritability due to missing rare variants and gene-environment interactions.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4hqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[60]</sup> These scores highlight causal pathways, such as variants near <em>MC4R</em> (e.g., rs17782313) affecting melanocortin pathways, but their clinical utility remains limited by polygenicity and the need for lifestyle integration to mitigate risk.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_chqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[61]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Metabolically, obesity often stems from dysregulated energy homeostasis, prominently involving leptin resistance, where elevated circulating leptin from adipose tissue fails to suppress appetite due to impaired hypothalamic transport and signaling. In most obese individuals, plasma leptin levels are 3-5 times higher than in lean counterparts, yet central resistance persists, driven by mechanisms like endoplasmic reticulum stress and inflammation, reducing basal metabolic rate by 10-20% and perpetuating hyperphagia.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4iabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[62]</sup> Insulin resistance compounds this, as chronic hyperinsulinemiaâ€”common in 70-80% of obese adultsâ€”exacerbates leptin resistance via shared downstream pathways, including SOCS3-mediated suppression of JAK-STAT signaling, forming a feedback loop that promotes fat storage over oxidation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8iabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[63]</sup> Rare congenital leptin deficiency (<em>LEP</em> gene mutations) causes profound early-onset obesity treatable with recombinant leptin, underscoring causality, but in polygenic obesity, these metabolic defects interact with genetic predispositions, such as <em>FTO</em> variants enhancing adipocyte leptin production without proportional satiety.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_kiabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[64]</sup> Thyroid dysfunction or mitochondrial inefficiencies contribute marginally in subsets, but hormonal axes dominate, with evidence from longitudinal studies linking prediagnostic insulin and leptin profiles to subsequent weight gain independent of caloric intake.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_oiabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[65]</sup></span>
<h3 id="behavioral-and-environmental-influences" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Behavioral and Environmental Influences<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Behavioral factors play a central role in the etiology of obesity by promoting a sustained positive energy balance through excessive caloric intake and reduced expenditure. Diets high in energy-dense, nutrient-poor foodsâ€”such as frequent fast food consumption, large portion sizes, and sugar-sweetened beveragesâ€”directly contribute to weight gain, with studies identifying these patterns as key obesity-promoting behaviors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4jabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[66]</sup> Sedentary lifestyles exacerbate this by lowering daily energy expenditure; meta-analyses confirm that low physical activity levels are associated with increased risk of obesity, independent of dietary factors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8jabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[67]</sup> In developed countries, recent doubly labeled water studies across populations reveal that dietary overconsumption, rather than reduced physical activity, accounts for the majority of the modern obesity epidemic, as total energy expenditure remains relatively stable despite rising body weights.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cjabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[68]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Additional behavioral contributors include inadequate sleep and stress-induced eating, which disrupt appetite-regulating hormones like leptin and ghrelin, fostering overeating.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4jqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[69]</sup> Systematic reviews highlight conflicting but supportive evidence for dietary intake, sedentary screen time, and irregular meal patterns in adolescent obesity onset, underscoring the cumulative impact of habitual choices on adipose accumulation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8jqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[70]</sup> These modifiable behaviors form the basis for bariatric interventions, which often incorporate cognitive-behavioral strategies to address maladaptive eating and activity patterns.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Environmental influences amplify behavioral risks by shaping access and cues for obesogenic choices. Food environments dominated by ultra-processed foods and aggressive marketing correlate with higher obesity prevalence, as meta-analyses link greater availability of unhealthy options to increased caloric intake and body mass index.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4kabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[71]</sup> Urban design factors, such as limited walkable spaces and reduced green areas, inversely associate with physical activity; reviews indicate that proximity to parks and bikeable infrastructure lowers obesity rates by facilitating energy expenditure.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8kabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[72]</sup> Increasing urbanization has paralleled rising obesity, with built environments prioritizing sedentary transport over active mobility contributing to lower overall activity levels.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ckabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[73]</sup> Socioeconomic disparities in these environmentsâ€”such as food deserts in low-income areasâ€”further entrench higher obesity risks through restricted healthy food access, though individual agency in navigating such contexts remains a critical determinant.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gkabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[74]</sup></span>
<h2 id="patient-characteristics-and-selection" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Patient Characteristics and Selection<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="eligibility-criteria-for-interventions" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Eligibility Criteria for Interventions<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Eligibility for metabolic and bariatric surgery (MBS) is guided by updated 2022 ASMBS/IFSO recommendations, which expanded criteria beyond the 1991 NIH consensus to reflect evidence of benefits in broader populations. MBS is recommended for adults with a body mass index (BMI) of 35 kg/mÂ² or greater, irrespective of comorbidities, and for those with BMI 30â€“34.9 kg/mÂ² accompanied by type 2 diabetes (T2D) or other metabolic diseases.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4lqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[75]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8lqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[76]</sup> For Asian populations, thresholds are lowered to BMI â‰¥27.5 kg/mÂ² or â‰¥25 kg/mÂ² with metabolic conditions due to higher cardiometabolic risks at lower BMIs.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_clqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[77]</sup> Candidates must demonstrate failure of sustained weight loss through intensive lifestyle interventions, typically 6â€“12 months of supervised diet and exercise yielding less than 10% body weight reduction.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_glqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[78]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Additional selection factors include multidisciplinary evaluation encompassing medical, psychological, and nutritional assessments to ensure operative safety and postoperative adherence. Psychological stability is required, excluding active untreated psychiatric disorders, severe depression, or substance abuse that could impair compliance; preoperative counseling addresses eating behaviors and expectations.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4mabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[79]</sup> Age limits are generally 18â€“65 years, though adolescents with BMI â‰¥120% of the 95th percentile plus comorbidities may qualify under separate pediatric guidelines.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8mabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[80]</sup> Contraindications encompass reversible causes of obesity (e.g., untreated hypothyroidism), high perioperative risks from coagulopathies or advanced heart failure, pregnancy, or inability to comprehend informed consent.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cmabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[81]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Pharmacological interventions for obesity, such as GLP-1 receptor agonists (e.g., semaglutide) or dual agonists (e.g., tirzepatide), target adults with BMI â‰¥30 kg/mÂ² or â‰¥27 kg/mÂ² with weight-related comorbidities like hypertension, dyslipidemia, or prediabetes, in conjunction with lifestyle modifications.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4mqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[41]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8mqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[82]</sup> FDA approvals specify chronic use for those not achieving adequate response to diet and exercise alone, with titration to minimize gastrointestinal side effects; efficacy requires at least 5% weight loss by 3â€“6 months to continue.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cmqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[83]</sup> Unlike surgery, pharmacotherapy has fewer absolute BMI barriers but mandates screening for contraindications including medullary thyroid carcinoma history, multiple endocrine neoplasia type 2, or pancreatitis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gmqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[84]</sup> Canadian 2025 guidelines emphasize individualized titration based on response and tolerability, prioritizing agents with cardiovascular risk reduction in high-risk patients.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_kmqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[85]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Across interventions, equity considerations arise from evidence that lower BMI thresholds improve access for underrepresented groups with early-onset metabolic risks, though real-world disparities persist due to socioeconomic barriers.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4nabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[86]</sup> Long-term eligibility reassessment is advised, as weight regain or evolving comorbidities may necessitate switching modalities.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8nabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[87]</sup></span>
<h3 id="associated-comorbidities-and-risk-profiling" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Associated Comorbidities and Risk Profiling<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Obesity, especially at levels qualifying patients for bariatric interventions (typically BMI â‰¥40 kg/mÂ² or â‰¥35 kg/mÂ² with complications), is causally linked to a cluster of comorbidities driven by excess adiposity, insulin resistance, and chronic inflammation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4oabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[88]</sup> Primary associated conditions include type 2 diabetes mellitus (T2DM), hypertension, dyslipidemia, obstructive sleep apnea (OSA), and nonalcoholic fatty liver disease (NAFLD), which collectively form metabolic syndrome in up to 70% of severe obesity cases with OSA.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8oabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[89]</sup> These comorbidities not only justify intervention eligibility under guidelines like those from the American Society for Metabolic and Bariatric Surgery but also elevate perioperative risks, necessitating comprehensive preoperative profiling.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_coabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[90]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Prevalence data from bariatric cohorts highlight the burden: OSA affects 63-83% of surgery candidates, often undiagnosed preoperatively and contributing to hypoxia-related complications.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4oqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[91]</sup> T2DM occurs in 20-40% of eligible patients, with higher rates (up to 78% OSA overlap) in those with severe obesity, exacerbating cardiovascular strain.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8oqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[92]</sup> Hypertension is documented in approximately 50% of cases, dyslipidemia in 30-50%, and NAFLD in 70-90% upon biopsy, reflecting hepatic fat accumulation from caloric surplus and metabolic dysregulation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_coqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[93]</sup> Less frequent but significant associations include osteoarthritis (limiting mobility), gastroesophageal reflux disease, and polycystic ovary syndrome in females, all empirically tied to adipose tissue dysfunction rather than solely behavioral factors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_goqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[90]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Risk profiling integrates these comorbidities into stratified models to predict adverse outcomes like 90-day mortality (0.2-2.4% across strata) and guide procedure selection.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4pabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[94]</sup> The validated Obesity Surgery Mortality Risk Score (OS-MRS) assigns one point each for five factorsâ€”BMI â‰¥50 kg/mÂ², male sex, hypertension, age â‰¥45 years, and pulmonary embolism risk factors (e.g., prior venous thromboembolism)â€”categorizing patients as low-risk (0 points), moderate (1-2 points), or high-risk (â‰¥3 points).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8pabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[95]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cpabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[96]</sup> Additional assessments include echocardiograms for heart failure (prevalent in 5-10% of high-BMI patients), polysomnography for OSA severity, and nutritional evaluations to mitigate malnutrition risks post-surgery.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gpabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[97]</sup> Multidisciplinary teams weigh these against benefits, prioritizing empirical predictors over unverified psychosocial metrics, as higher comorbidity loads correlate with greater postoperative resolution but also leak or infection risks.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_kpabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[98]</sup></span>
<h2 id="treatment-modalities" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Treatment Modalities<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="non-invasive-and-lifestyle-based-methods" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Non-Invasive and Lifestyle-Based Methods<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Comprehensive lifestyle interventions, comprising dietary modifications, physical activity, and behavioral strategies, represent the foundational non-invasive approach in bariatrics for managing obesity through sustained negative energy balance. These methods prioritize empirical adjustments to caloric intake and expenditure, guided by principles of energy homeostasis, with evidence from randomized controlled trials indicating average initial weight reductions of 8-10% of body weight at 6-12 months when delivered intensively.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4qqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[99]</sup> However, long-term maintenance remains challenging, with meta-analyses showing average sustained losses of 3-5% after 5 years, often accompanied by high rates of partial or full regain due to physiological adaptations such as reduced resting metabolic rate and increased appetite signaling.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8qqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[100]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_aqqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[101]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Dietary strategies focus on moderate caloric restriction (typically 500-1,000 kcal/day deficit) using balanced macronutrient distributions, such as 1,200-1,500 kcal diets emphasizing vegetables, lean proteins, and whole grains while limiting refined sugars and fats. Systematic reviews demonstrate comparable short-term efficacy across low-fat, low-carbohydrate, and Mediterranean-style diets, yielding 5-8 kg losses over 6 months, though adherence wanes without ongoing support.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4rabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[99]</sup> For severe obesity, very low-calorie diets (VLCDs, &lt;800 kcal/day, often formula-based and medically supervised for 12-16 weeks) achieve rapid losses of 15-25% body weight, improving glycemic control and facilitating transitions to maintenance phases, but require monitoring for nutrient deficiencies, gallstones, and muscle loss.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8rabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[102]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_arabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[103]</sup> Long-term outcomes for VLCDs mirror general dietary interventions, with regain exceeding 50% within 1-2 years absent behavioral reinforcement.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_erabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[101]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Physical activity components recommend at least 150-250 minutes weekly of moderate-intensity aerobic exercise (e.g., brisk walking) combined with resistance training 2-3 days per week to preserve lean mass and mitigate metabolic slowdown. Meta-analyses confirm that adding exercise to diet enhances initial losses by 1-3 kg and halves regain risk over 1-2 years compared to diet alone, with benefits extending to cardiovascular fitness independent of weight change.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4rqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[99]</sup> In the Look AHEAD trial, participants in an intensive lifestyle arm achieved 8.6% weight loss at 1 year through 175 minutes/week of activity plus diet, sustaining ~4.7% loss at 8 years versus 2.1% in controls, alongside reduced diabetes progression.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8rqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[104]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_arqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[105]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Behavioral therapies, drawing from cognitive-behavioral techniques, target habit formation via self-monitoring (e.g., food diaries), goal setting, stimulus control, and relapse prevention, typically delivered in 16-24 weekly sessions followed by maintenance boosters. These interventions improve adherence, with intensive programs yielding 5-10% losses sustained at 1 year in 60-70% of completers, though dropout rates reach 20-40%.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4sabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[106]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6sabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[107]</sup> Combined modalities amplify effects; for instance, the Diabetes Prevention Program showed 7% loss at 6 months via group sessions, halving diabetes incidence over 3 years despite partial regain.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_asabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[99]</sup> Modest losses (â‰¥5%) consistently remit comorbidities like hypertension and prediabetes, underscoring causal links between adiposity reduction and metabolic improvement, yet underscore the need for indefinite support given obesity&#x27;s chronicity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_esabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[108]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gsabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[101]</sup></span>
<h3 id="pharmacological-treatments" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Pharmacological Treatments<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Pharmacological treatments in bariatrics target physiological drivers of obesity, such as appetite dysregulation and impaired satiety signaling, with the goal of achieving sustained weight loss in patients with BMI â‰¥30 kg/mÂ² or â‰¥27 kg/mÂ² with comorbidities like type 2 diabetes or hypertension.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4tabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[109]</sup> These agents are positioned as adjuncts to lifestyle interventions or alternatives to surgery for select patients, though evidence indicates they generally produce less durable results than bariatric procedures, with weight regain common upon discontinuation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8tabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[110]</sup> Current FDA-approved options emphasize incretin-based therapies, which outperform older classes like lipase inhibitors or sympathomimetics in magnitude of effect.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ctabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[41]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide (Wegovy, approved 2021), mimic endogenous incretins to suppress appetite, delay gastric emptying, and enhance insulin secretion, yielding mean weight losses of 14.9-17.4% at 68 weeks in randomized trials of adults without diabetes.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4tqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[43]</sup> Tirzepatide (Zepbound, approved 2023), a dual GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) agonist, demonstrates superior efficacy, with placebo-adjusted reductions of 15-21% body weight over 72 weeks in phase 3 SURMOUNT trials, attributed to additive effects on energy intake and expenditure.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8tqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[48]</sup> Head-to-head comparisons confirm tirzepatide&#x27;s edge, achieving 5-7% greater loss than semaglutide 2.4 mg weekly at 72 weeks.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ctqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[49]</sup> Liraglutide (Saxenda, approved 2014), an earlier GLP-1 agonist, produces 5-8% loss but requires daily dosing and has lower adherence.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gtqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[41]</sup></span>





























<div class="border-border-l1 overflow-x-auto rounded-lg border my-6 w-full"><table node="[object Object]" class="w-full border-collapse text-sm"><thead node="[object Object]" class="border-border-l1 border-b bg-surface-l1"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Drug</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Mechanism</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Mean Weight Loss (% at 1 year)</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Common Adverse Effects</span></th></tr></thead><tbody node="[object Object]" class="divide-border-l1 divide-y"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Semaglutide (Wegovy)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">GLP-1 RA: appetite suppression, slowed gastric emptying</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">15-17%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Nausea (44%), diarrhea (30%), vomiting (25%)</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_kcuabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[111]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Tirzepatide (Zepbound)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Dual GLP-1/GIP RA: enhanced satiety, reduced caloric intake</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">18-21%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Nausea (25-35%), gastrointestinal intolerance leading to 4-7% discontinuation</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_kkuabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[112]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Liraglutide (Saxenda)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">GLP-1 RA: similar to semaglutide but shorter half-life</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">5-8%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Injection-site reactions, nausea (39%)</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ksuabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[41]</sup></td></tr></tbody></table></div>
<span class="mb-4 block break-words text-[1em] leading-7">Safety profiles feature predominantly gastrointestinal events, affecting 20-50% of users and driving 5-10% discontinuation rates, with dose escalation mitigating onset.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4uqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[111]</sup> Rare risks include acute pancreatitis (0.1-0.2% incidence), gallbladder disease (2-4% increased), and potential medullary thyroid carcinoma signals from rodent data, though human evidence remains inconclusive.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8uqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[113]</sup> Cardiovascular benefits, including reduced major adverse events, support use in high-risk patients, as seen in semaglutide&#x27;s 20% relative risk reduction in SELECT trial subsets.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cuqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[112]</sup> Older agents like orlistat (Xenical), which inhibits fat absorption for 5-10% loss, or phentermine (short-term sympathomimetic), offer modest effects but higher malabsorption or cardiovascular concerns, limiting bariatric preference.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_guqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[83]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Long-term data as of 2025 underscore the need for indefinite therapy, with 2/3 of lost weight regained within a year of cessation due to counter-regulatory adaptations in hunger signaling.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4vabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[87]</sup> In bariatric contexts, these drugs bridge to surgery, aid post-operative maintenance, or serve non-surgical candidates, but real-world adherence challenges and costs (often &gt;$1,000/month) constrain access.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8vabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[109]</sup> Emerging combinations, like GLP-1 agonists with amylin analogs, show promise for preserving lean mass during loss but await broader approval.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cvabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[114]</sup> Efficacy varies by genetics and baseline insulin resistance, with non-responders (&gt;5% loss threshold) comprising 20-30% in trials.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gvabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[87]</sup></span>
<h3 id="surgical-procedures" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Surgical Procedures<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Bariatric surgical procedures modify the digestive anatomy to induce weight loss via restrictive effects that limit gastric capacity, malabsorptive effects that bypass nutrient-absorbing intestinal segments, or both, often performed laparoscopically to minimize invasiveness. These interventions are indicated for patients with severe obesity (body mass index â‰¥35 kg/mÂ² with comorbidities or â‰¥40 kg/mÂ²), following multidisciplinary evaluation, and demonstrate sustained excess weight loss exceeding 60% in major procedures like sleeve gastrectomy and Roux-en-Y gastric bypass, surpassing non-surgical options.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_50abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[76]</sup> Perioperative mortality ranges from 0.03% to 0.2%, with complications influenced by patient factors such as BMI exceeding 60 kg/mÂ².<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_90abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[76]</sup> The American Society for Metabolic and Bariatric Surgery endorses procedures based on long-term data from randomized trials and cohorts, prioritizing those with durable outcomes over less effective alternatives.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d0abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[115]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7"><strong>Laparoscopic Sleeve Gastrectomy (LSG)</strong> involves resection of approximately 80% of the stomach along the greater curvature, forming a tubular remnant that restricts volume to about 100-150 mL and reduces ghrelin-secreting fundus tissue, thereby curbing appetite and caloric intake without intestinal bypass.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_70qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[11]</sup> This purely restrictive mechanism yields 60-70% excess weight loss (%EWL) at 1-2 years, with sustained rates of 50-60% at 10 years, alongside high type 2 diabetes remission (up to 70%).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_b0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[76]</sup> It is irreversible and carries risks of staple-line leak (0.5-2%), bleeding, nutrient deficiencies, and gastroesophageal reflux exacerbation, though it avoids malabsorption-related deficiencies.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_f0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[116]</sup> LSG predominates in the U.S., comprising over 50% of procedures due to its relative simplicity and lower operative time compared to bypass variants.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_j0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[76]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7"><strong>Roux-en-Y Gastric Bypass (RYGB)</strong> constructs a 15-30 mL proximal stomach pouch anastomosed to a Roux limb of jejunum, bypassing the distal stomach and proximal small intestine to combine restriction with malabsorption of calories and nutrients, while altering gut hormone profiles to enhance satiety and insulin sensitivity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_71abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[11]</sup> Established for over 50 years, it achieves 60-70% EWL short-term and 50% long-term, with superior diabetes remission (70-90%) versus restrictive-only methods, as evidenced by trials like STAMPEDE.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_b1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[76]</sup> Complications include marginal ulcers, dumping syndrome, and lifelong deficiencies in iron, vitamin B12, and calcium, necessitating supplementation; reoperation rates for failure or issues reach 10-20%.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_f1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[11]</sup> RYGB remains a benchmark for patients with reflux or sweet-eating behaviors, though it demands more technical expertise than LSG.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_j1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[76]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7"><strong>Adjustable Gastric Banding (AGB)</strong> deploys an inflatable silicone band around the proximal stomach to create a small pouch, adjustable via subcutaneous port to titrate restriction without resection or bypass, preserving anatomy for potential reversal.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_71qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[11]</sup> It induces modest 40-50% EWL initially, but long-term data show only 16-20% total body weight loss at 10 years, with inferior diabetes resolution and high failure prompting band removal or revision in 30-50% of cases due to slippage, erosion, or inadequate efficacy.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_b1qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[117]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_f1qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[118]</sup> Current utilization has declined sharply, representing under 1% of procedures, as superior alternatives like LSG offer better durability with comparable or lower morbidity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_j1qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[119]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7"><strong>Biliopancreatic Diversion with Duodenal Switch (BPD/DS)</strong> entails a distal gastrectomy akin to LSG combined with a duodenal sleeve and ileal switch, bypassing 75% of the small intestine to maximize malabsorption while retaining some pyloric function to mitigate dumping.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_72abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[11]</sup> Reserved for super-obese patients (BMI &gt;50 kg/mÂ²), it delivers the highest %EWL (70-80%) and comorbidity resolution, including 90% diabetes remission, per comparative studies against RYGB.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_b2abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[76]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_f2abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[120]</sup> Risks are elevated, including 10-15% major complications, severe malabsorption leading to protein-calorie deficits, and frequent deficiencies requiring intensive monitoring and supplementation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_j2abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[11]</sup> Its complexity limits adoption to specialized centers.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_n2abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[76]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Emerging variants like single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) simplify BPD/DS via one intestinal anastomosis, achieving comparable superior weight loss (60-75% EWL) and metabolic benefits with reduced operative risk, though long-term data remain limited to 5-10 years.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_52qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[11]</sup> Procedure selection hinges on patient anatomy, comorbidities, and surgeon expertise, with randomized evidence favoring malabsorptive options for maximal efficacy in refractory cases despite heightened nutritional oversight needs.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_92qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[76]</sup></span>
<h3 id="integrated-and-emerging-approaches" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Integrated and Emerging Approaches<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Integrated approaches in bariatrics emphasize multidisciplinary teams comprising surgeons, endocrinologists, dietitians, psychologists, and exercise specialists to address the multifaceted etiology of obesity, optimizing patient preparation, procedure selection, and long-term adherence.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_53qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[121]</sup> These models, such as hub-and-spokes frameworks, facilitate comprehensive preoperative evaluation for high-risk patients and postoperative support to mitigate regain, with studies demonstrating improved weight loss success rates and cardiometabolic outcomes compared to siloed interventions.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_93qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[122]</sup> For instance, multidisciplinary programs have achieved clinically meaningful weight reductions of 5-10% or more at 6-12 months, alongside reductions in blood glucose and lipid levels, particularly in severe obesity cases.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d3qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[123]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_f3qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[124]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Combination therapies integrate pharmacological agents with behavioral modifications or surgical procedures to enhance efficacy and durability. Anti-obesity medications (AOMs) like GLP-1 receptor agonists combined with structured lifestyle programs in employer-based settings yield superior mean weight lossâ€”up to 15-20%â€”over lifestyle alone, with sustained benefits at one year.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_54abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[125]</sup> Preoperative use of AOMs, such as semaglutide, has surged, aiding risk reduction for bariatric candidates by promoting 10-15% weight loss prior to surgery, thereby expanding eligibility.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_94abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[126]</sup> Postoperatively, adjunctive GLP-1 therapy in one in seven patients counters weight regain, though real-world data indicate variable adherence due to cost and side effects.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d4abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[127]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Emerging pharmacotherapies focus on multi-agonist mechanisms targeting incretin hormones, with dual GLP-1/GIP agonists like tirzepatide achieving 20-25% weight loss in trials, surpassing single-agent predecessors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_54qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[128]</sup> Triple agonists (e.g., retatrutide) and amylin-semaglutide combinations (e.g., CagriSema) in phase 3 trials as of 2025 promise further gains of 25% or more while preserving lean mass, addressing a key limitation of caloric restriction.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_94qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[129]</sup> These agents are increasingly combined with endoscopic bariatric therapies (EBTs), such as endoscopic sleeve gastroplasty (ESG) or intragastric balloons, which offer 15-20% weight loss with lower invasiveness than traditional surgery; preliminary data support their synergy for maintenance.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d4qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[130]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_f4qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[131]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Multimodal neoadjuvant AOM regimens prior to surgery enhance preoperative optimization, with evidence from 2025 studies showing greater weight loss than non-pharmacologic supervision alone, potentially reducing operative risks.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_55abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[132]</sup> However, while these integrations expand options, bariatric surgery retains advantages in sustained remission of comorbidities, with real-world analyses confirming 20-30% greater long-term weight loss versus pharmacotherapy alone.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_95abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[133]</sup> Ongoing trials emphasize personalized sequencing to balance efficacy against gastrointestinal adverse events and accessibility barriers.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d5abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[134]</sup></span>
<h2 id="efficacy-and-long-term-outcomes" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Efficacy and Long-Term Outcomes<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="weight-loss-metrics-and-remission-rates" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Weight Loss Metrics and Remission Rates<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Surgical interventions in bariatrics, such as Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG), typically achieve substantial weight loss, with mean total weight loss (%TWL) ranging from 20-33% at 2-5 years post-procedure and excess weight loss (%EWL) peaking at 50-75% before partial regain over longer terms.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_56qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[135]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_76qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[136]</sup> At 10 years, median %EWL stabilizes around 59% and %TWL at 23%, though reoperation rates influence durability.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_b6qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[137]</sup> Long-term data over 20 years indicate sustained %TWL of approximately 22% across procedures, outperforming non-surgical options in magnitude but requiring monitoring for weight regain.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_f6qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[138]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Type 2 diabetes (T2DM) remission rates following bariatric surgery are notably high initially, with complete or partial remission in 50-80% of cases at 1-2 years, driven by RYGB more than SG due to greater metabolic effects.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_57abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[139]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_77abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[140]</sup> However, long-term remission wanes, with complete T2DM remission at 31% and partial at 15% by 10 years, alongside 20-30% recurrence after initial response, underscoring the need for ongoing glycemic management.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_b7abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[141]</sup> Meta-analyses confirm surgery yields 5-8 times higher odds of T2DM remission versus conventional care, though definitions (e.g., HbA1c &lt;6.5% off medications) vary across studies.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_f7abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[142]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_h7abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[143]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Pharmacological treatments, particularly GLP-1 receptor agonists like semaglutide (2.4 mg weekly), induce 15-17% TWL at 1-2 years when combined with lifestyle intervention, with sustained effects over 4 years in non-diabetic obese adults, though discontinuation leads to substantial regain (two-thirds of lost weight within a year).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_57qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[43]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_77qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[44]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_97qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[144]</sup> T2DM remission occurs in 20-40% of cases with these agents, lower than surgical rates but with cardiometabolic benefits persisting during treatment.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[145]</sup> Other pharmacotherapies, such as liraglutide, yield 5-10% TWL at 1 year, with recent reviews emphasizing dose-dependent efficacy but highlighting adherence challenges for long-term maintenance.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_h7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[146]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_j7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[83]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Lifestyle interventions alone, including diet, exercise, and behavioral modifications, produce modest 3-8% TWL in short-term trials (6-12 months), with meta-analyses showing average BMI reductions of 0.5-1 unit but high heterogeneity and limited sustainability beyond 1 year without intensification.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_58abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[147]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_78abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[148]</sup> Comorbidity remission, such as T2DM, remains rare (&lt;10%) with these approaches, as evidenced by control arms in RCTs where even minimal interventions yield partial benefits but fail to match invasive methods.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_b8abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[149]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d8abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[150]</sup></span>





























<div class="border-border-l1 overflow-x-auto rounded-lg border my-6 w-full"><table node="[object Object]" class="w-full border-collapse text-sm"><thead node="[object Object]" class="border-border-l1 border-b bg-surface-l1"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Modality</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Typical %TWL (1-2 years)</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Long-term %TWL (5+ years)</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">T2DM Remission Rate (Short-term)</span></th></tr></thead><tbody node="[object Object]" class="divide-border-l1 divide-y"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Bariatric Surgery (e.g., RYGB/SG)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">25-35%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">20-25%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">50-80%</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">GLP-1 Agonists (e.g., Semaglutide)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">15-17%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">10-15% (with continuation)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">20-40%</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Lifestyle Interventions</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">3-8%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">&lt;5%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">&lt;10%</span></td></tr></tbody></table></div>
<h3 id="effects-on-comorbidities-and-mortality" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Effects on Comorbidities and Mortality<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Bariatric surgical interventions, such as Roux-en-Y gastric bypass and sleeve gastrectomy, yield marked improvements in type 2 diabetes mellitus, with meta-analyses reporting remission rates of 53% at 1 year post-surgery compared to 5% with medical management alone.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_59qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[151]</sup> Long-term data indicate sustained remission in 30-50% of patients at 5-10 years, particularly with gastric bypass outperforming sleeve gastrectomy in maintaining glycemic control and reducing reliance on antidiabetic medications.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_99qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[152]</sup> These outcomes stem from substantial weight loss (typically 20-30% of body weight) and metabolic reprogramming, including enhanced insulin sensitivity, though relapse occurs in up to 50% by 10 years due to weight regain or beta-cell dysfunction.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d9qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[141]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Hypertension resolves in 60-75% of patients following surgery, with systematic reviews showing superior blood pressure control compared to non-surgical therapies, alongside reductions in antihypertensive medication use by 50-70%.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5aabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[153]</sup> Cardiovascular risk factors improve broadly, including 40-56% lower incidence of heart failure and coronary heart disease, driven by decreases in dyslipidemia, inflammation, and left ventricular hypertrophy.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9aabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[154]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_baabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[155]</sup> Obstructive sleep apnea remits in 70-85% of cases, and non-alcoholic fatty liver disease progresses to less severe stages in most patients, with fibrosis regression in 30-50%.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_faabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[156]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">All-cause mortality decreases by 29-40% in long-term cohorts post-surgery versus intensive medical therapy, with hazard ratios of 0.71 for overall death and similar reductions in cardiovascular mortality.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5aqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[157]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_7aqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[158]</sup> The Swedish Obese Subjects study, tracking over 4,000 participants for up to 20 years, found life expectancy gains of 2.9 years for men and 5.1 years for women after gastric bypass, attributable to fewer fatal myocardial infarctions and cancers.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_baqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[157]</sup> These benefits persist across diabetes subgroups, though absolute gains are smaller in older patients or those with advanced comorbidities.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_faqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[159]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Pharmacological bariatric treatments, including GLP-1 receptor agonists like semaglutide, mitigate comorbidities through 15-25% weight loss, reducing cardiovascular events by 20-26% in trials of obese patients with established disease, but diabetes remission rates remain below 10-20% long-term due to incomplete glycemic normalization and higher relapse with discontinuation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5babav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[110]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_7babav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[160]</sup> Mortality data for GLP-1 agonists show neutral to modest reductions in all-cause death, primarily cardiovascular, but lack the durability of surgical outcomes in obesity cohorts without prior events.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_bbabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[161]</sup> Overall, while both modalities lower comorbidity burdens, surgery demonstrates greater causal impact on remission and survival via profound, sustained physiological changes.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_fbabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[23]</sup></span>
<h3 id="factors-influencing-durability-of-results" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Factors Influencing Durability of Results<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Patient adherence to postoperative lifestyle modifications, including sustained dietary changes and regular physical activity, is a primary determinant of long-term weight maintenance after bariatric surgery, with nonadherence linked to higher rates of weight regain in up to 49% of cases across procedures.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5cabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[162]</sup> Maladaptive eating behaviors such as grazing, loss-of-control eating, and binge eating, which emerge or persist post-surgery, significantly contribute to regain, as evidenced by systematic reviews identifying these patterns in patients experiencing suboptimal outcomes.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9cabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[162]</sup> Preoperative achievement of at least 20 kg weight loss during structured programs correlates strongly with durable results, likely due to established behavioral habits that carry forward.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dcabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[163]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Older age at surgery predicts greater weight regain or insufficient loss, with studies showing associations in cohorts followed for over 10 years, potentially due to reduced metabolic adaptability and comorbidities.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5cqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[164]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9cqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[165]</sup> Preoperative conditions like type 2 diabetes, hypertension, depression, or anxiety independently increase risk of unsuccessful outcomes, as meta-analyses indicate these factors impair metabolic and psychological resilience to surgical alterations.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dcqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[165]</sup> Ethnic variations and higher initial BMI also influence durability, with some evidence of differential regain rates across groups, though modifiable behaviors often mediate these effects more than fixed traits.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hcqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[166]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Procedure-specific factors affect longevity; for instance, Roux-en-Y gastric bypass exhibits higher weight regain prevalence (up to 64%) compared to other methods in meta-analyses, attributable to potential anatomical dilation or adaptation over time.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5dabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[167]</sup> Physiological mechanisms, including hormonal shifts like diminished fasting GLP-1 levels post-initial response, contribute to regain by reducing satiety signals, as observed in longitudinal studies following sleeve gastrectomy and bypass.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9dabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[168]</sup> Integrated follow-up emphasizing nutritional support and behavioral interventions can mitigate these, with evidence from prospective data showing preserved lean mass and reduced regain when energy needs for healing are met alongside activity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ddabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[169]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">For pharmacological and non-invasive modalities, durability hinges similarly on adherence, but with shorter evidence horizons; lifestyle interventions post-pharmacotherapy sustain modest losses (around 5% below baseline) only with ongoing behavioral reinforcement, per systematic reviews, underscoring the need for combined approaches to counter metabolic rebound.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5dqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[170]</sup> Overall, while initial losses are robust (often 20-30% excess weight), regain exceeding 10-15% occurs in 20-40% within 5-10 years, emphasizing multidisciplinary monitoring to address behavioral, metabolic, and procedural predictors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9dqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[138]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ddqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[171]</sup></span>
<h2 id="risks-complications-and-criticisms" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Risks, Complications, and Criticisms<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="perioperative-and-surgical-complications" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Perioperative and Surgical Complications<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Perioperative mortality following bariatric procedures such as Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) is low, typically ranging from 0.04% to 0.06% within 90 days, with no significant differences observed between procedures in large cohorts.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5fabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[172]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9fabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[173]</sup> Morbidity rates, encompassing 30-day adverse events, are higher for RYGB at approximately 15% compared to 9% for SG, driven primarily by surgical-site issues and readmissions (3-4% across procedures).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dfabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[174]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hfabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[173]</sup> Risk escalates with higher body mass index (BMI â‰¥50 kg/mÂ²), diabetes, and comorbidities like cardiovascular disease, potentially doubling complication odds.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_lfabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[175]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_pfabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[90]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Intraoperative and immediate postoperative bleeding represents a frequent surgical complication, occurring in 2.7% of RYGB cases and 0.6-2.3% of SG procedures, often necessitating transfusion or reoperation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5fqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[90]</sup> Anastomotic leaks, a critical perioperative event with mortality up to 10% if undetected, affect 1.5-3% of SG patients (primarily at the staple line) and 0.3-2% of RYGB cases (at gastrojejunostomy or jejunojejunostomy).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9fqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[90]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dfqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[176]</sup> Detection relies on clinical signs (tachycardia, fever), imaging, or endoscopy, with management involving drainage, antibiotics, or revisional surgery; leaks contribute to 1-3% of overall anastomosis-related issues.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hfqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[174]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Other common surgical complications include intestinal obstruction (5% post-RYGB vs. 1% post-SG, often from internal hernias or adhesions) and strictures/ulcers (3% for RYGB), prompting reoperations in 1-2% of SG and 2% of RYGB within 30 days.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5gabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[174]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9gabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[90]</sup> Surgical site infections occur in about 3% of cases, while venous thromboembolism risk, though mitigated by prophylaxis, remains elevated in the early postoperative period.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dgabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[135]</sup> Revisional rates for these issues are low overall (1-4% perioperative), but higher BMI and technical factors like staple line reinforcement influence outcomes.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hgabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[174]</sup> Long-term sequelae, such as marginal ulcers (4.6% post-RYGB), may stem from perioperative events like ischemia but are addressed here only insofar as they arise surgically.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_lgabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[90]</sup></span>
<h3 id="adverse-effects-of-pharmacotherapies" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Adverse Effects of Pharmacotherapies<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Pharmacological treatments for obesity, particularly glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as semaglutide and tirzepatide, are associated with gastrointestinal adverse effects in a majority of users, including nausea (affecting up to 44% in trials), vomiting (up to 25%), diarrhea (up to 30%), and constipation (up to 24%), which are typically mild to moderate, dose-dependent, and occur early in treatment before often resolving.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5habav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[49]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9habav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[177]</sup> These effects stem from delayed gastric emptying and reduced appetite signaling, contributing to weight loss but leading to discontinuation rates of 5-10% in clinical studies.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dhabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[113]</sup> Tirzepatide, a GLP-1/GIP co-agonist, shows higher risks for nausea and diarrhea compared to semaglutide, with relative risks elevated by 1.5-2 times in network meta-analyses.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hhabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[178]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Serious adverse events with GLP-1 RAs, though rarer (incidence &lt;5%), include acute pancreatitis (reported in 0.1-1% of users, with over 6,700 cases linked to semaglutide from 2005-2023 in pharmacovigilance data), gallbladder disease such as cholelithiasis (odds ratio 1.3-2.0), and gastroesophageal reflux disease exacerbation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5hqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[179]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9hqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[180]</sup> Acute kidney injury has been observed, potentially due to dehydration from gastrointestinal losses, with FDA warnings highlighting risks alongside hypersensitivity reactions and hypoglycemia in diabetic patients.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dhqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[181]</sup> Delayed gastric emptying also raises concerns for pulmonary aspiration during anesthesia, prompting FDA updates in 2024 on perioperative risks.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hhqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[182]</sup> Long-term data remain limited, but rodent studies and post-marketing surveillance suggest potential thyroid C-cell tumors, though human risk appears low based on trials up to four years.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_lhqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[113]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_phqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[183]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">For combination therapies like phentermine-topiramate (Qsymia), central nervous system effects predominate, including paresthesia (20-21%), dizziness (up to 10%), insomnia (5-9%), and mood alterations such as anxiety or depression (3-5%), alongside dry mouth (17-20%) and constipation (15-16%).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5iabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[184]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9iabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[185]</sup> Cardiovascular risks include elevated heart rate (mean increase 1-3 bpm) and blood pressure, necessitating monitoring and contraindication in patients with glaucoma or hyperthyroidism.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_diabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[186]</sup> Orlistat, a lipase inhibitor, primarily causes malabsorptive gastrointestinal issues like oily spotting, fecal urgency, and steatorrhea (affecting 15-30%), which can lead to fat-soluble vitamin deficiencies if supplementation is inadequate.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hiabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[187]</sup> Historical agents like sibutramine were withdrawn in 2010 due to increased myocardial infarction and stroke risks (hazard ratio 1.16 in trials), underscoring the need for cardiovascular safety assessments in newer drugs.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_liabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[188]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Compounded or unapproved versions of GLP-1 drugs pose amplified risks, including dosing errors and contamination, with FDA reports from 2023-2025 documenting thousands of adverse events like severe gastrointestinal reactions and incorrect administrations.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5iqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[189]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9iqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[190]</sup> Overall, while short-term tolerability is favorable for approved agents, real-world data indicate higher event rates than in randomized trials, emphasizing individualized risk-benefit evaluation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_diqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[191]</sup></span>
<h3 id="debates-on-personal-responsibility-and-over-medicalization" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Debates on Personal Responsibility and Over-Medicalization<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Critics of expansive bariatric interventions argue that emphasizing medical treatments risks over-medicalizing obesity, portraying it primarily as a biological disease requiring pharmacological or surgical fixes rather than a condition often rooted in modifiable behaviors such as excessive caloric intake and physical inactivity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5jqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[192]</sup> This perspective holds that labeling obesity as a chronic illnessâ€”independent of lifestyle factorsâ€”may discourage individuals from adopting sustainable habits, fostering dependency on interventions like GLP-1 receptor agonists or bariatric surgery, which frequently yield weight regain upon discontinuation without concurrent behavioral changes.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9jqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[21]</sup> For instance, long-term studies indicate that while medical management achieves initial weight loss, sustained results in severe obesity cases are rare without integrated lifestyle adherence, with regain rates exceeding 50% within five years in many cohorts.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_djqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[21]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Proponents of personal responsibility counter that obesity stems largely from individual choices influenced by environment but ultimately controllable through diet and exercise, supported by evidence from intensive lifestyle programs demonstrating average weight losses of 8-10% sustained over two years via reduced-calorie diets (500-1000 kcal deficit daily) combined with at least 150 minutes of weekly moderate activity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5kabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[99]</sup> Twin studies and meta-analyses attribute 40-70% of BMI variance to heritability, yet environmental and behavioral factors explain the rapid global rise in obesity rates since the 1980s, from 5% to over 13% in adults, underscoring agency over genetics alone.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9kabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[193]</sup> Advocates, including policy analysts, propose that framing obesity as a failure of self-controlâ€”rather than absolving via medicalizationâ€”could enhance accountability, as seen in public health campaigns linking personal ownership to higher adherence rates in behavioral interventions.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dkabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[194]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_fkabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[195]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">This debate intensifies around equity and incentives: over-medicalization, critics contend, benefits pharmaceutical industriesâ€”projected to generate $100 billion annually from obesity drugs by 2030â€”while sidelining cost-effective, non-invasive lifestyle modifications that empower self-efficacy without lifelong side effects like gastrointestinal issues or nutrient deficiencies common in surgical patients (affecting up to 20-30%).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5kqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[196]</sup> Conversely, defenders of medical approaches note that for Class III obesity (BMI â‰¥40), where lifestyle alone yields only 5-10% loss in 70-80% of cases, interventions like Roux-en-Y gastric bypass achieve 25-30% durable reduction, averting comorbidities such as type 2 diabetes remission in 60-80% of patients.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9kqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[99]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_bkqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[197]</sup> Yet, even here, postoperative recidivism underscores the need for personal commitment, with studies showing that adherence to follow-up nutrition and exercise protocols correlates with 15-20% better long-term outcomes, blurring lines between medical aid and individual discipline.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_fkqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[198]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Skeptics of predominant medical narratives highlight institutional tendencies to underemphasize behavioral causality, potentially due to funding influences in research favoring drug trials over population-level prevention; for example, while NIH trials confirm lifestyle interventions rival pharmacotherapy in mild-to-moderate obesity (e.g., 5-7% loss vs. 10% for drugs, both with high regain), policy discourse often prioritizes access to treatments over systemic promotion of caloric restraint and activity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5labav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[199]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_7labav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[200]</sup> This tension reflects broader causal realism: obesity&#x27;s etiology involves volitional elements amenable to first-line self-management, yet medicalization persists as a societal expedient, raising questions about whether it liberates or absolves, particularly when 95% of dieters regain weight long-term absent ongoing vigilance.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_blabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[201]</sup></span>
<h2 id="societal-and-economic-dimensions" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Societal and Economic Dimensions<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="public-health-implications-of-obesity" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Public Health Implications of Obesity<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Obesity constitutes a major public health crisis, with global prevalence among adults reaching 16% in 2022, affecting over one billion individuals and marking a tripling since 1975.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5mqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[202]</sup> Projections indicate that by the mid-2030s, more than half of the world&#x27;s adult populationâ€”approximately 3.8 billion peopleâ€”will be overweight or obese, driven by sustained rises in age-standardized prevalence estimated at 30.7% over the next three decades.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9mqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[203]</sup> In the United States, adult obesity prevalence stood at 40.3% from 2021 to 2023, with severe obesity affecting over 22 million adults, disproportionately impacting certain demographics and exacerbating disparities in health outcomes.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dmqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[204]</sup> These trends reflect a caloric imbalance rooted in dietary excess and sedentary behavior, overwhelming preventive measures and straining global health infrastructures.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hmqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[202]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The condition drives a cascade of comorbidities through mechanisms such as chronic inflammation, insulin resistance, and mechanical stress on organs, elevating risks for type 2 diabetes, cardiovascular diseases, and at least 13 types of cancer including endometrial, esophageal, and colorectal.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5nabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[205]</sup> Approximately 55% of women&#x27;s and 24% of men&#x27;s cancer diagnoses in the U.S. are linked to excess weight, while globally, high body mass index (BMI) accounts for 5.6% of incident cancers when combined with diabetes.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9nabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[206]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dnabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[207]</sup> Hypertension and dyslipidemia predominate as immediate complications, with prevalence intensifying with age and BMI severity; obesity also independently heightens heart failure risk even after adjusting for confounders like diabetes and smoking.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hnabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[208]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_lnabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[209]</sup> Mortality attributable to high BMI reached an estimated 3.7 million deaths from noncommunicable diseases in 2021, primarily cardiovascular and diabetes-related, underscoring obesity&#x27;s role in shortening life expectancy by up to 10 years in severe cases.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_pnabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[202]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_tnabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[204]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Public health systems face escalating burdens from obesity&#x27;s direct medical expenditures and indirect productivity losses, with U.S. costs exceeding $1.4 trillion annually as of 2023, encompassing treatments for comorbidities and absenteeism valued at $3.38â€“6.38 billion yearly.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5nqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[210]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9nqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[211]</sup> Globally, these impacts are forecasted to surpass $4 trillion per year by 2035, representing 0.8â€“2.4% of GDP across studied nations and rising to over $18 trillion by 2060 under current trajectories.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dnqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[212]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hnqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[213]</sup> The epidemic compounds challenges in low- and middle-income countries through a &quot;double burden&quot; of malnutrition, where obesity coexists with undernutrition, diverting resources from infectious diseases to chronic care amid overburdened facilities.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_lnqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[214]</sup> This fiscal and operational strain necessitates reevaluation of interventions, as traditional public health strategies like education have yielded limited reversal of trends, highlighting the need for scalable treatments to mitigate systemic overload.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_pnqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[215]</sup></span>
<h3 id="cost-benefit-analyses-of-bariatric-interventions" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Cost-Benefit Analyses of Bariatric Interventions<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Bariatric surgeries such as Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy typically incur upfront costs ranging from $20,000 to $30,000 in the United States, encompassing procedure, hospitalization, and initial follow-up, though these vary by procedure type, facility, and insurance coverage.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5oqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[216]</sup> These initial expenditures are offset by reductions in long-term healthcare utilization for obesity-related conditions like type 2 diabetes and cardiovascular disease, with multiple analyses demonstrating net cost savings emerging after 2 to 4 years post-surgery.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9oqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[217]</sup> For instance, commercially insured patients undergoing bariatric surgery experienced lower follow-up costs from year 2 through year 9 compared to non-surgical controls, driven by decreased expenditures on medications and inpatient care for comorbidities.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_doqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[217]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Comparative economic evaluations highlight bariatric surgery&#x27;s advantages over pharmacotherapies like GLP-1 receptor agonists (e.g., semaglutide), which require indefinite dosing at annual costs exceeding $10,000 per patient.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5pabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[216]</sup> A 2025 cohort study using U.S. insurance claims data found mean 2-year total costs of $51,794 for bariatric surgery versus $63,483 for GLP-1 therapy, alongside superior weight loss (approximately 20-25% total body weight loss with surgery versus 10-15% with drugs in real-world settings).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9pabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[110]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_bpabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[218]</sup> Long-term projections indicate surgery achieves cost savings of up to â‚¬24,392 per patient relative to medical management alone, primarily through remission of diabetes (reducing insulin and other therapy needs) and averted cardiovascular events.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_fpabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[219]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Cost-effectiveness is frequently assessed via incremental cost-effectiveness ratios (ICERs) measured in quality-adjusted life years (QALYs) gained, with bariatric surgery often falling below common willingness-to-pay thresholds of $50,000-$100,000 per QALY in high-income settings.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5pqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[220]</sup> RYGB, for example, yields an ICER of $17,497 per QALY gained over a 10-year horizon compared to intensive medical therapy, improving further with extended modeling to lifetime horizons where it becomes cost-saving.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9pqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[220]</sup> Endoscopic alternatives like sleeve gastroplasty show similar promise, with lifetime cost savings projected for patients with obesity and type 2 diabetes due to comparable metabolic benefits at lower procedural risks.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dpqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[221]</sup> However, short-term analyses (e.g., up to 4 years) may reveal elevated post-operative costs from complications or monitoring, underscoring the need for sustained weight maintenance to realize benefits.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hpqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[222]</sup></span>























<div class="border-border-l1 overflow-x-auto rounded-lg border my-6 w-full"><table node="[object Object]" class="w-full border-collapse text-sm"><thead node="[object Object]" class="border-border-l1 border-b bg-surface-l1"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Intervention</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Approximate Upfront/Annual Cost (USD)</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">ICER per QALY Gained (vs. Medical Therapy)</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Key Source</span></th></tr></thead><tbody node="[object Object]" class="divide-border-l1 divide-y"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">RYGB/Sleeve Gastrectomy</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">$20,000-$30,000 (one-time)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">$17,497 (10-year horizon)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4dqabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[220]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">GLP-1 Agonists (e.g., Semaglutide)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">$10,000+ (ongoing)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">&gt;$50,000 (short-term; improves long-term if combined with surgery)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_clqabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[110]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_klqabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[223]</sup></td></tr></tbody></table></div>
<span class="mb-4 block break-words text-[1em] leading-7">Societal benefits extend beyond direct medical savings to include enhanced workforce productivity and reduced disability claims, with obesity treatment via surgery estimated to yield industry-level savings of $153-326 billion over 5 years through modest population-level weight reductions.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5qqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[224]</sup> Nonetheless, cost-benefit realizations hinge on patient selection (e.g., BMI â‰¥40 or â‰¥35 with comorbidities), adherence to post-operative lifestyle changes, and access barriers, as suboptimal long-term weight regain in 20-30% of cases can erode projected gains.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9qqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[225]</sup> Studies emphasizing these factors, often from surgical societies, warrant scrutiny for potential selection bias toward favorable surgical cohorts, though independent claims data corroborate the directional trends.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dqqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[110]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_fqqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[226]</sup></span></article><div id="references" class="min-w-0 scroll-mt-8 overflow-hidden"><div class="text-[16px]"><h2 id="references" node="[object Object]" class="mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden">References</h2></div><ol class="columns-1 gap-x-12 [counter-reset:item] md:columns-2"><li id="https://www.brighamandwomens.org/assets/bwh/patients-and-families/rehabilitation-services/pdfs/inpt-bariatic.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.brighamandwomens.org/assets/bwh/patients-and-families/rehabilitation-services/pdfs/inpt-bariatic.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.brighamandwomens.org/assets/bwh/patients-and-families/rehabilitation-services/pdfs/inpt-bariatic.pdf</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC6806981/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6806981/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC6806981/</a></span></div></li><li id="https://www.oregon.gov/oha/HPA/DSI-HERC/EvidenceBasedReports/Coverage%2520Guidance%2520-%2520Bariatric%2520Procedures_as-approved-5-18-23.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.oregon.gov/oha/HPA/DSI-HERC/EvidenceBasedReports/Coverage%2520Guidance%2520-%2520Bariatric%2520Procedures_as-approved-5-18-23.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.oregon.gov/oha/HPA/DSI-HERC/EvidenceBasedReports/Coverage%2520Guidance%2520-%2520Bariatric%2520Procedures_as-approved-5-18-23.pdf</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/25690271/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/25690271/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/25690271/</a></span></div></li><li id="https://stacks.cdc.gov/view/cdc/132370/cdc_132370_DS1.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://stacks.cdc.gov/view/cdc/132370/cdc_132370_DS1.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://stacks.cdc.gov/view/cdc/132370/cdc_132370_DS1.pdf</a></span></div></li><li id="https://www.etymonline.com/word/bariatric" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.etymonline.com/word/bariatric" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.etymonline.com/word/bariatric</a></span></div></li><li id="https://www.oed.com/dictionary/bariatrics_n" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.oed.com/dictionary/bariatrics_n" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.oed.com/dictionary/bariatrics_n</a></span></div></li><li id="https://www.merriam-webster.com/dictionary/bariatrics" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.merriam-webster.com/dictionary/bariatrics" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.merriam-webster.com/dictionary/bariatrics</a></span></div></li><li id="https://www.oed.com/dictionary/bariatric_adj" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.oed.com/dictionary/bariatric_adj" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.oed.com/dictionary/bariatric_adj</a></span></div></li><li id="https://bariatrics.stonybrookmedicine.edu/patient-resources/bariatric-faqs" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://bariatrics.stonybrookmedicine.edu/patient-resources/bariatric-faqs" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://bariatrics.stonybrookmedicine.edu/patient-resources/bariatric-faqs</a></span></div></li><li id="https://asmbs.org/patients/bariatric-surgery-procedures/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://asmbs.org/patients/bariatric-surgery-procedures/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://asmbs.org/patients/bariatric-surgery-procedures/</a></span></div></li><li id="https://link.springer.com/article/10.1007/s11695-023-06624-0" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://link.springer.com/article/10.1007/s11695-023-06624-0" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://link.springer.com/article/10.1007/s11695-023-06624-0</a></span></div></li><li id="https://www.niddk.nih.gov/health-information/weight-management/bariatric-surgery/definition-facts" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.niddk.nih.gov/health-information/weight-management/bariatric-surgery/definition-facts" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.niddk.nih.gov/health-information/weight-management/bariatric-surgery/definition-facts</a></span></div></li><li id="https://emedicine.medscape.com/article/197081-overview" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://emedicine.medscape.com/article/197081-overview" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://emedicine.medscape.com/article/197081-overview</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC3806364/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3806364/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC3806364/</a></span></div></li><li id="https://gi.org/journals-publications/ebgi/fu_paul_july2023/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://gi.org/journals-publications/ebgi/fu_paul_july2023/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://gi.org/journals-publications/ebgi/fu_paul_july2023/</a></span></div></li><li id="https://www.mayoclinic.org/tests-procedures/bariatric-surgery/about/pac-20394258" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.mayoclinic.org/tests-procedures/bariatric-surgery/about/pac-20394258" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.mayoclinic.org/tests-procedures/bariatric-surgery/about/pac-20394258</a></span></div></li><li id="https://asmbs.org/resources/type-2-diabetes-and-metabolic-surgery-fact-sheet/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://asmbs.org/resources/type-2-diabetes-and-metabolic-surgery-fact-sheet/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://asmbs.org/resources/type-2-diabetes-and-metabolic-surgery-fact-sheet/</a></span></div></li><li id="https://jamanetwork.com/journals/jama/fullarticle/2815401" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://jamanetwork.com/journals/jama/fullarticle/2815401" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://jamanetwork.com/journals/jama/fullarticle/2815401</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/circresaha.116.307591" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/circresaha.116.307591" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/circresaha.116.307591</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC12497434/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12497434/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC12497434/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC6543048/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6543048/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC6543048/</a></span></div></li><li id="https://www.nature.com/articles/s41598-024-57724-5" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/s41598-024-57724-5" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/s41598-024-57724-5</a></span></div></li><li id="https://ales.amegroups.org/article/view/6202/html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://ales.amegroups.org/article/view/6202/html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://ales.amegroups.org/article/view/6202/html</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/26811245/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/26811245/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/26811245/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC4832440/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4832440/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC4832440/</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/books/NBK581942/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/books/NBK581942/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/books/NBK581942/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC1317063/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1317063/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC1317063/</a></span></div></li><li id="https://www.researchgate.net/publication/314280554_A_brief_history_of_bariatric_surgery" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.researchgate.net/publication/314280554_A_brief_history_of_bariatric_surgery" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.researchgate.net/publication/314280554_A_brief_history_of_bariatric_surgery</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC2682245/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2682245/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC2682245/</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/19437570/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/19437570/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/19437570/</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/8732969/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/8732969/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/8732969/</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S0039610916383840" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S0039610916383840" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S0039610916383840</a></span></div></li><li id="https://ajronline.org/doi/10.2214/AJR.12.10131" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://ajronline.org/doi/10.2214/AJR.12.10131" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://ajronline.org/doi/10.2214/AJR.12.10131</a></span></div></li><li id="https://jamanetwork.com/journals/jamasurgery/fullarticle/588469" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://jamanetwork.com/journals/jamasurgery/fullarticle/588469" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://jamanetwork.com/journals/jamasurgery/fullarticle/588469</a></span></div></li><li id="https://medicine.yale.edu/media-player/glp-1-agonists-wonder-drugs-of-the-21st-century/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://medicine.yale.edu/media-player/glp-1-agonists-wonder-drugs-of-the-21st-century/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://medicine.yale.edu/media-player/glp-1-agonists-wonder-drugs-of-the-21st-century/</a></span></div></li><li id="https://www.pnas.org/doi/10.1073/pnas.2415550121" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.pnas.org/doi/10.1073/pnas.2415550121" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.pnas.org/doi/10.1073/pnas.2415550121</a></span></div></li><li id="https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-weight-management-drug-patients-aged-12-and-older" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-weight-management-drug-patients-aged-12-and-older" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-weight-management-drug-patients-aged-12-and-older</a></span></div></li><li id="https://www.nejm.org/doi/full/10.1056/NEJMoa1411892" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1411892" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nejm.org/doi/full/10.1056/NEJMoa1411892</a></span></div></li><li id="https://www.aafp.org/pubs/afp/issues/2016/0715/p161.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.aafp.org/pubs/afp/issues/2016/0715/p161.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.aafp.org/pubs/afp/issues/2016/0715/p161.html</a></span></div></li><li id="https://obesitymedicine.org/blog/weight-loss-medications/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://obesitymedicine.org/blog/weight-loss-medications/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://obesitymedicine.org/blog/weight-loss-medications/</a></span></div></li><li id="https://diabetesjournals.org/care/article/47/10/1834/157059/Real-World-Use-of-Semaglutide-for-Weight" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://diabetesjournals.org/care/article/47/10/1834/157059/Real-World-Use-of-Semaglutide-for-Weight" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://diabetesjournals.org/care/article/47/10/1834/157059/Real-World-Use-of-Semaglutide-for-Weight</a></span></div></li><li id="https://www.nejm.org/doi/full/10.1056/NEJMoa2032183" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2032183" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nejm.org/doi/full/10.1056/NEJMoa2032183</a></span></div></li><li id="https://www.nature.com/articles/s41591-024-02996-7" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/s41591-024-02996-7" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/s41591-024-02996-7</a></span></div></li><li id="https://www.appliedclinicaltrialsonline.com/view/wegovy-weight-loss-obesity-diabetes" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.appliedclinicaltrialsonline.com/view/wegovy-weight-loss-obesity-diabetes" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.appliedclinicaltrialsonline.com/view/wegovy-weight-loss-obesity-diabetes</a></span></div></li><li id="https://www.massgeneralbrigham.org/en/about/newsroom/press-releases/study-finds-bariatric-surgery-declined-with-rise-in-glp-1-drugs" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.massgeneralbrigham.org/en/about/newsroom/press-releases/study-finds-bariatric-surgery-declined-with-rise-in-glp-1-drugs" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.massgeneralbrigham.org/en/about/newsroom/press-releases/study-finds-bariatric-surgery-declined-with-rise-in-glp-1-drugs</a></span></div></li><li id="https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management</a></span></div></li><li id="https://www.nejm.org/doi/full/10.1056/NEJMoa2206038" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2206038" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nejm.org/doi/full/10.1056/NEJMoa2206038</a></span></div></li><li id="https://www.nejm.org/doi/full/10.1056/NEJMoa2416394" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2416394" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nejm.org/doi/full/10.1056/NEJMoa2416394</a></span></div></li><li id="https://www.prnewswire.com/news-releases/zepbound-tirzepatide-showed-superior-weight-loss-over-wegovy-semaglutide-in-complete-surmount-5-results-published-in-the-new-england-journal-of-medicine-302451241.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.prnewswire.com/news-releases/zepbound-tirzepatide-showed-superior-weight-loss-over-wegovy-semaglutide-in-complete-surmount-5-results-published-in-the-new-england-journal-of-medicine-302451241.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.prnewswire.com/news-releases/zepbound-tirzepatide-showed-superior-weight-loss-over-wegovy-semaglutide-in-complete-surmount-5-results-published-in-the-new-england-journal-of-medicine-302451241.html</a></span></div></li><li id="https://academic.oup.com/edrv/advance-article/doi/10.1210/endrev/bnaf036/8276515?searchresult=1" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://academic.oup.com/edrv/advance-article/doi/10.1210/endrev/bnaf036/8276515?searchresult=1" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://academic.oup.com/edrv/advance-article/doi/10.1210/endrev/bnaf036/8276515?searchresult=1</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S0163725825000361" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S0163725825000361" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S0163725825000361</a></span></div></li><li id="https://academic.oup.com/edrv/article/38/4/267/3892397" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://academic.oup.com/edrv/article/38/4/267/3892397" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://academic.oup.com/edrv/article/38/4/267/3892397</a></span></div></li><li id="https://www.nejm.org/doi/full/10.1056/NEJMra1514009" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nejm.org/doi/full/10.1056/NEJMra1514009" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nejm.org/doi/full/10.1056/NEJMra1514009</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/books/NBK555906/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/books/NBK555906/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/books/NBK555906/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC10843116/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10843116/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC10843116/</a></span></div></li><li id="https://www.nature.com/articles/s41576-021-00414-z" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/s41576-021-00414-z" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/s41576-021-00414-z</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC9569701/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9569701/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC9569701/</a></span></div></li><li id="https://www.sciencedirect.com/science/article/abs/pii/S1871403X16000090" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/abs/pii/S1871403X16000090" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/abs/pii/S1871403X16000090</a></span></div></li><li id="https://www.nature.com/articles/s41591-025-03827-z" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/s41591-025-03827-z" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/s41591-025-03827-z</a></span></div></li><li id="https://onlinelibrary.wiley.com/doi/10.1111/obr.13978" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://onlinelibrary.wiley.com/doi/10.1111/obr.13978" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://onlinelibrary.wiley.com/doi/10.1111/obr.13978</a></span></div></li><li id="https://www.jci.org/articles/view/174595" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.jci.org/articles/view/174595" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.jci.org/articles/view/174595</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC7815269/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7815269/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC7815269/</a></span></div></li><li id="https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2021.585887/full" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2021.585887/full" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2021.585887/full</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/20432812/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/20432812/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/20432812/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC3431098/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3431098/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC3431098/</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/10593524/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/10593524/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/10593524/</a></span></div></li><li id="https://www.science.org/content/article/new-study-blames-diet-not-physical-inactivity-obesity-crisis" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.science.org/content/article/new-study-blames-diet-not-physical-inactivity-obesity-crisis" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.science.org/content/article/new-study-blames-diet-not-physical-inactivity-obesity-crisis</a></span></div></li><li id="https://www.thelancet.com/journals/landia/article/PIIS2213-8587%2822%2900047-X/fulltext" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.thelancet.com/journals/landia/article/PIIS2213-8587%2822%2900047-X/fulltext" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.thelancet.com/journals/landia/article/PIIS2213-8587%2822%2900047-X/fulltext</a></span></div></li><li id="https://www.researchgate.net/publication/332286809_Behavioral_contextual_and_biological_factors_associated_with_obesity_during_adolescence_A_systematic_review" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.researchgate.net/publication/332286809_Behavioral_contextual_and_biological_factors_associated_with_obesity_during_adolescence_A_systematic_review" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.researchgate.net/publication/332286809_Behavioral_contextual_and_biological_factors_associated_with_obesity_during_adolescence_A_systematic_review</a></span></div></li><li id="https://nutrition.bmj.com/content/early/2024/04/21/bmjnph-2023-000663" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://nutrition.bmj.com/content/early/2024/04/21/bmjnph-2023-000663" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://nutrition.bmj.com/content/early/2024/04/21/bmjnph-2023-000663</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S258993682400063X" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S258993682400063X" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S258993682400063X</a></span></div></li><li id="https://ij-healthgeographics.biomedcentral.com/articles/10.1186/s12942-021-00260-6" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://ij-healthgeographics.biomedcentral.com/articles/10.1186/s12942-021-00260-6" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://ij-healthgeographics.biomedcentral.com/articles/10.1186/s12942-021-00260-6</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/books/NBK278977/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/books/NBK278977/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/books/NBK278977/</a></span></div></li><li id="https://asmbs.org/patients/is-metabolic-and-bariatric-surgery-right-for-you/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://asmbs.org/patients/is-metabolic-and-bariatric-surgery-right-for-you/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://asmbs.org/patients/is-metabolic-and-bariatric-surgery-right-for-you/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC9834364/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9834364/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC9834364/</a></span></div></li><li id="https://emedicine.medscape.com/article/197081-guidelines" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://emedicine.medscape.com/article/197081-guidelines" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://emedicine.medscape.com/article/197081-guidelines</a></span></div></li><li id="https://link.springer.com/article/10.1007/s11695-024-07370-7" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://link.springer.com/article/10.1007/s11695-024-07370-7" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://link.springer.com/article/10.1007/s11695-024-07370-7</a></span></div></li><li id="https://asmbs.org/resources/bariatric-surgery-guidelines-and-recommendations/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://asmbs.org/resources/bariatric-surgery-guidelines-and-recommendations/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://asmbs.org/resources/bariatric-surgery-guidelines-and-recommendations/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC6097871/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6097871/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC6097871/</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/books/NBK546667/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/books/NBK546667/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/books/NBK546667/</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/books/NBK562269/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/books/NBK562269/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/books/NBK562269/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC12456317/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12456317/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC12456317/</a></span></div></li><li id="https://diabetesjournals.org/care/article/48/Supplement_1/S167/157555/8-Obesity-and-Weight-Management-for-the-Prevention" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://diabetesjournals.org/care/article/48/Supplement_1/S167/157555/8-Obesity-and-Weight-Management-for-the-Prevention" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://diabetesjournals.org/care/article/48/Supplement_1/S167/157555/8-Obesity-and-Weight-Management-for-the-Prevention</a></span></div></li><li id="https://obesitycanada.ca/wp-content/uploads/2025/08/11-Canadian-Adult-Obesity-CPG-Pharmacotherapy-2025-update.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://obesitycanada.ca/wp-content/uploads/2025/08/11-Canadian-Adult-Obesity-CPG-Pharmacotherapy-2025-update.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://obesitycanada.ca/wp-content/uploads/2025/08/11-Canadian-Adult-Obesity-CPG-Pharmacotherapy-2025-update.pdf</a></span></div></li><li id="https://www.gastrojournal.org/article/S0016-5085%2822%2901026-5/fulltext" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.gastrojournal.org/article/S0016-5085%2822%2901026-5/fulltext" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.gastrojournal.org/article/S0016-5085%2822%2901026-5/fulltext</a></span></div></li><li id="https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1569468/full" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1569468/full" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1569468/full</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC12439710/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12439710/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC12439710/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC6112821/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6112821/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC6112821/</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/books/NBK615299/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/books/NBK615299/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/books/NBK615299/</a></span></div></li><li id="https://www.sciencedirect.com/science/article/abs/pii/S2173573524000656" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/abs/pii/S2173573524000656" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/abs/pii/S2173573524000656</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC3206416/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3206416/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC3206416/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC3569476/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3569476/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC3569476/</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/22535443/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/22535443/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/22535443/</a></span></div></li><li id="https://www.mdcalc.com/calc/10520/obesity-surgery-mortality-risk-score-os-mrs" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.mdcalc.com/calc/10520/obesity-surgery-mortality-risk-score-os-mrs" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.mdcalc.com/calc/10520/obesity-surgery-mortality-risk-score-os-mrs</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC4520850/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4520850/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC4520850/</a></span></div></li><li id="https://www.sciencedirect.com/science/article/abs/pii/S1550728912003292" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/abs/pii/S1550728912003292" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/abs/pii/S1550728912003292</a></span></div></li><li id="https://onlinelibrary.wiley.com/doi/full/10.1002/osp4.628" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://onlinelibrary.wiley.com/doi/full/10.1002/osp4.628" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://onlinelibrary.wiley.com/doi/full/10.1002/osp4.628</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC7027681/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7027681/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC7027681/</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S0002916523063748" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S0002916523063748" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S0002916523063748</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC5764193/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5764193/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC5764193/</a></span></div></li><li id="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/609705" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/609705" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/609705</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/31705259/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/31705259/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/31705259/</a></span></div></li><li id="https://www.nejm.org/doi/full/10.1056/NEJMoa1212914" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1212914" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nejm.org/doi/full/10.1056/NEJMoa1212914</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC4339027/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4339027/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC4339027/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC3233993/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3233993/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC3233993/</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/books/NBK570565/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/books/NBK570565/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/books/NBK570565/</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/CIRCOUTCOMES.122.009348" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/CIRCOUTCOMES.122.009348" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/CIRCOUTCOMES.122.009348</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/40789597/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/40789597/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/40789597/</a></span></div></li><li id="https://jamanetwork.com/journals/jamasurgery/fullarticle/2839126" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://jamanetwork.com/journals/jamasurgery/fullarticle/2839126" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://jamanetwork.com/journals/jamasurgery/fullarticle/2839126</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/39761578/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/39761578/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/39761578/</a></span></div></li><li id="https://www.nature.com/articles/s41591-025-03978-z" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/s41591-025-03978-z" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/s41591-025-03978-z</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S2667368124000299" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S2667368124000299" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S2667368124000299</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S0014299925006041" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S0014299925006041" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S0014299925006041</a></span></div></li><li id="https://asmbs.org/resources/endorsed-procedures-and-devices/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://asmbs.org/resources/endorsed-procedures-and-devices/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://asmbs.org/resources/endorsed-procedures-and-devices/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC7052082/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7052082/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC7052082/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC5127420/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5127420/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC5127420/</a></span></div></li><li id="https://www.templehealth.org/about/blog/truth-about-adjustable-gastric-banding-surgery" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.templehealth.org/about/blog/truth-about-adjustable-gastric-banding-surgery" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.templehealth.org/about/blog/truth-about-adjustable-gastric-banding-surgery</a></span></div></li><li id="https://asmbs.org/resources/estimate-of-bariatric-surgery-numbers" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://asmbs.org/resources/estimate-of-bariatric-surgery-numbers" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://asmbs.org/resources/estimate-of-bariatric-surgery-numbers</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/34731300/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/34731300/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/34731300/</a></span></div></li><li id="https://asmbs.org/integrated-health/about-the-asmbs-integrated-health-section/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://asmbs.org/integrated-health/about-the-asmbs-integrated-health-section/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://asmbs.org/integrated-health/about-the-asmbs-integrated-health-section/</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S1550728916308103" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S1550728916308103" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S1550728916308103</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC12194354/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12194354/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC12194354/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC8129361/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8129361/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC8129361/</a></span></div></li><li id="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2781926" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2781926" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2781926</a></span></div></li><li id="https://www.facs.org/media-center/press-releases/2025/use-of-weight-loss-drugs-before-bariatric-surgery-has-soared-in-recent-years-study-finds/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.facs.org/media-center/press-releases/2025/use-of-weight-loss-drugs-before-bariatric-surgery-has-soared-in-recent-years-study-finds/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.facs.org/media-center/press-releases/2025/use-of-weight-loss-drugs-before-bariatric-surgery-has-soared-in-recent-years-study-finds/</a></span></div></li><li id="https://publichealth.jhu.edu/2025/one-in-seven-bariatric-surgery-patients-turn-to-new-weight-loss-drugs" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://publichealth.jhu.edu/2025/one-in-seven-bariatric-surgery-patients-turn-to-new-weight-loss-drugs" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://publichealth.jhu.edu/2025/one-in-seven-bariatric-surgery-patients-turn-to-new-weight-loss-drugs</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC12299311/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12299311/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC12299311/</a></span></div></li><li id="https://www.goodrx.com/conditions/weight-loss/new-weight-loss-drugs" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.goodrx.com/conditions/weight-loss/new-weight-loss-drugs" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.goodrx.com/conditions/weight-loss/new-weight-loss-drugs</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/40649055/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/40649055/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/40649055/</a></span></div></li><li id="https://www.sciencedirect.com/science/article/abs/pii/S2590030720300994" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/abs/pii/S2590030720300994" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/abs/pii/S2590030720300994</a></span></div></li><li id="https://www.nature.com/articles/s41366-025-01798-2" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/s41366-025-01798-2" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/s41366-025-01798-2</a></span></div></li><li id="https://asmbs.org/resources/glp-1-medications-vs-bariatric-surgery-what-the-latest-research-shows/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://asmbs.org/resources/glp-1-medications-vs-bariatric-surgery-what-the-latest-research-shows/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://asmbs.org/resources/glp-1-medications-vs-bariatric-surgery-what-the-latest-research-shows/</a></span></div></li><li id="https://www.nature.com/articles/s41366-025-01897-0" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/s41366-025-01897-0" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/s41366-025-01897-0</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S2667008924000090" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S2667008924000090" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S2667008924000090</a></span></div></li><li id="https://www.americanjournalofsurgery.com/article/S0002-9610%2824%2900703-7/fulltext" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.americanjournalofsurgery.com/article/S0002-9610%2824%2900703-7/fulltext" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.americanjournalofsurgery.com/article/S0002-9610%2824%2900703-7/fulltext</a></span></div></li><li id="https://link.springer.com/article/10.1007/s00423-025-03713-9" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://link.springer.com/article/10.1007/s00423-025-03713-9" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://link.springer.com/article/10.1007/s00423-025-03713-9</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC6320354/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6320354/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC6320354/</a></span></div></li><li id="https://link.springer.com/article/10.1007/s11695-023-06856-0" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://link.springer.com/article/10.1007/s11695-023-06856-0" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://link.springer.com/article/10.1007/s11695-023-06856-0</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S1550728922007572" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S1550728922007572" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S1550728922007572</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC11717815/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11717815/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC11717815/</a></span></div></li><li id="https://dmsjournal.biomedcentral.com/articles/10.1186/s13098-023-01001-4" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://dmsjournal.biomedcentral.com/articles/10.1186/s13098-023-01001-4" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://dmsjournal.biomedcentral.com/articles/10.1186/s13098-023-01001-4</a></span></div></li><li id="https://diabetesjournals.org/care/article/39/12/2247/31365/Reconciliation-of-Type-2-Diabetes-Remission-Rates" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://diabetesjournals.org/care/article/39/12/2247/31365/Reconciliation-of-Type-2-Diabetes-Remission-Rates" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://diabetesjournals.org/care/article/39/12/2247/31365/Reconciliation-of-Type-2-Diabetes-Remission-Rates</a></span></div></li><li id="https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.14725" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.14725" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.14725</a></span></div></li><li id="https://www.nejm.org/doi/full/10.1056/NEJMoa2307563" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2307563" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nejm.org/doi/full/10.1056/NEJMoa2307563</a></span></div></li><li id="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2823644" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2823644" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2823644</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC5575752/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5575752/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC5575752/</a></span></div></li><li id="https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-022-02067-3" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-022-02067-3" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-022-02067-3</a></span></div></li><li id="https://bmjopen.bmj.com/content/9/8/e029966" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://bmjopen.bmj.com/content/9/8/e029966" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://bmjopen.bmj.com/content/9/8/e029966</a></span></div></li><li id="https://bmcendocrdisord.biomedcentral.com/articles/10.1186/s12902-023-01283-9" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://bmcendocrdisord.biomedcentral.com/articles/10.1186/s12902-023-01283-9" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://bmcendocrdisord.biomedcentral.com/articles/10.1186/s12902-023-01283-9</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/40988570/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/40988570/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/40988570/</a></span></div></li><li id="https://www.sciencedirect.com/science/article/abs/pii/S2213858724003966" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/abs/pii/S2213858724003966" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/abs/pii/S2213858724003966</a></span></div></li><li id="https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-025-04640-9" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-025-04640-9" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-025-04640-9</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/JAHA.124.038191" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/JAHA.124.038191" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/JAHA.124.038191</a></span></div></li><li id="https://asmbs.org/news_releases/weight-loss-surgery-reduces-risk-of-coronary-heart-disease-by-40-percent/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://asmbs.org/news_releases/weight-loss-surgery-reduces-risk-of-coronary-heart-disease-by-40-percent/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://asmbs.org/news_releases/weight-loss-surgery-reduces-risk-of-coronary-heart-disease-by-40-percent/</a></span></div></li><li id="https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2019.00094/full" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2019.00094/full" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2019.00094/full</a></span></div></li><li id="https://www.nejm.org/doi/full/10.1056/NEJMoa2002449" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2002449" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nejm.org/doi/full/10.1056/NEJMoa2002449</a></span></div></li><li id="https://academic.oup.com/eurheartj/article/43/20/1955/6542137" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://academic.oup.com/eurheartj/article/43/20/1955/6542137" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://academic.oup.com/eurheartj/article/43/20/1955/6542137</a></span></div></li><li id="https://www.nature.com/articles/s41366-023-01332-2" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/s41366-023-01332-2" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/s41366-023-01332-2</a></span></div></li><li id="https://www.jacc.org/doi/10.1016/j.jacc.2024.08.007" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.jacc.org/doi/10.1016/j.jacc.2024.08.007" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.jacc.org/doi/10.1016/j.jacc.2024.08.007</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC11366408/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11366408/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC11366408/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC9906605/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9906605/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC9906605/</a></span></div></li><li id="https://www.cureus.com/articles/284070-long-term-effectiveness-and-outcomes-of-bariatric-surgery-a-comprehensive-review-of-current-evidence-and-emerging-trends" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.cureus.com/articles/284070-long-term-effectiveness-and-outcomes-of-bariatric-surgery-a-comprehensive-review-of-current-evidence-and-emerging-trends" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.cureus.com/articles/284070-long-term-effectiveness-and-outcomes-of-bariatric-surgery-a-comprehensive-review-of-current-evidence-and-emerging-trends</a></span></div></li><li id="https://jamanetwork.com/journals/jamasurgery/fullarticle/600864" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://jamanetwork.com/journals/jamasurgery/fullarticle/600864" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://jamanetwork.com/journals/jamasurgery/fullarticle/600864</a></span></div></li><li id="https://bmcendocrdisord.biomedcentral.com/articles/10.1186/s12902-020-0499-4" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://bmcendocrdisord.biomedcentral.com/articles/10.1186/s12902-020-0499-4" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://bmcendocrdisord.biomedcentral.com/articles/10.1186/s12902-020-0499-4</a></span></div></li><li id="https://www.sciencedirect.com/science/article/abs/pii/S1878788622001758" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/abs/pii/S1878788622001758" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/abs/pii/S1878788622001758</a></span></div></li><li id="https://www.sciencedirect.com/science/article/abs/pii/S2451847623000520" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/abs/pii/S2451847623000520" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/abs/pii/S2451847623000520</a></span></div></li><li id="https://www.nature.com/articles/s41366-024-01461-2" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/s41366-024-01461-2" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/s41366-024-01461-2</a></span></div></li><li id="https://www.mdpi.com/2072-6643/16/24/4399" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.mdpi.com/2072-6643/16/24/4399" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.mdpi.com/2072-6643/16/24/4399</a></span></div></li><li id="https://www.sciencedirect.com/science/article/abs/pii/S2405457722002017" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/abs/pii/S2405457722002017" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/abs/pii/S2405457722002017</a></span></div></li><li id="https://www.wjgnet.com/2308-3840/full/v9/i5/438.htm" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.wjgnet.com/2308-3840/full/v9/i5/438.htm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.wjgnet.com/2308-3840/full/v9/i5/438.htm</a></span></div></li><li id="https://www.healio.com/news/endocrinology/20220822/mortality-risk-higher-with-sleeve-gastrectomy-vs-gastric-bypass-for-adults-with-diabetes" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.healio.com/news/endocrinology/20220822/mortality-risk-higher-with-sleeve-gastrectomy-vs-gastric-bypass-for-adults-with-diabetes" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.healio.com/news/endocrinology/20220822/mortality-risk-higher-with-sleeve-gastrectomy-vs-gastric-bypass-for-adults-with-diabetes</a></span></div></li><li id="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2814336" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2814336" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2814336</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC10771970/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10771970/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC10771970/</a></span></div></li><li id="https://asmbs.org/news_releases/the-higher-the-body-mass-index-the-higher-the-risk-for-complications-after-bariatric-surgery/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://asmbs.org/news_releases/the-higher-the-body-mass-index-the-higher-the-risk-for-complications-after-bariatric-surgery/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://asmbs.org/news_releases/the-higher-the-body-mass-index-the-higher-the-risk-for-complications-after-bariatric-surgery/</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/40526322/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/40526322/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/40526322/</a></span></div></li><li id="https://www.nature.com/articles/s41366-025-01859-6" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/s41366-025-01859-6" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/s41366-025-01859-6</a></span></div></li><li id="https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1613610/full" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1613610/full" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1613610/full</a></span></div></li><li id="https://nypost.com/2025/07/06/health/potentially-fatal-side-effect-of-weight-loss-drugs-sparks-new-investigation/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://nypost.com/2025/07/06/health/potentially-fatal-side-effect-of-weight-loss-drugs-sparks-new-investigation/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://nypost.com/2025/07/06/health/potentially-fatal-side-effect-of-weight-loss-drugs-sparks-new-investigation/</a></span></div></li><li id="https://www.gastrojournal.org/article/S0016-5085%2825%2900845-5/abstract" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.gastrojournal.org/article/S0016-5085%2825%2900845-5/abstract" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.gastrojournal.org/article/S0016-5085%2825%2900845-5/abstract</a></span></div></li><li id="https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eli-lilly-and-company-716485-09092025" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eli-lilly-and-company-716485-09092025" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eli-lilly-and-company-716485-09092025</a></span></div></li><li id="https://medshadow.org/fda-side-effects-update-glp1-drugs-pulmonary-aspiration/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://medshadow.org/fda-side-effects-update-glp1-drugs-pulmonary-aspiration/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://medshadow.org/fda-side-effects-update-glp1-drugs-pulmonary-aspiration/</a></span></div></li><li id="https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/novo-nordisk-inc-716495-09092025" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/novo-nordisk-inc-716495-09092025" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/novo-nordisk-inc-716495-09092025</a></span></div></li><li id="https://medlineplus.gov/druginfo/meds/a612037.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://medlineplus.gov/druginfo/meds/a612037.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://medlineplus.gov/druginfo/meds/a612037.html</a></span></div></li><li id="https://www.mayoclinic.org/drugs-supplements/phentermine-and-topiramate-oral-route/description/drg-20075700" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.mayoclinic.org/drugs-supplements/phentermine-and-topiramate-oral-route/description/drg-20075700" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.mayoclinic.org/drugs-supplements/phentermine-and-topiramate-oral-route/description/drg-20075700</a></span></div></li><li id="https://www.aafp.org/pubs/afp/issues/2014/1015/p576.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.aafp.org/pubs/afp/issues/2014/1015/p576.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.aafp.org/pubs/afp/issues/2014/1015/p576.html</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC7994651/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7994651/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC7994651/</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/26934640/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/26934640/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/26934640/</a></span></div></li><li id="https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC12469573/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12469573/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC12469573/</a></span></div></li><li id="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2821080" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2821080" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2821080</a></span></div></li><li id="https://journalofethics.ama-assn.org/article/medicalizing-obesity-individual-economic-and-medical-consequences/2011-12" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://journalofethics.ama-assn.org/article/medicalizing-obesity-individual-economic-and-medical-consequences/2011-12" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://journalofethics.ama-assn.org/article/medicalizing-obesity-individual-economic-and-medical-consequences/2011-12</a></span></div></li><li id="https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2020.00002/full" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2020.00002/full" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2020.00002/full</a></span></div></li><li id="https://academic.oup.com/book/56271/chapter/445196864" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://academic.oup.com/book/56271/chapter/445196864" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://academic.oup.com/book/56271/chapter/445196864</a></span></div></li><li id="https://www.hoover.org/research/obesity-and-responsibility" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.hoover.org/research/obesity-and-responsibility" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.hoover.org/research/obesity-and-responsibility</a></span></div></li><li id="https://journals.sagepub.com/doi/abs/10.1177/1363459316660858" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://journals.sagepub.com/doi/abs/10.1177/1363459316660858" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://journals.sagepub.com/doi/abs/10.1177/1363459316660858</a></span></div></li><li id="https://www.gastrojournal.org/article/S0016-5085%2817%2930139-7/fulltext" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.gastrojournal.org/article/S0016-5085%2817%2930139-7/fulltext" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.gastrojournal.org/article/S0016-5085%2817%2930139-7/fulltext</a></span></div></li><li id="https://www.nature.com/articles/s41366-024-01499-2" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/s41366-024-01499-2" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/s41366-024-01499-2</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/20194976/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/20194976/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/20194976/</a></span></div></li><li id="https://nyaspubs.onlinelibrary.wiley.com/doi/full/10.1111/nyas.15278" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://nyaspubs.onlinelibrary.wiley.com/doi/full/10.1111/nyas.15278" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://nyaspubs.onlinelibrary.wiley.com/doi/full/10.1111/nyas.15278</a></span></div></li><li id="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0117565" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0117565" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0117565</a></span></div></li><li id="https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight</a></span></div></li><li id="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2825%2900355-1/fulltext" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2825%2900355-1/fulltext" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2825%2900355-1/fulltext</a></span></div></li><li id="https://www.cdc.gov/nchs/products/databriefs/db508.htm" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.cdc.gov/nchs/products/databriefs/db508.htm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.cdc.gov/nchs/products/databriefs/db508.htm</a></span></div></li><li id="https://www.cancer.gov/about-cancer/causes-prevention/risk/obesity/obesity-fact-sheet" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.cancer.gov/about-cancer/causes-prevention/risk/obesity/obesity-fact-sheet" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.cancer.gov/about-cancer/causes-prevention/risk/obesity/obesity-fact-sheet</a></span></div></li><li id="https://stop.publichealth.gwu.edu/fast-facts/obesity-related-chronic-disease" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://stop.publichealth.gwu.edu/fast-facts/obesity-related-chronic-disease" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://stop.publichealth.gwu.edu/fast-facts/obesity-related-chronic-disease</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC5805864/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5805864/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC5805864/</a></span></div></li><li id="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-024-21061-z" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-024-21061-z" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-024-21061-z</a></span></div></li><li id="https://dom-pubs.onlinelibrary.wiley.com/doi/full/10.1111/dom.16263" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://dom-pubs.onlinelibrary.wiley.com/doi/full/10.1111/dom.16263" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://dom-pubs.onlinelibrary.wiley.com/doi/full/10.1111/dom.16263</a></span></div></li><li id="https://obesitymedicine.org/blog/health-economic-impact-of-obesity/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://obesitymedicine.org/blog/health-economic-impact-of-obesity/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://obesitymedicine.org/blog/health-economic-impact-of-obesity/</a></span></div></li><li id="https://www.cdc.gov/obesity/basics/consequences.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.cdc.gov/obesity/basics/consequences.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.cdc.gov/obesity/basics/consequences.html</a></span></div></li><li id="https://www.statnews.com/2023/03/02/obesity-costs-4-trillion-2035/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.statnews.com/2023/03/02/obesity-costs-4-trillion-2035/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.statnews.com/2023/03/02/obesity-costs-4-trillion-2035/</a></span></div></li><li id="https://data.worldobesity.org/publications/WOF-Economic-Impacts-2-V2.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://data.worldobesity.org/publications/WOF-Economic-Impacts-2-V2.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://data.worldobesity.org/publications/WOF-Economic-Impacts-2-V2.pdf</a></span></div></li><li id="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2823%2902750-2/fulltext" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2823%2902750-2/fulltext" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2823%2902750-2/fulltext</a></span></div></li><li id="https://www.healthdata.org/news-events/newsroom/news-releases/lancet-more-half-adults-and-third-children-and-adolescents" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.healthdata.org/news-events/newsroom/news-releases/lancet-more-half-adults-and-third-children-and-adolescents" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.healthdata.org/news-events/newsroom/news-releases/lancet-more-half-adults-and-third-children-and-adolescents</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/39285034/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/39285034/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/39285034/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC10766043/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10766043/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC10766043/</a></span></div></li><li id="https://www.tctmd.com/news/better-outcomes-and-lower-cost-bariatric-surgery-over-glp-1s" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.tctmd.com/news/better-outcomes-and-lower-cost-bariatric-surgery-over-glp-1s" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.tctmd.com/news/better-outcomes-and-lower-cost-bariatric-surgery-over-glp-1s</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S1550728921004950" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S1550728921004950" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S1550728921004950</a></span></div></li><li id="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2789003" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2789003" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2789003</a></span></div></li><li id="https://www.sciencedirect.com/science/article/abs/pii/S2590030724000357" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/abs/pii/S2590030724000357" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/abs/pii/S2590030724000357</a></span></div></li><li id="https://www.americanjournalofsurgery.com/article/S0002-9610%2825%2900488-X/abstract" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.americanjournalofsurgery.com/article/S0002-9610%2825%2900488-X/abstract" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.americanjournalofsurgery.com/article/S0002-9610%2825%2900488-X/abstract</a></span></div></li><li id="https://www.facs.org/media-center/press-releases/2024/bariatric-surgery-is-more-cost-effective-than-newer-weight-loss-drugs-alone/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.facs.org/media-center/press-releases/2024/bariatric-surgery-is-more-cost-effective-than-newer-weight-loss-drugs-alone/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.facs.org/media-center/press-releases/2024/bariatric-surgery-is-more-cost-effective-than-newer-weight-loss-drugs-alone/</a></span></div></li><li id="https://www.nature.com/articles/s41387-024-00352-9" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/s41387-024-00352-9" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/s41387-024-00352-9</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC11381104/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11381104/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC11381104/</a></span></div></li><li id="https://asmbs.org/news_releases/popular-weight-loss-drugs-prove-more-costly-than-metabolic-and-bariatric-surgery-within-one-year/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://asmbs.org/news_releases/popular-weight-loss-drugs-prove-more-costly-than-metabolic-and-bariatric-surgery-within-one-year/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://asmbs.org/news_releases/popular-weight-loss-drugs-prove-more-costly-than-metabolic-and-bariatric-surgery-within-one-year/</a></span></div></li></ol></div></div></div><div class="hidden min-[1400px]:block"></div></div></div><!--$--><!--/$--><div role="region" aria-label="Notifications (F8)" tabindex="-1" style="pointer-events:none"><ol tabindex="-1" class="pointer-events-none fixed top-0 z-[100] flex max-h-screen w-full flex-col-reverse p-4 max-sm:left-0 sm:bottom-0 sm:right-0 sm:top-auto sm:max-w-[420px] sm:flex-col pl-16 pr-2 pt-16 sm:px-4"></ol></div><script type="application/json" id="server-client-data-experimentation">{"status":"uninitialized"}</script><script src="/_next/static/chunks/webpack-e121ed42680f327e.js" nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh" id="_R_" async=""></script><script nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh">(self.__next_f=self.__next_f||[]).push([0])</script><script nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh">self.__next_f.push([1,"1:\"$Sreact.fragment\"\n3:I[91363,[],\"\"]\n4:I[23775,[],\"\"]\n5:I[57654,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"PageHeaderProvider\"]\n6:I[17618,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"HeaderContent\"]\n7:I[25529,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"6751\",\"static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js\"],\"default\"]\n9:I[6666,[],\"OutletBoundary\"]\nb:I[80415,[],\"AsyncMetadataOutlet\"]\nd:I[6666,[],\"ViewportBoundary\"]\nf:I[6666,[],\"MetadataBoundary\"]\n10:\"$Sreact.suspense\"\n12:I[95909,[\"4219\",\"static/chunks/app/global-error-4d07d20223cd4b4c.js\"],\"default\"]\n"])</script><script nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh">self.__next_f.push([1,"13:I[51498,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"ConstantsProvider\"]\n"])</script><script nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh">self.__next_f.push([1,"14:I[91073,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh">self.__next_f.push([1,"15:I[38642,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh">self.__next_f.push([1,"16:I[99648,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh">self.__next_f.push([1,"17:I[78825,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh">self.__next_f.push([1,"18:I[8550,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MixpanelProvider\"]\n"])</script><script nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh">self.__next_f.push([1,"19:I[12290,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MobileTocProvider\"]\n"])</script><script nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh">self.__next_f.push([1,"1a:I[53947,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"NuqsAdapter\"]\n"])</script><script nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh">self.__next_f.push([1,"1b:I[91873,[\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8039\",\"static/chunks/app/error-4a29e9399afba038.js\"],\"default\"]\n1c:I[5091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"4345\",\"static/chunks/app/not-found-dd95690acf732f18.js\"],\"default\"]\n"])</script><script nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh">self.__next_f.push([1,"1d:I[16091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh">self.__next_f.push([1,":HL[\"/_next/static/media/1f2316909698f815.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/3d4419af2cf8609b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/4dec29efcaeb336c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/74452ea3ef0f9101.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/904ef0a86fe32a00.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/d886a03bcda7ad8f.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/e1447589d6f59c4b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/f5a90156f8995c8c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/css/62c4caba71dfda84.css\",\"style\",{\"nonce\":\"NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh\"}]\n:HL[\"/_next/static/css/eb3d87f98fe1565f.css\",\"style\",{\"nonce\":\"NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh\"}]\n:HL[\"/_next/static/css/1b5e561215938d4d.css\",\"style\",{\"nonce\":\"NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh\"}]\n:HL[\"/_next/static/css/0227d069a630d414.css\",\"style\",{\"nonce\":\"NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh\"}]\n:HL[\"/_next/static/css/f87fff2ab93d05a7.css\",\"style\",{\"nonce\":\"NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh\"}]\n"])</script><script nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh">self.__next_f.push([1,"0:{\"P\":null,\"b\":\"BpM29AX4fmgcUxZ_6t0le\",\"p\":\"\",\"c\":[\"\",\"page\",\"Bariatrics\"],\"i\":false,\"f\":[[[\"\",{\"children\":[\"page\",{\"children\":[[\"slug\",\"Bariatrics\",\"d\"],{\"children\":[\"__PAGE__\",{}]}]}]},\"$undefined\",\"$undefined\",true],[\"\",[\"$\",\"$1\",\"c\",{\"children\":[[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/62c4caba71dfda84.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh\"}],[\"$\",\"link\",\"1\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/eb3d87f98fe1565f.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh\"}],[\"$\",\"link\",\"2\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/1b5e561215938d4d.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh\"}],[\"$\",\"link\",\"3\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/0227d069a630d414.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh\"}]],\"$L2\"]}],{\"children\":[\"page\",[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}],{\"children\":[[\"slug\",\"Bariatrics\",\"d\"],[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L5\",null,{\"children\":[[\"$\",\"$L6\",null,{\"maxWidth\":\"full\",\"mobileOptions\":{\"right\":{\"showFixedIssues\":true,\"showThemeSwitcher\":true,\"showSearch\":true,\"showTableOfContents\":true}}}],[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L7\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}]]}],{\"children\":[\"__PAGE__\",[\"$\",\"$1\",\"c\",{\"children\":[\"$L8\",[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/f87fff2ab93d05a7.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh\"}]],[\"$\",\"$L9\",null,{\"children\":[\"$La\",[\"$\",\"$Lb\",null,{\"promise\":\"$@c\"}]]}]]}],{},null,false]},null,false]},null,false]},null,false],[\"$\",\"$1\",\"h\",{\"children\":[null,[[\"$\",\"$Ld\",null,{\"children\":\"$Le\"}],[\"$\",\"meta\",null,{\"name\":\"next-size-adjust\",\"content\":\"\"}]],[\"$\",\"$Lf\",null,{\"children\":[\"$\",\"div\",null,{\"hidden\":true,\"children\":[\"$\",\"$10\",null,{\"fallback\":null,\"children\":\"$L11\"}]}]}]]}],false]],\"m\":\"$undefined\",\"G\":[\"$12\",[]],\"s\":false,\"S\":false}\n"])</script><script nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh">self.__next_f.push([1,"2:[\"$\",\"html\",null,{\"lang\":\"en\",\"className\":\"bg-surface-base antialiased\",\"suppressHydrationWarning\":true,\"children\":[[\"$\",\"head\",null,{\"children\":[[\"$\",\"title\",null,{\"children\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"type\":\"image/x-icon\",\"href\":\"/favicon.ico\",\"sizes\":\"48x48\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-dark.png\",\"media\":\"(prefers-color-scheme: light)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-light.png\",\"media\":\"(prefers-color-scheme: dark)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"apple-touch-icon\",\"href\":\"/icon-192x192.png\"}],[\"$\",\"link\",null,{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\"}],[\"$\",\"meta\",null,{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",null,{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"meta\",null,{\"property\":\"og:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"property\":\"og:url\",\"content\":\"https://grokipedia.com\"}],[\"$\",\"meta\",null,{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:locale\",\"content\":\"en_US\"}],[\"$\",\"meta\",null,{\"property\":\"og:type\",\"content\":\"website\"}],[\"$\",\"meta\",null,{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:alt\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}]]}],[\"$\",\"body\",null,{\"className\":\"flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b\",\"children\":[[\"$\",\"$L13\",null,{\"children\":[\"$\",\"$L14\",null,{\"children\":[\"$\",\"$L15\",null,{\"defaultTheme\":\"dark\",\"nonce\":\"NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh\",\"children\":[\"$\",\"$L16\",null,{\"children\":[\"$\",\"$L17\",null,{\"children\":[\"$\",\"$L18\",null,{\"children\":[\"$\",\"$L19\",null,{\"children\":[\"$\",\"$L1a\",null,{\"children\":[[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$1b\",\"errorStyles\":[],\"errorScripts\":[],\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L1c\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}],[\"$\",\"$L1d\",null,{}]]}]}]}]}]}]}]}]}],[\"$\",\"script\",null,{\"type\":\"application/json\",\"id\":\"server-client-data-experimentation\",\"children\":\"{\\\"status\\\":\\\"uninitialized\\\"}\"}]]}]]}]\n"])</script><script nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh">self.__next_f.push([1,"e:[[\"$\",\"meta\",\"0\",{\"charSet\":\"utf-8\"}],[\"$\",\"meta\",\"1\",{\"name\":\"viewport\",\"content\":\"width=device-width, initial-scale=1, interactive-widget=resizes-content\"}]]\na:null\n"])</script><script nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh">self.__next_f.push([1,"1e:I[42712,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"HydrationBoundary\"]\n"])</script><script nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh">self.__next_f.push([1,"21:I[6367,[],\"IconMark\"]\n1f:T161f0,"])</script><script nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh">self.__next_f.push([1,"# Bariatrics\n\nBariatrics is the branch of medicine dedicated to the prevention, diagnosis, treatment, and management of obesity and its associated comorbidities, encompassing both nonsurgical interventions and surgical procedures aimed at inducing sustained weight loss through alterations in gastrointestinal anatomy or function.[](https://www.brighamandwomens.org/assets/bwh/patients-and-families/rehabilitation-services/pdfs/inpt-bariatic.pdf)\n\nThe field addresses obesity primarily as a chronic condition driven by caloric surplus relative to expenditure, with treatments prioritizing empirical evidence of efficacy over unsubstantiated environmental or genetic determinism alone. Nonsurgical approaches include behavioral modifications, pharmacotherapy, and very-low-calorie diets, though these often yield modest, less durable results compared to surgery in severe cases (body mass index â‰¥40 kg/mÂ² or â‰¥35 kg/mÂ² with comorbidities).[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6806981/) Bariatric surgery, the cornerstone of advanced intervention, modifies digestive processes to restrict intake, reduce absorption, or both, with procedures like Roux-en-Y gastric bypass (first performed in 1967) and vertical sleeve gastrectomy achieving average excess weight loss of 50-70% at 5-10 years post-operation.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6806981/)[](https://www.oregon.gov/oha/HPA/DSI-HERC/EvidenceBasedReports/Coverage%2520Guidance%2520-%2520Bariatric%2520Procedures_as-approved-5-18-23.pdf)\n\nSignificant achievements include marked remission rates for type 2 diabetes (up to 70% in some cohorts) and reductions in cardiovascular risk factors, outperforming medical management in randomized trials.[](https://www.oregon.gov/oha/HPA/DSI-HERC/EvidenceBasedReports/Coverage%2520Guidance%2520-%2520Bariatric%2520Procedures_as-approved-5-18-23.pdf) Controversies persist regarding long-term durability, with weight regain in 20-30% of patients after 10 years necessitating revisions, alongside operative risks like anastomotic leaks (1-2%), venous thromboembolism, and lifelong micronutrient supplementation to mitigate deficiencies in iron, vitamin B12, and calcium.[](https://pubmed.ncbi.nlm.nih.gov/25690271/) Emerging data also highlight debated associations, such as potential shifts in colorectal cancer incidence post-surgery, underscoring the need for rigorous, extended surveillance beyond initial benefits.[](https://stacks.cdc.gov/view/cdc/132370/cdc_132370_DS1.pdf) Despite these challenges, bariatrics has evolved from experimental intestinal bypasses in the 1950s to standardized, laparoscopically refined techniques, reflecting causal emphasis on mechanical restriction and hormonal modulation over palliative measures.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6806981/)\n\n## Definition and Scope\n\n### Etymology and Terminology\n\nThe term *bariatrics* derives from the Ancient Greek *baros* (Î²Î¬ÏÎ¿Ï‚), meaning \"weight\" or \"pressure,\" combined with *-iatrics*, from *iatros* (á¼°Î±Ï„ÏÏŒÏ‚), denoting a physician or healer, thus signifying the branch of medicine focused on the treatment of weight disorders, especially obesity.[](https://www.etymonline.com/word/bariatric) The suffix *-iatric* reflects therapeutic practices, distinguishing bariatrics as a specialized medical discipline rather than mere descriptive physiology.[](https://www.oed.com/dictionary/bariatrics_n)\n\nThe word *bariatrics* first appeared in English in the early 1960s, with documented usage by 1963, and is attributed to physician Raymond E. Dietz, who coined it in 1961 to describe obesity management strategies.[](https://www.merriam-webster.com/dictionary/bariatrics)[](https://www.oed.com/dictionary/bariatrics_n) In modern contexts, *bariatric* adjectives apply to equipment, procedures, or facilities adapted for obese patients, such as bariatric beds or ambulances designed to accommodate higher body weights.[](https://www.oed.com/dictionary/bariatric_adj)\n\nKey terminology in bariatrics includes *morbid obesity*, clinically defined as a body mass index (BMI) of 40 kg/mÂ² or greater, or 35 kg/mÂ² or greater with obesity-related comorbidities like type 2 diabetes or hypertension, indicating severe health risks warranting intervention.[](https://bariatrics.stonybrookmedicine.edu/patient-resources/bariatric-faqs) *Bariatric surgery* refers to procedures like gastric bypass or sleeve gastrectomy that induce weight loss by altering gastrointestinal anatomy, often termed *metabolic surgery* to emphasize improvements in insulin resistance and other metabolic parameters beyond mere weight reduction.[](https://asmbs.org/patients/bariatric-surgery-procedures/) These terms underscore bariatrics' emphasis on interventional therapies for sustained outcomes in severe cases, distinct from conservative measures like diet or pharmacotherapy.[](https://link.springer.com/article/10.1007/s11695-023-06624-0)\n\n### Distinction from General Obesity Management\n\nBariatrics primarily addresses severe obesity through specialized interventions, including metabolic and bariatric surgery, that modify the gastrointestinal tract to induce weight loss and metabolic improvements, in contrast to general obesity management, which emphasizes non-invasive strategies like caloric restriction, increased physical activity, behavioral counseling, and pharmacotherapy for a broader spectrum of body mass index (BMI) levels.[](https://www.niddk.nih.gov/health-information/weight-management/bariatric-surgery/definition-facts)[](https://emedicine.medscape.com/article/197081-overview) While general management aims for modest, often temporary weight reductions of 5-10% via lifestyle changes, bariatric procedures such as Roux-en-Y gastric bypass or sleeve gastrectomy typically yield 20-30% total body weight loss sustained over years, particularly in patients unresponsive to conservative therapies.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3806364/)[](https://gi.org/journals-publications/ebgi/fu_paul_july2023/)\n\nThe distinction is evident in patient selection criteria: bariatric surgery is indicated for individuals with BMI â‰¥40 kg/mÂ² (or â‰¥35 kg/mÂ² with comorbidities like type 2 diabetes or hypertension) only after documented failure of intensive non-surgical efforts, whereas general management serves as the initial approach for overweight (BMI 25-29.9 kg/mÂ²) and class I-II obesity (BMI 30-39.9 kg/mÂ²) without mandating prior interventions for milder cases.[](https://www.mayoclinic.org/tests-procedures/bariatric-surgery/about/pac-20394258)[](https://asmbs.org/resources/type-2-diabetes-and-metabolic-surgery-fact-sheet/) This threshold reflects empirical evidence that non-surgical methods rarely achieve durable remission of obesity-related conditions in severe cases, with randomized trials showing bariatric surgery superior for long-term glycemic control (e.g., hemoglobin A1c reductions of 1.4% greater at 7 years) and cardiovascular risk reduction compared to medical/lifestyle therapy.[](https://jamanetwork.com/journals/jama/fullarticle/2815401)[](https://www.ahajournals.org/doi/10.1161/circresaha.116.307591)\n\nFurthermore, bariatrics incorporates multidisciplinary preoperative optimization and postoperative monitoring to mitigate surgical risks, diverging from the less intensive follow-up in general programs, which often rely on primary care or self-directed efforts.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC12497434/) Long-term data from cohort studies confirm bariatric approaches reduce obesity-associated mortality by up to 30-50% in eligible patients, outcomes not replicated in conservative cohorts despite equivalent initial BMI.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6543048/)[](https://www.nature.com/articles/s41598-024-57724-5) This separation underscores bariatrics' focus on causal disruption of overeating and malabsorption via anatomical changes, rather than solely addressing behavioral or environmental drivers central to general management.[](https://ales.amegroups.org/article/view/6202/html)\n\n## Historical Development\n\n### Pre-20th Century Approaches\n\nEarly recognition of obesity as a medical concern dates to ancient civilizations, where treatments emphasized humoral balance through dietary restraint, physical exertion, and purgative measures. Hippocrates (c. 460â€“377 BCE) identified health risks such as sudden death from overabundant flesh and prescribed reduced food intake, walking, running, and the use of emetics like hellebore or cathartics such as scammony juice to counteract excess.[](https://pubmed.ncbi.nlm.nih.gov/26811245/) Galen (c. 129â€“200 CE) extended these principles, advocating strenuous running, warm baths, light meals, and manual labor to diminish fat accumulation.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC4832440/) In parallel Eastern traditions, Sushruta (c. 500 BCE) linked obesity to overeating and diabetes-like conditions, recommending fasting, vigorous exercise, and depletory therapies, while Hindu practices included massage with pea flour or wolf flesh compresses.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC4832440/)[](https://www.ncbi.nlm.nih.gov/books/NBK581942/) Soranus of Ephesus (2nd century CE) further detailed Greco-Roman methods, employing laxatives, heat applications, massage, induced vomiting via hyssop mixtures, and vinegar as a drying agent to restore bodily equilibrium.[](https://www.ncbi.nlm.nih.gov/books/NBK581942/)\n\nMedieval Islamic medicine built upon these foundations, integrating lifestyle modifications with pharmacological aids. Avicenna (980â€“1037 CE) promoted bulky, low-nutrient foods to slow digestion, pre-meal baths, and exercise to manage corpulence.[](https://www.ncbi.nlm.nih.gov/books/NBK581942/) A notable case involved Hasdai ibn Shaprut treating King Sancho I of LeÃ³n (958 CE) with theriacaâ€”a compound of opium, ginger, and other substancesâ€”which facilitated sufficient weight loss for the king to resume his throne.[](https://www.ncbi.nlm.nih.gov/books/NBK581942/) In Europe, obesity was often framed morally as gluttony, with remedies like fasting persisting from religious practices, though medical texts retained Greco-Roman emphases on diet and activity.[](https://pubmed.ncbi.nlm.nih.gov/26811245/)\n\nBy the 17th to 19th centuries, European approaches incorporated emerging substances alongside traditional methods, reflecting a shift toward viewing excess weight as a treatable affliction amid changing social ideals. Physicians like Tobias Venner (1620s) suggested mineral springs for purging, while ThÃ©ophile Bonet (17th century) endorsed vinegar, rhubarb purgatives, aloes, and tobacco to reduce fat.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC4832440/)[](https://www.ncbi.nlm.nih.gov/books/NBK581942/) Thomas Short (1727) and Malcolm Flemyng (1760) stressed exercise, caloric restriction, and even soap applications to eliminate oils.[](https://www.ncbi.nlm.nih.gov/books/NBK581942/) A landmark non-pharmacological intervention came in 1863 with William Banting's \"Letter on Corpulence,\" detailing a low-carbohydrate regimen avoiding bread, beer, milk, sugar, and potatoes in favor of meats, greens, and dry wine; Banting, initially 202 pounds at 5 feet 5 inches, lost 35 pounds within a year under physician William Harvey's guidance, popularizing structured dieting.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC1317063/) These efforts laid groundwork for bariatrics by prioritizing empirical observation over humoral theory, though efficacy varied and risks from purgatives were unrecognized.[](https://www.ncbi.nlm.nih.gov/books/NBK581942/)\n\n### Emergence of Surgical Techniques (20th Century)\n\nThe first surgical interventions specifically aimed at weight reduction in morbidly obese patients emerged in the mid-20th century, initially focusing on malabsorptive techniques to bypass portions of the small intestine and induce nutrient malabsorption. In 1954, Kremen, Linner, and Nelson at the University of Minnesota performed the inaugural jejunoileal bypass (JIB) in animal models, adapting it for human use shortly thereafter to shorten the intestinal absorptive surface and promote caloric restriction through diarrhea and malabsorption.[](https://www.researchgate.net/publication/314280554_A_brief_history_of_bariatric_surgery) This procedure gained traction in the 1960s, with Payne and DeWind refining jejunoileostomy in 1969 by anastomosing the proximal jejunum to the distal ileum, leaving only about 35-45 cm of functional small bowel, which achieved substantial weight loss averaging 40-50% excess body weight but at the cost of severe complications including electrolyte imbalances, liver failure, and bacterial overgrowth.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2682245/) By the 1970s, JIB's high morbidityâ€”reported in up to 20-30% of cases with life-threatening issuesâ€”led to its decline and near abandonment by the early 1980s, prompting a paradigm shift toward safer, primarily restrictive gastric procedures.[](https://pubmed.ncbi.nlm.nih.gov/19437570/)\n\nA pivotal advancement occurred in 1967 when Edward E. Mason and Chikashi Ito introduced gastric bypass surgery, marking the transition to operations that limited stomach capacity while preserving intestinal absorption. Performed at the University of Iowa, this technique involved partitioning the stomach to create a small proximal pouch (approximately 15-30 ml) connected via a loop gastrojejunostomy, restricting food intake and inducing early satiety without extensive malabsorption; initial outcomes in over 100 patients demonstrated 30-50% excess weight loss with reduced complication rates compared to intestinal bypasses.[](https://pubmed.ncbi.nlm.nih.gov/8732969/) Mason's innovation stemmed from observations in ulcer surgeries where partial gastrectomies inadvertently led to weight loss, emphasizing gastric restriction as a more physiological and reversible approach; refinements, such as the Roux-en-Y configuration to prevent reflux, followed in subsequent decades.[](https://www.sciencedirect.com/science/article/pii/S0039610916383840)\n\nFurther refinements in restrictive surgery appeared in the 1980s with the development of gastroplasty variants. In 1980, Mason pioneered vertical banded gastroplasty (VBG), which stapled the stomach vertically to form a 15-30 ml pouch reinforced by a prosthetic band at the outlet to maintain a fixed 10-12 mm stoma, aiming for pure restriction without bypass; early series reported 40-60% excess weight loss in 200+ patients with lower operative risks than malabsorptive methods.[](https://ajronline.org/doi/10.2214/AJR.12.10131) These techniques, while effective for short-term weight control, revealed limitations like staple-line disruptions and pouch dilation over time, influencing later hybrid procedures; by the late 20th century, gastric bypass and gastroplasties had established bariatric surgery as a viable option for patients with BMI exceeding 40 kg/mÂ² unresponsive to conservative measures, with cumulative data from thousands of cases validating their role in comorbidity resolution such as diabetes and hypertension.[](https://jamanetwork.com/journals/jamasurgery/fullarticle/588469)\n\n### Pharmacological and Metabolic Advances (21st Century)\n\nThe 21st century has seen the emergence of glucagon-like peptide-1 (GLP-1) receptor agonists as a major pharmacological advance in obesity management within bariatrics, targeting incretin hormones to suppress appetite, slow gastric emptying, and enhance insulin secretion. These agents address obesity as a chronic metabolic disorder by mimicking physiological pathways disrupted in severe cases, offering non-surgical alternatives or adjuncts to bariatric procedures. Initial approvals focused on diabetes but expanded to weight management, with clinical trials demonstrating sustained reductions in body weight when combined with lifestyle interventions.[](https://medicine.yale.edu/media-player/glp-1-agonists-wonder-drugs-of-the-21st-century/) [](https://www.pnas.org/doi/10.1073/pnas.2415550121)\n\nLiraglutide, approved by the FDA as Saxenda for chronic weight management in adults on December 23, 2014, represents the first GLP-1 agonist specifically indicated for obesity. In the SCALE trial, a 56-week randomized controlled study, liraglutide 3.0 mg daily led to a mean weight loss of 8.0% versus 2.6% with placebo, with 63.2% of participants achieving at least 5% weight reduction compared to 27.1% in the placebo group. Efficacy persisted at two years in follow-up analyses, outperforming orlistat, though gastrointestinal side effects like nausea affected up to 39% of users. Real-world data confirm approximately 8% average weight loss, positioning it as a foundational therapy before more potent successors.[](https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-weight-management-drug-patients-aged-12-and-older) [](https://www.nejm.org/doi/full/10.1056/NEJMoa1411892) [](https://www.aafp.org/pubs/afp/issues/2016/0715/p161.html) [](https://obesitymedicine.org/blog/weight-loss-medications/)\n\nSemaglutide, a longer-acting GLP-1 analog, advanced this class with FDA approval of Wegovy for weight loss on June 4, 2021. The STEP 1 trial, a 68-week study in adults with obesity, reported mean weight reductions of 14.9% at 2.4 mg weekly versus 2.4% with placebo, with 86.4% achieving â‰¥5% loss. Long-term data from the SELECT trial at 208 weeks showed sustained benefits, including cardiovascular risk reduction independent of weight loss extent. Higher investigational doses, such as 7.2 mg, yielded up to 21% loss in non-diabetic patients, though discontinuation leads to substantial regain, underscoring the need for ongoing therapy. These outcomes have correlated with an 8.7% decline in bariatric surgeries from 2022 to 2023 amid rising prescriptions.[](https://diabetesjournals.org/care/article/47/10/1834/157059/Real-World-Use-of-Semaglutide-for-Weight) [](https://www.nejm.org/doi/full/10.1056/NEJMoa2032183) [](https://www.nature.com/articles/s41591-024-02996-7) [](https://www.appliedclinicaltrialsonline.com/view/wegovy-weight-loss-obesity-diabetes) [](https://www.massgeneralbrigham.org/en/about/newsroom/press-releases/study-finds-bariatric-surgery-declined-with-rise-in-glp-1-drugs)\n\nTirzepatide, a dual GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) agonist, further refined metabolic targeting, gaining FDA approval as Zepbound for obesity on November 8, 2023. In the SURMOUNT-1 trial over 72 weeks, doses of 5 mg, 10 mg, or 15 mg weekly produced mean weight losses of 15.0%, 19.5%, and 20.9%, respectively, versus 3.1% with placebo, with 89% achieving â‰¥5% reduction at the highest dose. Head-to-head comparison in SURMOUNT-5 showed 20.2% loss with tirzepatide versus 13.7% with semaglutide at 72 weeks. Withdrawal in extension studies resulted in near-complete regain, affirming its role in maintenance rather than cure, while enhancing glycemic control and lipid profiles through dual incretin modulation.[](https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management) [](https://www.nejm.org/doi/full/10.1056/NEJMoa2206038) [](https://www.nejm.org/doi/full/10.1056/NEJMoa2416394) [](https://www.prnewswire.com/news-releases/zepbound-tirzepatide-showed-superior-weight-loss-over-wegovy-semaglutide-in-complete-surmount-5-results-published-in-the-new-england-journal-of-medicine-302451241.html)\n\nMetabolic insights from these pharmacotherapies have illuminated bariatrics' focus on enteroendocrine signaling and gut-brain axes, revealing how GLP-1/GIP activation recalibrates energy homeostasis akin to post-bariatric surgery remodeling. Unlike earlier agents like orlistat, which primarily inhibit fat absorption with modest 5-10% efficacy, incretin mimetics yield superior, dose-dependent outcomes but require monitoring for pancreatitis risk and muscle loss. Ongoing trials explore combinations and next-generation multi-agonists, potentially integrating with surgical outcomes for personalized metabolic restoration.[](https://academic.oup.com/edrv/advance-article/doi/10.1210/endrev/bnaf036/8276515?searchresult=1) [](https://www.sciencedirect.com/science/article/pii/S0163725825000361)\n\n## Etiology of Obesity Addressed in Bariatrics\n\n### Physiological Mechanisms of Weight Gain\n\nWeight gain occurs through a sustained positive energy balance, where caloric intake chronically exceeds energy expenditure, resulting in the storage of excess energy primarily as triglycerides in adipose tissue.[](https://academic.oup.com/edrv/article/38/4/267/3892397) This process adheres to the first law of thermodynamics, with adipose tissue serving as the principal reservoir for surplus energy; even a modest daily imbalance of 1-3% can lead to substantial fat accumulation over years, as evidenced by average adult weight gains exceeding 10 kg over 3-4 decades in U.S. populations.[](https://academic.oup.com/edrv/article/38/4/267/3892397)[](https://www.nejm.org/doi/full/10.1056/NEJMra1514009)\n\nCentral nervous system regulation, particularly via the hypothalamus, integrates peripheral signals to maintain energy homeostasis, but dysregulation favors overconsumption and reduced expenditure. The arcuate nucleus processes inputs from hormones such as ghrelin, which rises preprandially to stimulate appetite through activation of orexigenic neurons like AgRP/NPY, promoting feeding and decreasing energy use.[](https://www.ncbi.nlm.nih.gov/books/NBK555906/) In contrast, satiety is mediated by anorexigenic signals including leptin from adipocytes and insulin from pancreatic beta cells, which activate POMC/CART neurons to suppress intake; however, in obesity, **leptin resistance** impairs hypothalamic responsiveness, allowing elevated circulating leptin levels to fail in curbing hyperphagia despite increased fat mass.[](https://academic.oup.com/edrv/article/38/4/267/3892397)[](https://www.ncbi.nlm.nih.gov/books/NBK555906/) Insulin further promotes lipogenesis by enhancing lipoprotein lipase activity in adipocytes, facilitating fatty acid uptake and storage while inhibiting lipolysis.[](https://www.nejm.org/doi/full/10.1056/NEJMra1514009)\n\nAdipose tissue expands via **hypertrophy** (increased adipocyte size) and, to a lesser extent, **hyperplasia** (new cell formation) in response to caloric surplus, but impaired expansion in obesity leads to ectopic lipid deposition in non-adipose organs like liver and muscle, exacerbating metabolic dysfunction.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC10843116/) This expansion triggers local inflammation and altered adipokine secretion, including reduced adiponectin, which normally enhances insulin sensitivity and fatty acid oxidation, thereby perpetuating a cycle of insulin resistance and further fat accrual.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC10843116/) Overall, these mechanisms defend an elevated \"set point\" of adiposity in obese individuals, resisting weight reduction through adaptive increases in hunger and decreases in resting metabolic rate.[](https://academic.oup.com/edrv/article/38/4/267/3892397)\n\n### Genetic and Metabolic Factors\n\nObesity exhibits substantial genetic heritability, with twin and family studies estimating that genetic factors account for 40% to 70% of variation in body mass index (BMI) and adiposity across populations.[](https://www.nature.com/articles/s41576-021-00414-z) This heritability arises from both rare monogenic mutations and common polygenic variants, though environmental influences modulate expression, as evidenced by rising obesity rates despite stable genetic pools. Monogenic forms, while rare (affecting \u003c5% of severe cases), provide causal insights; for instance, mutations in the melanocortin-4 receptor (*MC4R*) gene, located on chromosome 18, are the most prevalent, contributing to approximately 4% of childhood-onset severe obesity by impairing hypothalamic signaling that regulates appetite and energy expenditure.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9569701/) Similarly, variants in the fat mass and obesity-associated (*FTO*) gene, such as rs9939609, correlate with increased BMI by influencing DNA demethylation and hypothalamic gene expression, raising obesity risk by 20-30% per risk allele in meta-analyses of diverse cohorts.[](https://www.sciencedirect.com/science/article/abs/pii/S1871403X16000090)\n\nPolygenic risk scores (PRS), aggregating hundreds of common variants identified via genome-wide association studies (GWAS), better capture population-level genetic predisposition, explaining up to 6-10% of BMI variance in recent multi-ancestry models. A 2025 study across UK Biobank and other cohorts demonstrated that PRS predicts BMI trajectories from childhood through adulthood, with high-risk individuals showing 2-5 kg/mÂ² higher BMI by age 40, though this accounts for only about one-third of total genetic heritability due to missing rare variants and gene-environment interactions.[](https://www.nature.com/articles/s41591-025-03827-z) These scores highlight causal pathways, such as variants near *MC4R* (e.g., rs17782313) affecting melanocortin pathways, but their clinical utility remains limited by polygenicity and the need for lifestyle integration to mitigate risk.[](https://onlinelibrary.wiley.com/doi/10.1111/obr.13978)\n\nMetabolically, obesity often stems from dysregulated energy homeostasis, prominently involving leptin resistance, where elevated circulating leptin from adipose tissue fails to suppress appetite due to impaired hypothalamic transport and signaling. In most obese individuals, plasma leptin levels are 3-5 times higher than in lean counterparts, yet central resistance persists, driven by mechanisms like endoplasmic reticulum stress and inflammation, reducing basal metabolic rate by 10-20% and perpetuating hyperphagia.[](https://www.jci.org/articles/view/174595) Insulin resistance compounds this, as chronic hyperinsulinemiaâ€”common in 70-80% of obese adultsâ€”exacerbates leptin resistance via shared downstream pathways, including SOCS3-mediated suppression of JAK-STAT signaling, forming a feedback loop that promotes fat storage over oxidation.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC7815269/) Rare congenital leptin deficiency (*LEP* gene mutations) causes profound early-onset obesity treatable with recombinant leptin, underscoring causality, but in polygenic obesity, these metabolic defects interact with genetic predispositions, such as *FTO* variants enhancing adipocyte leptin production without proportional satiety.[](https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2021.585887/full) Thyroid dysfunction or mitochondrial inefficiencies contribute marginally in subsets, but hormonal axes dominate, with evidence from longitudinal studies linking prediagnostic insulin and leptin profiles to subsequent weight gain independent of caloric intake.[](https://pubmed.ncbi.nlm.nih.gov/20432812/)\n\n### Behavioral and Environmental Influences\n\nBehavioral factors play a central role in the etiology of obesity by promoting a sustained positive energy balance through excessive caloric intake and reduced expenditure. Diets high in energy-dense, nutrient-poor foodsâ€”such as frequent fast food consumption, large portion sizes, and sugar-sweetened beveragesâ€”directly contribute to weight gain, with studies identifying these patterns as key obesity-promoting behaviors.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3431098/) Sedentary lifestyles exacerbate this by lowering daily energy expenditure; meta-analyses confirm that low physical activity levels are associated with increased risk of obesity, independent of dietary factors.[](https://pubmed.ncbi.nlm.nih.gov/10593524/) In developed countries, recent doubly labeled water studies across populations reveal that dietary overconsumption, rather than reduced physical activity, accounts for the majority of the modern obesity epidemic, as total energy expenditure remains relatively stable despite rising body weights.[](https://www.science.org/content/article/new-study-blames-diet-not-physical-inactivity-obesity-crisis)\n\nAdditional behavioral contributors include inadequate sleep and stress-induced eating, which disrupt appetite-regulating hormones like leptin and ghrelin, fostering overeating.[](https://www.thelancet.com/journals/landia/article/PIIS2213-8587%2822%2900047-X/fulltext) Systematic reviews highlight conflicting but supportive evidence for dietary intake, sedentary screen time, and irregular meal patterns in adolescent obesity onset, underscoring the cumulative impact of habitual choices on adipose accumulation.[](https://www.researchgate.net/publication/332286809_Behavioral_contextual_and_biological_factors_associated_with_obesity_during_adolescence_A_systematic_review) These modifiable behaviors form the basis for bariatric interventions, which often incorporate cognitive-behavioral strategies to address maladaptive eating and activity patterns.\n\nEnvironmental influences amplify behavioral risks by shaping access and cues for obesogenic choices. Food environments dominated by ultra-processed foods and aggressive marketing correlate with higher obesity prevalence, as meta-analyses link greater availability of unhealthy options to increased caloric intake and body mass index.[](https://nutrition.bmj.com/content/early/2024/04/21/bmjnph-2023-000663) Urban design factors, such as limited walkable spaces and reduced green areas, inversely associate with physical activity; reviews indicate that proximity to parks and bikeable infrastructure lowers obesity rates by facilitating energy expenditure.[](https://www.sciencedirect.com/science/article/pii/S258993682400063X) Increasing urbanization has paralleled rising obesity, with built environments prioritizing sedentary transport over active mobility contributing to lower overall activity levels.[](https://ij-healthgeographics.biomedcentral.com/articles/10.1186/s12942-021-00260-6) Socioeconomic disparities in these environmentsâ€”such as food deserts in low-income areasâ€”further entrench higher obesity risks through restricted healthy food access, though individual agency in navigating such contexts remains a critical determinant.[](https://www.ncbi.nlm.nih.gov/books/NBK278977/)\n\n## Patient Characteristics and Selection\n\n### Eligibility Criteria for Interventions\n\nEligibility for metabolic and bariatric surgery (MBS) is guided by updated 2022 ASMBS/IFSO recommendations, which expanded criteria beyond the 1991 NIH consensus to reflect evidence of benefits in broader populations. MBS is recommended for adults with a body mass index (BMI) of 35 kg/mÂ² or greater, irrespective of comorbidities, and for those with BMI 30â€“34.9 kg/mÂ² accompanied by type 2 diabetes (T2D) or other metabolic diseases.[](https://asmbs.org/patients/is-metabolic-and-bariatric-surgery-right-for-you/) [](https://pmc.ncbi.nlm.nih.gov/articles/PMC9834364/) For Asian populations, thresholds are lowered to BMI â‰¥27.5 kg/mÂ² or â‰¥25 kg/mÂ² with metabolic conditions due to higher cardiometabolic risks at lower BMIs.[](https://emedicine.medscape.com/article/197081-guidelines) Candidates must demonstrate failure of sustained weight loss through intensive lifestyle interventions, typically 6â€“12 months of supervised diet and exercise yielding less than 10% body weight reduction.[](https://link.springer.com/article/10.1007/s11695-024-07370-7)\n\nAdditional selection factors include multidisciplinary evaluation encompassing medical, psychological, and nutritional assessments to ensure operative safety and postoperative adherence. Psychological stability is required, excluding active untreated psychiatric disorders, severe depression, or substance abuse that could impair compliance; preoperative counseling addresses eating behaviors and expectations.[](https://asmbs.org/resources/bariatric-surgery-guidelines-and-recommendations/) Age limits are generally 18â€“65 years, though adolescents with BMI â‰¥120% of the 95th percentile plus comorbidities may qualify under separate pediatric guidelines.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6097871/) Contraindications encompass reversible causes of obesity (e.g., untreated hypothyroidism), high perioperative risks from coagulopathies or advanced heart failure, pregnancy, or inability to comprehend informed consent.[](https://www.ncbi.nlm.nih.gov/books/NBK546667/)\n\nPharmacological interventions for obesity, such as GLP-1 receptor agonists (e.g., semaglutide) or dual agonists (e.g., tirzepatide), target adults with BMI â‰¥30 kg/mÂ² or â‰¥27 kg/mÂ² with weight-related comorbidities like hypertension, dyslipidemia, or prediabetes, in conjunction with lifestyle modifications.[](https://obesitymedicine.org/blog/weight-loss-medications/) [](https://www.ncbi.nlm.nih.gov/books/NBK562269/) FDA approvals specify chronic use for those not achieving adequate response to diet and exercise alone, with titration to minimize gastrointestinal side effects; efficacy requires at least 5% weight loss by 3â€“6 months to continue.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC12456317/) Unlike surgery, pharmacotherapy has fewer absolute BMI barriers but mandates screening for contraindications including medullary thyroid carcinoma history, multiple endocrine neoplasia type 2, or pancreatitis.[](https://diabetesjournals.org/care/article/48/Supplement_1/S167/157555/8-Obesity-and-Weight-Management-for-the-Prevention) Canadian 2025 guidelines emphasize individualized titration based on response and tolerability, prioritizing agents with cardiovascular risk reduction in high-risk patients.[](https://obesitycanada.ca/wp-content/uploads/2025/08/11-Canadian-Adult-Obesity-CPG-Pharmacotherapy-2025-update.pdf)\n\nAcross interventions, equity considerations arise from evidence that lower BMI thresholds improve access for underrepresented groups with early-onset metabolic risks, though real-world disparities persist due to socioeconomic barriers.[](https://www.gastrojournal.org/article/S0016-5085%2822%2901026-5/fulltext) Long-term eligibility reassessment is advised, as weight regain or evolving comorbidities may necessitate switching modalities.[](https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1569468/full)\n\n### Associated Comorbidities and Risk Profiling\n\nObesity, especially at levels qualifying patients for bariatric interventions (typically BMI â‰¥40 kg/mÂ² or â‰¥35 kg/mÂ² with complications), is causally linked to a cluster of comorbidities driven by excess adiposity, insulin resistance, and chronic inflammation.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC12439710/) Primary associated conditions include type 2 diabetes mellitus (T2DM), hypertension, dyslipidemia, obstructive sleep apnea (OSA), and nonalcoholic fatty liver disease (NAFLD), which collectively form metabolic syndrome in up to 70% of severe obesity cases with OSA.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6112821/) These comorbidities not only justify intervention eligibility under guidelines like those from the American Society for Metabolic and Bariatric Surgery but also elevate perioperative risks, necessitating comprehensive preoperative profiling.[](https://www.ncbi.nlm.nih.gov/books/NBK615299/)\n\nPrevalence data from bariatric cohorts highlight the burden: OSA affects 63-83% of surgery candidates, often undiagnosed preoperatively and contributing to hypoxia-related complications.[](https://www.sciencedirect.com/science/article/abs/pii/S2173573524000656) T2DM occurs in 20-40% of eligible patients, with higher rates (up to 78% OSA overlap) in those with severe obesity, exacerbating cardiovascular strain.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3206416/) Hypertension is documented in approximately 50% of cases, dyslipidemia in 30-50%, and NAFLD in 70-90% upon biopsy, reflecting hepatic fat accumulation from caloric surplus and metabolic dysregulation.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3569476/) Less frequent but significant associations include osteoarthritis (limiting mobility), gastroesophageal reflux disease, and polycystic ovary syndrome in females, all empirically tied to adipose tissue dysfunction rather than solely behavioral factors.[](https://www.ncbi.nlm.nih.gov/books/NBK615299/)\n\nRisk profiling integrates these comorbidities into stratified models to predict adverse outcomes like 90-day mortality (0.2-2.4% across strata) and guide procedure selection.[](https://pubmed.ncbi.nlm.nih.gov/22535443/) The validated Obesity Surgery Mortality Risk Score (OS-MRS) assigns one point each for five factorsâ€”BMI â‰¥50 kg/mÂ², male sex, hypertension, age â‰¥45 years, and pulmonary embolism risk factors (e.g., prior venous thromboembolism)â€”categorizing patients as low-risk (0 points), moderate (1-2 points), or high-risk (â‰¥3 points).[](https://www.mdcalc.com/calc/10520/obesity-surgery-mortality-risk-score-os-mrs) [](https://pmc.ncbi.nlm.nih.gov/articles/PMC4520850/) Additional assessments include echocardiograms for heart failure (prevalent in 5-10% of high-BMI patients), polysomnography for OSA severity, and nutritional evaluations to mitigate malnutrition risks post-surgery.[](https://www.sciencedirect.com/science/article/abs/pii/S1550728912003292) Multidisciplinary teams weigh these against benefits, prioritizing empirical predictors over unverified psychosocial metrics, as higher comorbidity loads correlate with greater postoperative resolution but also leak or infection risks.[](https://onlinelibrary.wiley.com/doi/full/10.1002/osp4.628)\n\n## Treatment Modalities\n\n### Non-Invasive and Lifestyle-Based Methods\n\nComprehensive lifestyle interventions, comprising dietary modifications, physical activity, and behavioral strategies, represent the foundational non-invasive approach in bariatrics for managing obesity through sustained negative energy balance. These methods prioritize empirical adjustments to caloric intake and expenditure, guided by principles of energy homeostasis, with evidence from randomized controlled trials indicating average initial weight reductions of 8-10% of body weight at 6-12 months when delivered intensively.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC7027681/) However, long-term maintenance remains challenging, with meta-analyses showing average sustained losses of 3-5% after 5 years, often accompanied by high rates of partial or full regain due to physiological adaptations such as reduced resting metabolic rate and increased appetite signaling.[](https://www.sciencedirect.com/science/article/pii/S0002916523063748)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC5764193/)\n\nDietary strategies focus on moderate caloric restriction (typically 500-1,000 kcal/day deficit) using balanced macronutrient distributions, such as 1,200-1,500 kcal diets emphasizing vegetables, lean proteins, and whole grains while limiting refined sugars and fats. Systematic reviews demonstrate comparable short-term efficacy across low-fat, low-carbohydrate, and Mediterranean-style diets, yielding 5-8 kg losses over 6 months, though adherence wanes without ongoing support.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC7027681/) For severe obesity, very low-calorie diets (VLCDs, \u003c800 kcal/day, often formula-based and medically supervised for 12-16 weeks) achieve rapid losses of 15-25% body weight, improving glycemic control and facilitating transitions to maintenance phases, but require monitoring for nutrient deficiencies, gallstones, and muscle loss.[](https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/609705)[](https://pubmed.ncbi.nlm.nih.gov/31705259/) Long-term outcomes for VLCDs mirror general dietary interventions, with regain exceeding 50% within 1-2 years absent behavioral reinforcement.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC5764193/)\n\nPhysical activity components recommend at least 150-250 minutes weekly of moderate-intensity aerobic exercise (e.g., brisk walking) combined with resistance training 2-3 days per week to preserve lean mass and mitigate metabolic slowdown. Meta-analyses confirm that adding exercise to diet enhances initial losses by 1-3 kg and halves regain risk over 1-2 years compared to diet alone, with benefits extending to cardiovascular fitness independent of weight change.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC7027681/) In the Look AHEAD trial, participants in an intensive lifestyle arm achieved 8.6% weight loss at 1 year through 175 minutes/week of activity plus diet, sustaining ~4.7% loss at 8 years versus 2.1% in controls, alongside reduced diabetes progression.[](https://www.nejm.org/doi/full/10.1056/NEJMoa1212914)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC4339027/)\n\nBehavioral therapies, drawing from cognitive-behavioral techniques, target habit formation via self-monitoring (e.g., food diaries), goal setting, stimulus control, and relapse prevention, typically delivered in 16-24 weekly sessions followed by maintenance boosters. These interventions improve adherence, with intensive programs yielding 5-10% losses sustained at 1 year in 60-70% of completers, though dropout rates reach 20-40%.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3233993/)[](https://www.ncbi.nlm.nih.gov/books/NBK570565/) Combined modalities amplify effects; for instance, the Diabetes Prevention Program showed 7% loss at 6 months via group sessions, halving diabetes incidence over 3 years despite partial regain.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC7027681/) Modest losses (â‰¥5%) consistently remit comorbidities like hypertension and prediabetes, underscoring causal links between adiposity reduction and metabolic improvement, yet underscore the need for indefinite support given obesity's chronicity.[](https://www.ahajournals.org/doi/10.1161/CIRCOUTCOMES.122.009348)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC5764193/)\n\n### Pharmacological Treatments\n\nPharmacological treatments in bariatrics target physiological drivers of obesity, such as appetite dysregulation and impaired satiety signaling, with the goal of achieving sustained weight loss in patients with BMI â‰¥30 kg/mÂ² or â‰¥27 kg/mÂ² with comorbidities like type 2 diabetes or hypertension.[](https://pubmed.ncbi.nlm.nih.gov/40789597/) These agents are positioned as adjuncts to lifestyle interventions or alternatives to surgery for select patients, though evidence indicates they generally produce less durable results than bariatric procedures, with weight regain common upon discontinuation.[](https://jamanetwork.com/journals/jamasurgery/fullarticle/2839126) Current FDA-approved options emphasize incretin-based therapies, which outperform older classes like lipase inhibitors or sympathomimetics in magnitude of effect.[](https://obesitymedicine.org/blog/weight-loss-medications/)\n\nGlucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide (Wegovy, approved 2021), mimic endogenous incretins to suppress appetite, delay gastric emptying, and enhance insulin secretion, yielding mean weight losses of 14.9-17.4% at 68 weeks in randomized trials of adults without diabetes.[](https://www.nejm.org/doi/full/10.1056/NEJMoa2032183) Tirzepatide (Zepbound, approved 2023), a dual GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) agonist, demonstrates superior efficacy, with placebo-adjusted reductions of 15-21% body weight over 72 weeks in phase 3 SURMOUNT trials, attributed to additive effects on energy intake and expenditure.[](https://www.nejm.org/doi/full/10.1056/NEJMoa2206038) Head-to-head comparisons confirm tirzepatide's edge, achieving 5-7% greater loss than semaglutide 2.4 mg weekly at 72 weeks.[](https://www.nejm.org/doi/full/10.1056/NEJMoa2416394) Liraglutide (Saxenda, approved 2014), an earlier GLP-1 agonist, produces 5-8% loss but requires daily dosing and has lower adherence.[](https://obesitymedicine.org/blog/weight-loss-medications/)\n\n| Drug | Mechanism | Mean Weight Loss (% at 1 year) | Common Adverse Effects |\n|------|-----------|-------------------------------|-------------------------|\n| Semaglutide (Wegovy) | GLP-1 RA: appetite suppression, slowed gastric emptying | 15-17% | Nausea (44%), diarrhea (30%), vomiting (25%)[](https://pubmed.ncbi.nlm.nih.gov/39761578/) |\n| Tirzepatide (Zepbound) | Dual GLP-1/GIP RA: enhanced satiety, reduced caloric intake | 18-21% | Nausea (25-35%), gastrointestinal intolerance leading to 4-7% discontinuation[](https://www.nature.com/articles/s41591-025-03978-z) |\n| Liraglutide (Saxenda) | GLP-1 RA: similar to semaglutide but shorter half-life | 5-8% | Injection-site reactions, nausea (39%)[](https://obesitymedicine.org/blog/weight-loss-medications/) |\n\nSafety profiles feature predominantly gastrointestinal events, affecting 20-50% of users and driving 5-10% discontinuation rates, with dose escalation mitigating onset.[](https://pubmed.ncbi.nlm.nih.gov/39761578/) Rare risks include acute pancreatitis (0.1-0.2% incidence), gallbladder disease (2-4% increased), and potential medullary thyroid carcinoma signals from rodent data, though human evidence remains inconclusive.[](https://www.sciencedirect.com/science/article/pii/S2667368124000299) Cardiovascular benefits, including reduced major adverse events, support use in high-risk patients, as seen in semaglutide's 20% relative risk reduction in SELECT trial subsets.[](https://www.nature.com/articles/s41591-025-03978-z) Older agents like orlistat (Xenical), which inhibits fat absorption for 5-10% loss, or phentermine (short-term sympathomimetic), offer modest effects but higher malabsorption or cardiovascular concerns, limiting bariatric preference.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC12456317/)\n\nLong-term data as of 2025 underscore the need for indefinite therapy, with 2/3 of lost weight regained within a year of cessation due to counter-regulatory adaptations in hunger signaling.[](https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1569468/full) In bariatric contexts, these drugs bridge to surgery, aid post-operative maintenance, or serve non-surgical candidates, but real-world adherence challenges and costs (often \u003e$1,000/month) constrain access.[](https://pubmed.ncbi.nlm.nih.gov/40789597/) Emerging combinations, like GLP-1 agonists with amylin analogs, show promise for preserving lean mass during loss but await broader approval.[](https://www.sciencedirect.com/science/article/pii/S0014299925006041) Efficacy varies by genetics and baseline insulin resistance, with non-responders (\u003e5% loss threshold) comprising 20-30% in trials.[](https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1569468/full)\n\n### Surgical Procedures\n\nBariatric surgical procedures modify the digestive anatomy to induce weight loss via restrictive effects that limit gastric capacity, malabsorptive effects that bypass nutrient-absorbing intestinal segments, or both, often performed laparoscopically to minimize invasiveness. These interventions are indicated for patients with severe obesity (body mass index â‰¥35 kg/mÂ² with comorbidities or â‰¥40 kg/mÂ²), following multidisciplinary evaluation, and demonstrate sustained excess weight loss exceeding 60% in major procedures like sleeve gastrectomy and Roux-en-Y gastric bypass, surpassing non-surgical options.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9834364/) Perioperative mortality ranges from 0.03% to 0.2%, with complications influenced by patient factors such as BMI exceeding 60 kg/mÂ².[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9834364/) The American Society for Metabolic and Bariatric Surgery endorses procedures based on long-term data from randomized trials and cohorts, prioritizing those with durable outcomes over less effective alternatives.[](https://asmbs.org/resources/endorsed-procedures-and-devices/)\n\n**Laparoscopic Sleeve Gastrectomy (LSG)** involves resection of approximately 80% of the stomach along the greater curvature, forming a tubular remnant that restricts volume to about 100-150 mL and reduces ghrelin-secreting fundus tissue, thereby curbing appetite and caloric intake without intestinal bypass.[](https://asmbs.org/patients/bariatric-surgery-procedures/) This purely restrictive mechanism yields 60-70% excess weight loss (%EWL) at 1-2 years, with sustained rates of 50-60% at 10 years, alongside high type 2 diabetes remission (up to 70%).[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9834364/) It is irreversible and carries risks of staple-line leak (0.5-2%), bleeding, nutrient deficiencies, and gastroesophageal reflux exacerbation, though it avoids malabsorption-related deficiencies.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC7052082/) LSG predominates in the U.S., comprising over 50% of procedures due to its relative simplicity and lower operative time compared to bypass variants.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9834364/)\n\n**Roux-en-Y Gastric Bypass (RYGB)** constructs a 15-30 mL proximal stomach pouch anastomosed to a Roux limb of jejunum, bypassing the distal stomach and proximal small intestine to combine restriction with malabsorption of calories and nutrients, while altering gut hormone profiles to enhance satiety and insulin sensitivity.[](https://asmbs.org/patients/bariatric-surgery-procedures/) Established for over 50 years, it achieves 60-70% EWL short-term and 50% long-term, with superior diabetes remission (70-90%) versus restrictive-only methods, as evidenced by trials like STAMPEDE.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9834364/) Complications include marginal ulcers, dumping syndrome, and lifelong deficiencies in iron, vitamin B12, and calcium, necessitating supplementation; reoperation rates for failure or issues reach 10-20%.[](https://asmbs.org/patients/bariatric-surgery-procedures/) RYGB remains a benchmark for patients with reflux or sweet-eating behaviors, though it demands more technical expertise than LSG.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9834364/)\n\n**Adjustable Gastric Banding (AGB)** deploys an inflatable silicone band around the proximal stomach to create a small pouch, adjustable via subcutaneous port to titrate restriction without resection or bypass, preserving anatomy for potential reversal.[](https://asmbs.org/patients/bariatric-surgery-procedures/) It induces modest 40-50% EWL initially, but long-term data show only 16-20% total body weight loss at 10 years, with inferior diabetes resolution and high failure prompting band removal or revision in 30-50% of cases due to slippage, erosion, or inadequate efficacy.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC5127420/) [](https://www.templehealth.org/about/blog/truth-about-adjustable-gastric-banding-surgery) Current utilization has declined sharply, representing under 1% of procedures, as superior alternatives like LSG offer better durability with comparable or lower morbidity.[](https://asmbs.org/resources/estimate-of-bariatric-surgery-numbers)\n\n**Biliopancreatic Diversion with Duodenal Switch (BPD/DS)** entails a distal gastrectomy akin to LSG combined with a duodenal sleeve and ileal switch, bypassing 75% of the small intestine to maximize malabsorption while retaining some pyloric function to mitigate dumping.[](https://asmbs.org/patients/bariatric-surgery-procedures/) Reserved for super-obese patients (BMI \u003e50 kg/mÂ²), it delivers the highest %EWL (70-80%) and comorbidity resolution, including 90% diabetes remission, per comparative studies against RYGB.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9834364/) [](https://pubmed.ncbi.nlm.nih.gov/34731300/) Risks are elevated, including 10-15% major complications, severe malabsorption leading to protein-calorie deficits, and frequent deficiencies requiring intensive monitoring and supplementation.[](https://asmbs.org/patients/bariatric-surgery-procedures/) Its complexity limits adoption to specialized centers.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9834364/)\n\nEmerging variants like single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) simplify BPD/DS via one intestinal anastomosis, achieving comparable superior weight loss (60-75% EWL) and metabolic benefits with reduced operative risk, though long-term data remain limited to 5-10 years.[](https://asmbs.org/patients/bariatric-surgery-procedures/) Procedure selection hinges on patient anatomy, comorbidities, and surgeon expertise, with randomized evidence favoring malabsorptive options for maximal efficacy in refractory cases despite heightened nutritional oversight needs.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9834364/)\n\n### Integrated and Emerging Approaches\n\nIntegrated approaches in bariatrics emphasize multidisciplinary teams comprising surgeons, endocrinologists, dietitians, psychologists, and exercise specialists to address the multifaceted etiology of obesity, optimizing patient preparation, procedure selection, and long-term adherence.[](https://asmbs.org/integrated-health/about-the-asmbs-integrated-health-section/) These models, such as hub-and-spokes frameworks, facilitate comprehensive preoperative evaluation for high-risk patients and postoperative support to mitigate regain, with studies demonstrating improved weight loss success rates and cardiometabolic outcomes compared to siloed interventions.[](https://www.sciencedirect.com/science/article/pii/S1550728916308103) For instance, multidisciplinary programs have achieved clinically meaningful weight reductions of 5-10% or more at 6-12 months, alongside reductions in blood glucose and lipid levels, particularly in severe obesity cases.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC12194354/)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC8129361/)\n\nCombination therapies integrate pharmacological agents with behavioral modifications or surgical procedures to enhance efficacy and durability. Anti-obesity medications (AOMs) like GLP-1 receptor agonists combined with structured lifestyle programs in employer-based settings yield superior mean weight lossâ€”up to 15-20%â€”over lifestyle alone, with sustained benefits at one year.[](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2781926) Preoperative use of AOMs, such as semaglutide, has surged, aiding risk reduction for bariatric candidates by promoting 10-15% weight loss prior to surgery, thereby expanding eligibility.[](https://www.facs.org/media-center/press-releases/2025/use-of-weight-loss-drugs-before-bariatric-surgery-has-soared-in-recent-years-study-finds/) Postoperatively, adjunctive GLP-1 therapy in one in seven patients counters weight regain, though real-world data indicate variable adherence due to cost and side effects.[](https://publichealth.jhu.edu/2025/one-in-seven-bariatric-surgery-patients-turn-to-new-weight-loss-drugs)\n\nEmerging pharmacotherapies focus on multi-agonist mechanisms targeting incretin hormones, with dual GLP-1/GIP agonists like tirzepatide achieving 20-25% weight loss in trials, surpassing single-agent predecessors.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC12299311/) Triple agonists (e.g., retatrutide) and amylin-semaglutide combinations (e.g., CagriSema) in phase 3 trials as of 2025 promise further gains of 25% or more while preserving lean mass, addressing a key limitation of caloric restriction.[](https://www.goodrx.com/conditions/weight-loss/new-weight-loss-drugs) These agents are increasingly combined with endoscopic bariatric therapies (EBTs), such as endoscopic sleeve gastroplasty (ESG) or intragastric balloons, which offer 15-20% weight loss with lower invasiveness than traditional surgery; preliminary data support their synergy for maintenance.[](https://pubmed.ncbi.nlm.nih.gov/40649055/)[](https://www.sciencedirect.com/science/article/abs/pii/S2590030720300994)\n\nMultimodal neoadjuvant AOM regimens prior to surgery enhance preoperative optimization, with evidence from 2025 studies showing greater weight loss than non-pharmacologic supervision alone, potentially reducing operative risks.[](https://www.nature.com/articles/s41366-025-01798-2) However, while these integrations expand options, bariatric surgery retains advantages in sustained remission of comorbidities, with real-world analyses confirming 20-30% greater long-term weight loss versus pharmacotherapy alone.[](https://asmbs.org/resources/glp-1-medications-vs-bariatric-surgery-what-the-latest-research-shows/) Ongoing trials emphasize personalized sequencing to balance efficacy against gastrointestinal adverse events and accessibility barriers.[](https://www.nature.com/articles/s41366-025-01897-0)\n\n## Efficacy and Long-Term Outcomes\n\n### Weight Loss Metrics and Remission Rates\n\nSurgical interventions in bariatrics, such as Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG), typically achieve substantial weight loss, with mean total weight loss (%TWL) ranging from 20-33% at 2-5 years post-procedure and excess weight loss (%EWL) peaking at 50-75% before partial regain over longer terms.[](https://www.sciencedirect.com/science/article/pii/S2667008924000090)[](https://www.americanjournalofsurgery.com/article/S0002-9610%2824%2900703-7/fulltext) At 10 years, median %EWL stabilizes around 59% and %TWL at 23%, though reoperation rates influence durability.[](https://link.springer.com/article/10.1007/s00423-025-03713-9) Long-term data over 20 years indicate sustained %TWL of approximately 22% across procedures, outperforming non-surgical options in magnitude but requiring monitoring for weight regain.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6320354/)\n\nType 2 diabetes (T2DM) remission rates following bariatric surgery are notably high initially, with complete or partial remission in 50-80% of cases at 1-2 years, driven by RYGB more than SG due to greater metabolic effects.[](https://link.springer.com/article/10.1007/s11695-023-06856-0)[](https://www.sciencedirect.com/science/article/pii/S1550728922007572) However, long-term remission wanes, with complete T2DM remission at 31% and partial at 15% by 10 years, alongside 20-30% recurrence after initial response, underscoring the need for ongoing glycemic management.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC11717815/) Meta-analyses confirm surgery yields 5-8 times higher odds of T2DM remission versus conventional care, though definitions (e.g., HbA1c \u003c6.5% off medications) vary across studies.[](https://dmsjournal.biomedcentral.com/articles/10.1186/s13098-023-01001-4)[](https://diabetesjournals.org/care/article/39/12/2247/31365/Reconciliation-of-Type-2-Diabetes-Remission-Rates)\n\nPharmacological treatments, particularly GLP-1 receptor agonists like semaglutide (2.4 mg weekly), induce 15-17% TWL at 1-2 years when combined with lifestyle intervention, with sustained effects over 4 years in non-diabetic obese adults, though discontinuation leads to substantial regain (two-thirds of lost weight within a year).[](https://www.nejm.org/doi/full/10.1056/NEJMoa2032183)[](https://www.nature.com/articles/s41591-024-02996-7)[](https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.14725) T2DM remission occurs in 20-40% of cases with these agents, lower than surgical rates but with cardiometabolic benefits persisting during treatment.[](https://www.nejm.org/doi/full/10.1056/NEJMoa2307563) Other pharmacotherapies, such as liraglutide, yield 5-10% TWL at 1 year, with recent reviews emphasizing dose-dependent efficacy but highlighting adherence challenges for long-term maintenance.[](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2823644)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC12456317/)\n\nLifestyle interventions alone, including diet, exercise, and behavioral modifications, produce modest 3-8% TWL in short-term trials (6-12 months), with meta-analyses showing average BMI reductions of 0.5-1 unit but high heterogeneity and limited sustainability beyond 1 year without intensification.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC5575752/)[](https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-022-02067-3) Comorbidity remission, such as T2DM, remains rare (\u003c10%) with these approaches, as evidenced by control arms in RCTs where even minimal interventions yield partial benefits but fail to match invasive methods.[](https://bmjopen.bmj.com/content/9/8/e029966)[](https://bmcendocrdisord.biomedcentral.com/articles/10.1186/s12902-023-01283-9)\n\n| Modality | Typical %TWL (1-2 years) | Long-term %TWL (5+ years) | T2DM Remission Rate (Short-term) |\n|----------|---------------------------|----------------------------|----------------------------------|\n| Bariatric Surgery (e.g., RYGB/SG) | 25-35% | 20-25% | 50-80% |[](https://www.sciencedirect.com/science/article/pii/S2667008924000090)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6320354/)[](https://link.springer.com/article/10.1007/s11695-023-06856-0)\n| GLP-1 Agonists (e.g., Semaglutide) | 15-17% | 10-15% (with continuation) | 20-40% |[](https://www.nejm.org/doi/full/10.1056/NEJMoa2032183)[](https://www.nature.com/articles/s41591-024-02996-7)[](https://www.nejm.org/doi/full/10.1056/NEJMoa2307563)\n| Lifestyle Interventions | 3-8% | \u003c5% | \u003c10% |[](https://pmc.ncbi.nlm.nih.gov/articles/PMC5575752/)[](https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-022-02067-3)[](https://bmcendocrdisord.biomedcentral.com/articles/10.1186/s12902-023-01283-9)\n\n### Effects on Comorbidities and Mortality\n\nBariatric surgical interventions, such as Roux-en-Y gastric bypass and sleeve gastrectomy, yield marked improvements in type 2 diabetes mellitus, with meta-analyses reporting remission rates of 53% at 1 year post-surgery compared to 5% with medical management alone.[](https://pubmed.ncbi.nlm.nih.gov/40988570/) Long-term data indicate sustained remission in 30-50% of patients at 5-10 years, particularly with gastric bypass outperforming sleeve gastrectomy in maintaining glycemic control and reducing reliance on antidiabetic medications.[](https://www.sciencedirect.com/science/article/abs/pii/S2213858724003966) These outcomes stem from substantial weight loss (typically 20-30% of body weight) and metabolic reprogramming, including enhanced insulin sensitivity, though relapse occurs in up to 50% by 10 years due to weight regain or beta-cell dysfunction.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC11717815/)\n\nHypertension resolves in 60-75% of patients following surgery, with systematic reviews showing superior blood pressure control compared to non-surgical therapies, alongside reductions in antihypertensive medication use by 50-70%.[](https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-025-04640-9) Cardiovascular risk factors improve broadly, including 40-56% lower incidence of heart failure and coronary heart disease, driven by decreases in dyslipidemia, inflammation, and left ventricular hypertrophy.[](https://www.ahajournals.org/doi/10.1161/JAHA.124.038191)[](https://asmbs.org/news_releases/weight-loss-surgery-reduces-risk-of-coronary-heart-disease-by-40-percent/) Obstructive sleep apnea remits in 70-85% of cases, and non-alcoholic fatty liver disease progresses to less severe stages in most patients, with fibrosis regression in 30-50%.[](https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2019.00094/full)\n\nAll-cause mortality decreases by 29-40% in long-term cohorts post-surgery versus intensive medical therapy, with hazard ratios of 0.71 for overall death and similar reductions in cardiovascular mortality.[](https://www.nejm.org/doi/full/10.1056/NEJMoa2002449)[](https://academic.oup.com/eurheartj/article/43/20/1955/6542137) The Swedish Obese Subjects study, tracking over 4,000 participants for up to 20 years, found life expectancy gains of 2.9 years for men and 5.1 years for women after gastric bypass, attributable to fewer fatal myocardial infarctions and cancers.[](https://www.nejm.org/doi/full/10.1056/NEJMoa2002449) These benefits persist across diabetes subgroups, though absolute gains are smaller in older patients or those with advanced comorbidities.[](https://www.nature.com/articles/s41366-023-01332-2)\n\nPharmacological bariatric treatments, including GLP-1 receptor agonists like semaglutide, mitigate comorbidities through 15-25% weight loss, reducing cardiovascular events by 20-26% in trials of obese patients with established disease, but diabetes remission rates remain below 10-20% long-term due to incomplete glycemic normalization and higher relapse with discontinuation.[](https://jamanetwork.com/journals/jamasurgery/fullarticle/2839126)[](https://www.jacc.org/doi/10.1016/j.jacc.2024.08.007) Mortality data for GLP-1 agonists show neutral to modest reductions in all-cause death, primarily cardiovascular, but lack the durability of surgical outcomes in obesity cohorts without prior events.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC11366408/) Overall, while both modalities lower comorbidity burdens, surgery demonstrates greater causal impact on remission and survival via profound, sustained physiological changes.[](https://www.nature.com/articles/s41598-024-57724-5)\n\n### Factors Influencing Durability of Results\n\nPatient adherence to postoperative lifestyle modifications, including sustained dietary changes and regular physical activity, is a primary determinant of long-term weight maintenance after bariatric surgery, with nonadherence linked to higher rates of weight regain in up to 49% of cases across procedures.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9906605/) Maladaptive eating behaviors such as grazing, loss-of-control eating, and binge eating, which emerge or persist post-surgery, significantly contribute to regain, as evidenced by systematic reviews identifying these patterns in patients experiencing suboptimal outcomes.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9906605/) Preoperative achievement of at least 20 kg weight loss during structured programs correlates strongly with durable results, likely due to established behavioral habits that carry forward.[](https://www.cureus.com/articles/284070-long-term-effectiveness-and-outcomes-of-bariatric-surgery-a-comprehensive-review-of-current-evidence-and-emerging-trends)\n\nOlder age at surgery predicts greater weight regain or insufficient loss, with studies showing associations in cohorts followed for over 10 years, potentially due to reduced metabolic adaptability and comorbidities.[](https://jamanetwork.com/journals/jamasurgery/fullarticle/600864) [](https://bmcendocrdisord.biomedcentral.com/articles/10.1186/s12902-020-0499-4) Preoperative conditions like type 2 diabetes, hypertension, depression, or anxiety independently increase risk of unsuccessful outcomes, as meta-analyses indicate these factors impair metabolic and psychological resilience to surgical alterations.[](https://bmcendocrdisord.biomedcentral.com/articles/10.1186/s12902-020-0499-4) Ethnic variations and higher initial BMI also influence durability, with some evidence of differential regain rates across groups, though modifiable behaviors often mediate these effects more than fixed traits.[](https://www.sciencedirect.com/science/article/abs/pii/S1878788622001758)\n\nProcedure-specific factors affect longevity; for instance, Roux-en-Y gastric bypass exhibits higher weight regain prevalence (up to 64%) compared to other methods in meta-analyses, attributable to potential anatomical dilation or adaptation over time.[](https://www.sciencedirect.com/science/article/abs/pii/S2451847623000520) Physiological mechanisms, including hormonal shifts like diminished fasting GLP-1 levels post-initial response, contribute to regain by reducing satiety signals, as observed in longitudinal studies following sleeve gastrectomy and bypass.[](https://www.nature.com/articles/s41366-024-01461-2) Integrated follow-up emphasizing nutritional support and behavioral interventions can mitigate these, with evidence from prospective data showing preserved lean mass and reduced regain when energy needs for healing are met alongside activity.[](https://www.mdpi.com/2072-6643/16/24/4399)\n\nFor pharmacological and non-invasive modalities, durability hinges similarly on adherence, but with shorter evidence horizons; lifestyle interventions post-pharmacotherapy sustain modest losses (around 5% below baseline) only with ongoing behavioral reinforcement, per systematic reviews, underscoring the need for combined approaches to counter metabolic rebound.[](https://www.sciencedirect.com/science/article/abs/pii/S2405457722002017) Overall, while initial losses are robust (often 20-30% excess weight), regain exceeding 10-15% occurs in 20-40% within 5-10 years, emphasizing multidisciplinary monitoring to address behavioral, metabolic, and procedural predictors.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6320354/) [](https://www.wjgnet.com/2308-3840/full/v9/i5/438.htm)\n\n## Risks, Complications, and Criticisms\n\n### Perioperative and Surgical Complications\n\nPerioperative mortality following bariatric procedures such as Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) is low, typically ranging from 0.04% to 0.06% within 90 days, with no significant differences observed between procedures in large cohorts.[](https://www.healio.com/news/endocrinology/20220822/mortality-risk-higher-with-sleeve-gastrectomy-vs-gastric-bypass-for-adults-with-diabetes) [](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2814336) Morbidity rates, encompassing 30-day adverse events, are higher for RYGB at approximately 15% compared to 9% for SG, driven primarily by surgical-site issues and readmissions (3-4% across procedures).[](https://pmc.ncbi.nlm.nih.gov/articles/PMC10771970/) [](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2814336) Risk escalates with higher body mass index (BMI â‰¥50 kg/mÂ²), diabetes, and comorbidities like cardiovascular disease, potentially doubling complication odds.[](https://asmbs.org/news_releases/the-higher-the-body-mass-index-the-higher-the-risk-for-complications-after-bariatric-surgery/) [](https://www.ncbi.nlm.nih.gov/books/NBK615299/)\n\nIntraoperative and immediate postoperative bleeding represents a frequent surgical complication, occurring in 2.7% of RYGB cases and 0.6-2.3% of SG procedures, often necessitating transfusion or reoperation.[](https://www.ncbi.nlm.nih.gov/books/NBK615299/) Anastomotic leaks, a critical perioperative event with mortality up to 10% if undetected, affect 1.5-3% of SG patients (primarily at the staple line) and 0.3-2% of RYGB cases (at gastrojejunostomy or jejunojejunostomy).[](https://www.ncbi.nlm.nih.gov/books/NBK615299/) [](https://pubmed.ncbi.nlm.nih.gov/40526322/) Detection relies on clinical signs (tachycardia, fever), imaging, or endoscopy, with management involving drainage, antibiotics, or revisional surgery; leaks contribute to 1-3% of overall anastomosis-related issues.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC10771970/)\n\nOther common surgical complications include intestinal obstruction (5% post-RYGB vs. 1% post-SG, often from internal hernias or adhesions) and strictures/ulcers (3% for RYGB), prompting reoperations in 1-2% of SG and 2% of RYGB within 30 days.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC10771970/) [](https://www.ncbi.nlm.nih.gov/books/NBK615299/) Surgical site infections occur in about 3% of cases, while venous thromboembolism risk, though mitigated by prophylaxis, remains elevated in the early postoperative period.[](https://www.sciencedirect.com/science/article/pii/S2667008924000090) Revisional rates for these issues are low overall (1-4% perioperative), but higher BMI and technical factors like staple line reinforcement influence outcomes.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC10771970/) Long-term sequelae, such as marginal ulcers (4.6% post-RYGB), may stem from perioperative events like ischemia but are addressed here only insofar as they arise surgically.[](https://www.ncbi.nlm.nih.gov/books/NBK615299/)\n\n### Adverse Effects of Pharmacotherapies\n\nPharmacological treatments for obesity, particularly glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as semaglutide and tirzepatide, are associated with gastrointestinal adverse effects in a majority of users, including nausea (affecting up to 44% in trials), vomiting (up to 25%), diarrhea (up to 30%), and constipation (up to 24%), which are typically mild to moderate, dose-dependent, and occur early in treatment before often resolving.[](https://www.nejm.org/doi/full/10.1056/NEJMoa2416394) [](https://www.nature.com/articles/s41366-025-01859-6) These effects stem from delayed gastric emptying and reduced appetite signaling, contributing to weight loss but leading to discontinuation rates of 5-10% in clinical studies.[](https://www.sciencedirect.com/science/article/pii/S2667368124000299) Tirzepatide, a GLP-1/GIP co-agonist, shows higher risks for nausea and diarrhea compared to semaglutide, with relative risks elevated by 1.5-2 times in network meta-analyses.[](https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1613610/full)\n\nSerious adverse events with GLP-1 RAs, though rarer (incidence \u003c5%), include acute pancreatitis (reported in 0.1-1% of users, with over 6,700 cases linked to semaglutide from 2005-2023 in pharmacovigilance data), gallbladder disease such as cholelithiasis (odds ratio 1.3-2.0), and gastroesophageal reflux disease exacerbation.[](https://nypost.com/2025/07/06/health/potentially-fatal-side-effect-of-weight-loss-drugs-sparks-new-investigation/) [](https://www.gastrojournal.org/article/S0016-5085%2825%2900845-5/abstract) Acute kidney injury has been observed, potentially due to dehydration from gastrointestinal losses, with FDA warnings highlighting risks alongside hypersensitivity reactions and hypoglycemia in diabetic patients.[](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eli-lilly-and-company-716485-09092025) Delayed gastric emptying also raises concerns for pulmonary aspiration during anesthesia, prompting FDA updates in 2024 on perioperative risks.[](https://medshadow.org/fda-side-effects-update-glp1-drugs-pulmonary-aspiration/) Long-term data remain limited, but rodent studies and post-marketing surveillance suggest potential thyroid C-cell tumors, though human risk appears low based on trials up to four years.[](https://www.sciencedirect.com/science/article/pii/S2667368124000299) [](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/novo-nordisk-inc-716495-09092025)\n\nFor combination therapies like phentermine-topiramate (Qsymia), central nervous system effects predominate, including paresthesia (20-21%), dizziness (up to 10%), insomnia (5-9%), and mood alterations such as anxiety or depression (3-5%), alongside dry mouth (17-20%) and constipation (15-16%).[](https://medlineplus.gov/druginfo/meds/a612037.html) [](https://www.mayoclinic.org/drugs-supplements/phentermine-and-topiramate-oral-route/description/drg-20075700) Cardiovascular risks include elevated heart rate (mean increase 1-3 bpm) and blood pressure, necessitating monitoring and contraindication in patients with glaucoma or hyperthyroidism.[](https://www.aafp.org/pubs/afp/issues/2014/1015/p576.html) Orlistat, a lipase inhibitor, primarily causes malabsorptive gastrointestinal issues like oily spotting, fecal urgency, and steatorrhea (affecting 15-30%), which can lead to fat-soluble vitamin deficiencies if supplementation is inadequate.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC7994651/) Historical agents like sibutramine were withdrawn in 2010 due to increased myocardial infarction and stroke risks (hazard ratio 1.16 in trials), underscoring the need for cardiovascular safety assessments in newer drugs.[](https://pubmed.ncbi.nlm.nih.gov/26934640/)\n\nCompounded or unapproved versions of GLP-1 drugs pose amplified risks, including dosing errors and contamination, with FDA reports from 2023-2025 documenting thousands of adverse events like severe gastrointestinal reactions and incorrect administrations.[](https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss) [](https://pmc.ncbi.nlm.nih.gov/articles/PMC12469573/) Overall, while short-term tolerability is favorable for approved agents, real-world data indicate higher event rates than in randomized trials, emphasizing individualized risk-benefit evaluation.[](https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2821080)\n\n### Debates on Personal Responsibility and Over-Medicalization\n\nCritics of expansive bariatric interventions argue that emphasizing medical treatments risks over-medicalizing obesity, portraying it primarily as a biological disease requiring pharmacological or surgical fixes rather than a condition often rooted in modifiable behaviors such as excessive caloric intake and physical inactivity.[](https://journalofethics.ama-assn.org/article/medicalizing-obesity-individual-economic-and-medical-consequences/2011-12) This perspective holds that labeling obesity as a chronic illnessâ€”independent of lifestyle factorsâ€”may discourage individuals from adopting sustainable habits, fostering dependency on interventions like GLP-1 receptor agonists or bariatric surgery, which frequently yield weight regain upon discontinuation without concurrent behavioral changes.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC12497434/) For instance, long-term studies indicate that while medical management achieves initial weight loss, sustained results in severe obesity cases are rare without integrated lifestyle adherence, with regain rates exceeding 50% within five years in many cohorts.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC12497434/)\n\nProponents of personal responsibility counter that obesity stems largely from individual choices influenced by environment but ultimately controllable through diet and exercise, supported by evidence from intensive lifestyle programs demonstrating average weight losses of 8-10% sustained over two years via reduced-calorie diets (500-1000 kcal deficit daily) combined with at least 150 minutes of weekly moderate activity.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC7027681/) Twin studies and meta-analyses attribute 40-70% of BMI variance to heritability, yet environmental and behavioral factors explain the rapid global rise in obesity rates since the 1980s, from 5% to over 13% in adults, underscoring agency over genetics alone.[](https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2020.00002/full) Advocates, including policy analysts, propose that framing obesity as a failure of self-controlâ€”rather than absolving via medicalizationâ€”could enhance accountability, as seen in public health campaigns linking personal ownership to higher adherence rates in behavioral interventions.[](https://academic.oup.com/book/56271/chapter/445196864)[](https://www.hoover.org/research/obesity-and-responsibility)\n\nThis debate intensifies around equity and incentives: over-medicalization, critics contend, benefits pharmaceutical industriesâ€”projected to generate $100 billion annually from obesity drugs by 2030â€”while sidelining cost-effective, non-invasive lifestyle modifications that empower self-efficacy without lifelong side effects like gastrointestinal issues or nutrient deficiencies common in surgical patients (affecting up to 20-30%).[](https://journals.sagepub.com/doi/abs/10.1177/1363459316660858) Conversely, defenders of medical approaches note that for Class III obesity (BMI â‰¥40), where lifestyle alone yields only 5-10% loss in 70-80% of cases, interventions like Roux-en-Y gastric bypass achieve 25-30% durable reduction, averting comorbidities such as type 2 diabetes remission in 60-80% of patients.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC7027681/)[](https://www.gastrojournal.org/article/S0016-5085%2817%2930139-7/fulltext) Yet, even here, postoperative recidivism underscores the need for personal commitment, with studies showing that adherence to follow-up nutrition and exercise protocols correlates with 15-20% better long-term outcomes, blurring lines between medical aid and individual discipline.[](https://www.nature.com/articles/s41366-024-01499-2)\n\nSkeptics of predominant medical narratives highlight institutional tendencies to underemphasize behavioral causality, potentially due to funding influences in research favoring drug trials over population-level prevention; for example, while NIH trials confirm lifestyle interventions rival pharmacotherapy in mild-to-moderate obesity (e.g., 5-7% loss vs. 10% for drugs, both with high regain), policy discourse often prioritizes access to treatments over systemic promotion of caloric restraint and activity.[](https://pubmed.ncbi.nlm.nih.gov/20194976/)[](https://nyaspubs.onlinelibrary.wiley.com/doi/full/10.1111/nyas.15278) This tension reflects broader causal realism: obesity's etiology involves volitional elements amenable to first-line self-management, yet medicalization persists as a societal expedient, raising questions about whether it liberates or absolves, particularly when 95% of dieters regain weight long-term absent ongoing vigilance.[](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0117565)\n\n## Societal and Economic Dimensions\n\n### Public Health Implications of Obesity\n\nObesity constitutes a major public health crisis, with global prevalence among adults reaching 16% in 2022, affecting over one billion individuals and marking a tripling since 1975.[](https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight) Projections indicate that by the mid-2030s, more than half of the world's adult populationâ€”approximately 3.8 billion peopleâ€”will be overweight or obese, driven by sustained rises in age-standardized prevalence estimated at 30.7% over the next three decades.[](https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2825%2900355-1/fulltext) In the United States, adult obesity prevalence stood at 40.3% from 2021 to 2023, with severe obesity affecting over 22 million adults, disproportionately impacting certain demographics and exacerbating disparities in health outcomes.[](https://www.cdc.gov/nchs/products/databriefs/db508.htm) These trends reflect a caloric imbalance rooted in dietary excess and sedentary behavior, overwhelming preventive measures and straining global health infrastructures.[](https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight)\n\nThe condition drives a cascade of comorbidities through mechanisms such as chronic inflammation, insulin resistance, and mechanical stress on organs, elevating risks for type 2 diabetes, cardiovascular diseases, and at least 13 types of cancer including endometrial, esophageal, and colorectal.[](https://www.cancer.gov/about-cancer/causes-prevention/risk/obesity/obesity-fact-sheet) Approximately 55% of women's and 24% of men's cancer diagnoses in the U.S. are linked to excess weight, while globally, high body mass index (BMI) accounts for 5.6% of incident cancers when combined with diabetes.[](https://stop.publichealth.gwu.edu/fast-facts/obesity-related-chronic-disease) [](https://pmc.ncbi.nlm.nih.gov/articles/PMC5805864/) Hypertension and dyslipidemia predominate as immediate complications, with prevalence intensifying with age and BMI severity; obesity also independently heightens heart failure risk even after adjusting for confounders like diabetes and smoking.[](https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-024-21061-z) [](https://dom-pubs.onlinelibrary.wiley.com/doi/full/10.1111/dom.16263) Mortality attributable to high BMI reached an estimated 3.7 million deaths from noncommunicable diseases in 2021, primarily cardiovascular and diabetes-related, underscoring obesity's role in shortening life expectancy by up to 10 years in severe cases.[](https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight) [](https://www.cdc.gov/nchs/products/databriefs/db508.htm)\n\nPublic health systems face escalating burdens from obesity's direct medical expenditures and indirect productivity losses, with U.S. costs exceeding $1.4 trillion annually as of 2023, encompassing treatments for comorbidities and absenteeism valued at $3.38â€“6.38 billion yearly.[](https://obesitymedicine.org/blog/health-economic-impact-of-obesity/) [](https://www.cdc.gov/obesity/basics/consequences.html) Globally, these impacts are forecasted to surpass $4 trillion per year by 2035, representing 0.8â€“2.4% of GDP across studied nations and rising to over $18 trillion by 2060 under current trajectories.[](https://www.statnews.com/2023/03/02/obesity-costs-4-trillion-2035/) [](https://data.worldobesity.org/publications/WOF-Economic-Impacts-2-V2.pdf) The epidemic compounds challenges in low- and middle-income countries through a \"double burden\" of malnutrition, where obesity coexists with undernutrition, diverting resources from infectious diseases to chronic care amid overburdened facilities.[](https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2823%2902750-2/fulltext) This fiscal and operational strain necessitates reevaluation of interventions, as traditional public health strategies like education have yielded limited reversal of trends, highlighting the need for scalable treatments to mitigate systemic overload.[](https://www.healthdata.org/news-events/newsroom/news-releases/lancet-more-half-adults-and-third-children-and-adolescents)\n\n### Cost-Benefit Analyses of Bariatric Interventions\n\nBariatric surgeries such as Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy typically incur upfront costs ranging from $20,000 to $30,000 in the United States, encompassing procedure, hospitalization, and initial follow-up, though these vary by procedure type, facility, and insurance coverage.[](https://pubmed.ncbi.nlm.nih.gov/39285034/) These initial expenditures are offset by reductions in long-term healthcare utilization for obesity-related conditions like type 2 diabetes and cardiovascular disease, with multiple analyses demonstrating net cost savings emerging after 2 to 4 years post-surgery.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC10766043/) For instance, commercially insured patients undergoing bariatric surgery experienced lower follow-up costs from year 2 through year 9 compared to non-surgical controls, driven by decreased expenditures on medications and inpatient care for comorbidities.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC10766043/)\n\nComparative economic evaluations highlight bariatric surgery's advantages over pharmacotherapies like GLP-1 receptor agonists (e.g., semaglutide), which require indefinite dosing at annual costs exceeding $10,000 per patient.[](https://pubmed.ncbi.nlm.nih.gov/39285034/) A 2025 cohort study using U.S. insurance claims data found mean 2-year total costs of $51,794 for bariatric surgery versus $63,483 for GLP-1 therapy, alongside superior weight loss (approximately 20-25% total body weight loss with surgery versus 10-15% with drugs in real-world settings).[](https://jamanetwork.com/journals/jamasurgery/fullarticle/2839126)[](https://www.tctmd.com/news/better-outcomes-and-lower-cost-bariatric-surgery-over-glp-1s) Long-term projections indicate surgery achieves cost savings of up to â‚¬24,392 per patient relative to medical management alone, primarily through remission of diabetes (reducing insulin and other therapy needs) and averted cardiovascular events.[](https://www.sciencedirect.com/science/article/pii/S1550728921004950)\n\nCost-effectiveness is frequently assessed via incremental cost-effectiveness ratios (ICERs) measured in quality-adjusted life years (QALYs) gained, with bariatric surgery often falling below common willingness-to-pay thresholds of $50,000-$100,000 per QALY in high-income settings.[](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2789003) RYGB, for example, yields an ICER of $17,497 per QALY gained over a 10-year horizon compared to intensive medical therapy, improving further with extended modeling to lifetime horizons where it becomes cost-saving.[](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2789003) Endoscopic alternatives like sleeve gastroplasty show similar promise, with lifetime cost savings projected for patients with obesity and type 2 diabetes due to comparable metabolic benefits at lower procedural risks.[](https://www.sciencedirect.com/science/article/abs/pii/S2590030724000357) However, short-term analyses (e.g., up to 4 years) may reveal elevated post-operative costs from complications or monitoring, underscoring the need for sustained weight maintenance to realize benefits.[](https://www.americanjournalofsurgery.com/article/S0002-9610%2825%2900488-X/abstract)\n\n| Intervention | Approximate Upfront/Annual Cost (USD) | ICER per QALY Gained (vs. Medical Therapy) | Key Source |\n|--------------|---------------------------------------|--------------------------------------------|------------|\n| RYGB/Sleeve Gastrectomy | $20,000-$30,000 (one-time) | $17,497 (10-year horizon) | [](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2789003) |\n| GLP-1 Agonists (e.g., Semaglutide) | $10,000+ (ongoing) | \u003e$50,000 (short-term; improves long-term if combined with surgery) | [](https://jamanetwork.com/journals/jamasurgery/fullarticle/2839126)[](https://www.facs.org/media-center/press-releases/2024/bariatric-surgery-is-more-cost-effective-than-newer-weight-loss-drugs-alone/) |\n\nSocietal benefits extend beyond direct medical savings to include enhanced workforce productivity and reduced disability claims, with obesity treatment via surgery estimated to yield industry-level savings of $153-326 billion over 5 years through modest population-level weight reductions.[](https://www.nature.com/articles/s41387-024-00352-9) Nonetheless, cost-benefit realizations hinge on patient selection (e.g., BMI â‰¥40 or â‰¥35 with comorbidities), adherence to post-operative lifestyle changes, and access barriers, as suboptimal long-term weight regain in 20-30% of cases can erode projected gains.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC11381104/) Studies emphasizing these factors, often from surgical societies, warrant scrutiny for potential selection bias toward favorable surgical cohorts, though independent claims data corroborate the directional trends.[](https://jamanetwork.com/journals/jamasurgery/fullarticle/2839126)[](https://asmbs.org/news_releases/popular-weight-loss-drugs-prove-more-costly-than-metabolic-and-bariatric-surgery-within-one-year/)"])</script><script nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh">self.__next_f.push([1,"8:[\"$\",\"$L1e\",null,{\"state\":{\"mutations\":[],\"queries\":[{\"dehydratedAt\":1761884348380,\"state\":{\"data\":{\"page\":{\"citations\":[{\"id\":\"1\",\"title\":\"[PDF] Standard of Care: Bariatric ICD 10 Codes: Case Type / Diagnosis\",\"description\":\"Bariatrics is a branch of medicine that aims to control obesity as well as treat patients with obesity and its sequelae1. The purpose of this standard ofÂ ...\",\"url\":\"https://www.brighamandwomens.org/assets/bwh/patients-and-families/rehabilitation-services/pdfs/inpt-bariatic.pdf\",\"favicon\":\"\"},{\"id\":\"2\",\"title\":\"A brief history of bariatric surgery - PMC - NIH\",\"description\":\"Mar 6, 2017 Â· Historical reports claim that the first bariatric surgery was performed in Spain, in the 10th century. Â· Even though specific weight lossÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC6806981/\",\"favicon\":\"\"},{\"id\":\"3\",\"title\":\"[PDF] BARIATRIC PROCEDURES - Oregon.gov\",\"description\":\"May 18, 2023 Â· Evidence indicates that these procedures significantly improve weight outcomes and rates of diabetes remission for patients with T2DM, which isÂ ...\",\"url\":\"https://www.oregon.gov/oha/HPA/DSI-HERC/EvidenceBasedReports/Coverage%2520Guidance%2520-%2520Bariatric%2520Procedures_as-approved-5-18-23.pdf\",\"favicon\":\"\"},{\"id\":\"4\",\"title\":\"Controversies in bariatric surgery - PubMed\",\"description\":\"Weight loss must be durable. Long-term outcome studies (more than 10-year follow-up) show that biliopancreatic diversion is most effective, with 72 per centÂ ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/25690271/\",\"favicon\":\"\"},{\"id\":\"5\",\"title\":\"[PDF] Long-term Cancer Outcome After Bariatric Surgery - CDC Stacks\",\"description\":\"Sep 1, 2024 Â· Reported risk of colorectal cancer following bariatric surgery has been controversial. Retrospective studies have found increased risk forÂ ...\u003c|control11|\u003e\u003c|separator|\u003e\",\"url\":\"https://stacks.cdc.gov/view/cdc/132370/cdc_132370_DS1.pdf\",\"favicon\":\"\"},{\"id\":\"6\",\"title\":\"Bariatric - Etymology, Origin \u0026 Meaning\",\"description\":\"Originating from Greek baros meaning \\\"weight,\\\" combined with -iatric, this term relates to obesity and its medical aspects.Missing:  bariatrics | Show results with:bariatrics\",\"url\":\"https://www.etymonline.com/word/bariatric\",\"favicon\":\"\"},{\"id\":\"7\",\"title\":\"bariatrics, n. meanings, etymology and more\",\"description\":\"OED's earliest evidence for bariatrics is from 1963, in El Paso (Texas) Herald-Post. bariatrics is formed within English, by derivation. Etymons: baro- comb.Â ...\",\"url\":\"https://www.oed.com/dictionary/bariatrics_n\",\"favicon\":\"\"},{\"id\":\"8\",\"title\":\"BARIATRICS Definition \u0026 Meaning - Merriam-Webster\",\"description\":\"Note: According to the blog ConscienHealth (conscienhealth.org), August 1, 2015, the word bariatrics was coined by the physician Raymond E. Dietz in 1961.\",\"url\":\"https://www.merriam-webster.com/dictionary/bariatrics\",\"favicon\":\"\"},{\"id\":\"9\",\"title\":\"bariatric, adj. meanings, etymology and more\",\"description\":\"The earliest known use of the adjective bariatric is in the 1960s. OED's earliest evidence for bariatric is from 1966, in Drug Safety: Hearings before Subcomm.\u003c|separator|\u003e\",\"url\":\"https://www.oed.com/dictionary/bariatric_adj\",\"favicon\":\"\"},{\"id\":\"10\",\"title\":\"Bariatric FAQs\",\"description\":\"Obesity and Bariatric Surgery. What is morbid obesity? Morbid obesity is generally defined as a Body Mass Index (BMI) of 40 or greater, which is roughly equalÂ ...\",\"url\":\"https://bariatrics.stonybrookmedicine.edu/patient-resources/bariatric-faqs\",\"favicon\":\"\"},{\"id\":\"11\",\"title\":\"Bariatric Surgery Procedures - American Society for Metabolic and ...\",\"description\":\"The goal of these operations is to modify the stomach and intestines to treat obesity and related diseases.\",\"url\":\"https://asmbs.org/patients/bariatric-surgery-procedures/\",\"favicon\":\"\"},{\"id\":\"12\",\"title\":\"The Term Bariatric: Time for a Well-Deserved Retirement\",\"description\":\"May 3, 2023 Â· The term bari comes from the Greek and means weight. With a poor understanding of the physiological origins of obesity, early bariatric surgeryÂ ...\",\"url\":\"https://link.springer.com/article/10.1007/s11695-023-06624-0\",\"favicon\":\"\"},{\"id\":\"13\",\"title\":\"Definition \u0026 Facts of Weight-loss Surgery - NIDDK\",\"description\":\"Weight-loss surgery encompasses a group of operations that help you lose weight by making changes to your digestive system.\",\"url\":\"https://www.niddk.nih.gov/health-information/weight-management/bariatric-surgery/definition-facts\",\"favicon\":\"\"},{\"id\":\"14\",\"title\":\"Bariatric Surgery: Practice Essentials, Pathophysiology, Etiology\",\"description\":\"Mar 16, 2023 Â· Bariatric surgery is currently the only modality that provides a significant, sustained weight loss for morbidly obese patients.\",\"url\":\"https://emedicine.medscape.com/article/197081-overview\",\"favicon\":\"\"},{\"id\":\"15\",\"title\":\"Bariatric surgery versus non-surgical treatment for obesity - NIH\",\"description\":\"Oct 22, 2013 Â· Compared with non-surgical treatment of obesity, bariatric surgery leads to greater body weight loss and higher remission rates of type 2 diabetes andÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC3806364/\",\"favicon\":\"\"},{\"id\":\"16\",\"title\":\"Bariatric Surgery Is Superior to Lifestyle Changes + Best Medical ...\",\"description\":\"Jul 12, 2023 Â· Historically, bariatric surgery has had the most efficacious weight loss compared to pharmacotherapy, resulting in 25% to 30% weight reductionÂ ...\",\"url\":\"https://gi.org/journals-publications/ebgi/fu_paul_july2023/\",\"favicon\":\"\"},{\"id\":\"17\",\"title\":\"Bariatric surgery - Mayo Clinic\",\"description\":\"Bariatric surgery is done to help you lose extra weight and reduce your risk of possibly life-threatening weight-related health problems.\",\"url\":\"https://www.mayoclinic.org/tests-procedures/bariatric-surgery/about/pac-20394258\",\"favicon\":\"\"},{\"id\":\"18\",\"title\":\"Type 2 Diabetes and Metabolic Surgery - asmbs\",\"description\":\"2015: Joint statement by the American Heart Association and the ADA recommends bariatric surgery be considered for adults who have a BMI greater than 35 and anÂ ...\u003c|control11|\u003e\u003c|separator|\u003e\",\"url\":\"https://asmbs.org/resources/type-2-diabetes-and-metabolic-surgery-fact-sheet/\",\"favicon\":\"\"},{\"id\":\"19\",\"title\":\"Long-Term Outcomes of Medical Management vs Bariatric Surgery ...\",\"description\":\"Feb 27, 2024 Â· Bariatric surgery led to superior glycemic control compared with medical/lifestyle intervention (between-group difference in hemoglobin A 1c of 1.4% at 7 yearsÂ ...\",\"url\":\"https://jamanetwork.com/journals/jama/fullarticle/2815401\",\"favicon\":\"\"},{\"id\":\"20\",\"title\":\"Treatment of Obesity: Weight Loss and Bariatric Surgery\",\"description\":\"May 27, 2016 Â· This review focuses on the mechanisms underlying, and indications for, bariatric surgery in the reduction of cardiovascular disease (CVD),Â ...\",\"url\":\"https://www.ahajournals.org/doi/10.1161/circresaha.116.307591\",\"favicon\":\"\"},{\"id\":\"21\",\"title\":\"Medical vs. Surgical Obesity Management: A Narrative Review of ...\",\"description\":\"Sep 5, 2025 Â· Bariatric surgery offers the most effective and durable weight loss outcomes, significantly improving obesity-related comorbidities and long-Â ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC12497434/\",\"favicon\":\"\"},{\"id\":\"22\",\"title\":\"Long-term effect of bariatric surgery versus conventional therapy in ...\",\"description\":\"In conclusion, over the long-term, bariatric surgery achieved and maintained significantly greater weight reduction, as well as a decrease in obesity-relatedÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC6543048/\",\"favicon\":\"\"},{\"id\":\"23\",\"title\":\"Surgery is associated with better long-term outcomes than ... - Nature\",\"description\":\"Apr 25, 2024 Â· Several studies have demonstrated the effectiveness of bariatric surgery in the short and medium term for the treatment of obesity. More recentÂ ...\",\"url\":\"https://www.nature.com/articles/s41598-024-57724-5\",\"favicon\":\"\"},{\"id\":\"24\",\"title\":\"Definitions and current indications for obesity and metabolic surgery\",\"description\":\"These operations are for the treatment of the Obesity disease and its related metabolic complications such as, Type 2 Diabetes, hypertension, obstructive sleepÂ ...\",\"url\":\"https://ales.amegroups.org/article/view/6202/html\",\"favicon\":\"\"},{\"id\":\"25\",\"title\":\"Weight management in obesity - past and present - PubMed\",\"description\":\"Health risks of obesity were noted by the Greek physician Hippocrates (460-377 BCE) when the earliest anti-obesity recommendations on diet, exercise, lifestyleÂ ...Missing:  approaches | Show results with:approaches\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/26811245/\",\"favicon\":\"\"},{\"id\":\"26\",\"title\":\"Weight management in obesity â€“ past and present - PMC\",\"description\":\"Early in the 20th century, obese individuals began to search for effective remedies, to reach the societal ideal of slimness; manufacturers preyed upon theirÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC4832440/\",\"favicon\":\"\"},{\"id\":\"27\",\"title\":\"An Historical Review of Steps and Missteps in the Discovery of Anti ...\",\"description\":\"Jul 10, 2022 Â· This review examines some historical developments in the management of obesity prior to the 20 th century followed by more recent efforts to find a â€œcure.â€ABSTRACT Â· TREATMENT OF OBESITY... Â· DRUGS FOR TREATMENT OF...\",\"url\":\"https://www.ncbi.nlm.nih.gov/books/NBK581942/\",\"favicon\":\"\"},{\"id\":\"28\",\"title\":\"Facts and ideas from anywhere - PMC - NIH\",\"description\":\"A high-protein, low-carbohydrate diet was first popularized in 1863 by William Banting (no relation to the discoverer of insulin), a retired London undertakerÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC1317063/\",\"favicon\":\"\"},{\"id\":\"29\",\"title\":\"A brief history of bariatric surgery - ResearchGate\",\"description\":\"... The first bariatric surgery, deemed \\\"jejuno-ileal bypass\\\" was performed in 1954 (Kremen,Linner,and Nelson 15). Though this form ofÂ ...\u003c|separator|\u003e\",\"url\":\"https://www.researchgate.net/publication/314280554_A_brief_history_of_bariatric_surgery\",\"favicon\":\"\"},{\"id\":\"30\",\"title\":\"Jejunoileal bypass: A surgery of the past and a review of its ... - NIH\",\"description\":\"May 14, 2009 Â· Jejunoileal bypass (JIB), popular in the 1960s and 1970s, had remarkable success in achieving weight loss by creating a surgical short bowel syndrome.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC2682245/\",\"favicon\":\"\"},{\"id\":\"31\",\"title\":\"Jejunoileal bypass: a surgery of the past and a review of ... - PubMed\",\"description\":\"May 14, 2009 Â· Jejunoileal bypass (JIB), popular in the 1960s and 1970s, had remarkable success in achieving weight loss by creating a surgical short bowelÂ ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/19437570/\",\"favicon\":\"\"},{\"id\":\"32\",\"title\":\"Gastric bypass in obesity. 1967 - PubMed\",\"description\":\"Gastric bypass in obesity. 1967. ... Obesity, Morbid / surgery. Personal name as subject. E E Mason; C Ito.Missing:  Edward | Show results with:Edward\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/8732969/\",\"favicon\":\"\"},{\"id\":\"33\",\"title\":\"Gastric Bypass in Obesity - ScienceDirect\",\"description\":\"December 1967, Pages 1345-1351. Surgical Clinics of North America. Gastric Bypass in Obesity. Author links open overlay panel. Edward E. Mason M.D., Ph.D.,Â ...\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S0039610916383840\",\"favicon\":\"\"},{\"id\":\"34\",\"title\":\"Evolution of Bariatric Surgery: A Historical Perspective | AJR\",\"description\":\"Jun 21, 2013 Â· The purpose of this article is to describe the evolutionary development of various bariatric surgical techniques and the associated surgical anatomy.Surgical Techniques Â· Jejunoileal Bypass Â· Gastric Bypass With Loop...\",\"url\":\"https://ajronline.org/doi/10.2214/AJR.12.10131\",\"favicon\":\"\"},{\"id\":\"35\",\"title\":\"Vertical Banded Gastroplasty for Obesity | JAMA Surgery\",\"description\":\"This banding provides an outlet diameter that remains constant. In experience with 42 patients during a one-year period, there were fewer complications andÂ ...\",\"url\":\"https://jamanetwork.com/journals/jamasurgery/fullarticle/588469\",\"favicon\":\"\"},{\"id\":\"36\",\"title\":\"GLP-1 Agonists: Wonder Drugs of the 21st Century?\",\"description\":\"Jul 1, 2024 Â· The first drug in a class known as GLP-1 agonists was approved in 2005 to treat diabetes. GLP-1 drugs subsequently proved their mettle to treat obesity.Missing:  bariatrics | Show results with:bariatrics\",\"url\":\"https://medicine.yale.edu/media-player/glp-1-agonists-wonder-drugs-of-the-21st-century/\",\"favicon\":\"\"},{\"id\":\"37\",\"title\":\"The discovery and development of GLP-1 based drugs that ... - PNAS\",\"description\":\"Sep 19, 2024 Â· In 2022, a modified version of the GLP-1/GIP dual agonist, tirzepatide (ZepboundÂ®), developed by Eli Lilly induced an average weight loss of 21Â ...Missing:  21st | Show results with:21st\",\"url\":\"https://www.pnas.org/doi/10.1073/pnas.2415550121\",\"favicon\":\"\"},{\"id\":\"38\",\"title\":\"FDA approves weight management drug for patients aged 12 and ...\",\"description\":\"Dec 4, 2020 Â· Saxenda has been approved since December 2014 for chronic weight management in adults with a BMI of 30 kg/m2 or higher or a BMI of 27 kg/m2 orÂ ...\",\"url\":\"https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-weight-management-drug-patients-aged-12-and-older\",\"favicon\":\"\"},{\"id\":\"39\",\"title\":\"A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight ...\",\"description\":\"Jul 2, 2015 Â· In this study, 3.0 mg of liraglutide, as an adjunct to diet and exercise, was associated with reduced body weight and improved metabolic control.\",\"url\":\"https://www.nejm.org/doi/full/10.1056/NEJMoa1411892\",\"favicon\":\"\"},{\"id\":\"40\",\"title\":\"Liraglutide (Saxenda) for Weight Loss - AAFP\",\"description\":\"Jul 15, 2016 Â· Liraglutide has been shown to be superior to orlistat (Xenical) for achieving clinically significant weight loss at one and two years of use.\",\"url\":\"https://www.aafp.org/pubs/afp/issues/2016/0715/p161.html\",\"favicon\":\"\"},{\"id\":\"41\",\"title\":\"Top Weight Loss Medications | Obesity Medicine Association\",\"description\":\"Jul 29, 2025 Â· Liraglutide is also approved for Type 2 Diabetes, under the brand name Victoza. ... Liraglutide (Saxenda): ~8% average weight loss; PhentermineÂ ...Semaglutide (wegovy... Â· Liraglutide (saxenda) Â· Direct Purchase Options\",\"url\":\"https://obesitymedicine.org/blog/weight-loss-medications/\",\"favicon\":\"\"},{\"id\":\"42\",\"title\":\"Real-World Use of Semaglutide for Weight Management\",\"description\":\"Aug 6, 2024 Â· On 4 June 2021, the U.S. Food and Drug Administration approved semaglutide (Wegovy) for chronic weight management in adults (1) based onÂ ...\",\"url\":\"https://diabetesjournals.org/care/article/47/10/1834/157059/Real-World-Use-of-Semaglutide-for-Weight\",\"favicon\":\"\"},{\"id\":\"43\",\"title\":\"Once-Weekly Semaglutide in Adults with Overweight or Obesity\",\"description\":\"Feb 10, 2021 Â· This 68-week trial evaluated the efficacy and safety of semaglutide as compared with placebo as an adjunct to lifestyle intervention forÂ ...\",\"url\":\"https://www.nejm.org/doi/full/10.1056/NEJMoa2032183\",\"favicon\":\"\"},{\"id\":\"44\",\"title\":\"Long-term weight loss effects of semaglutide in obesity without ...\",\"description\":\"May 13, 2024 Â· In SELECT, at 208 weeks, semaglutide produced clinically significant weight loss and improvements in anthropometric measurements versus placebo.\",\"url\":\"https://www.nature.com/articles/s41591-024-02996-7\",\"favicon\":\"\"},{\"id\":\"45\",\"title\":\"STEP UP Trial Shows Higher Dose of Wegovy Produces Significant ...\",\"description\":\"Jun 25, 2025 Â· An investigational 7.2 mg dose of Wegovy (semaglutide) led to a mean weight loss of 21% in adults with obesity and no diabetes.\",\"url\":\"https://www.appliedclinicaltrialsonline.com/view/wegovy-weight-loss-obesity-diabetes\",\"favicon\":\"\"},{\"id\":\"46\",\"title\":\"Study Finds Bariatric Surgery Declined with Rise in GLP-1 Drugs to ...\",\"description\":\"Oct 25, 2024 Â· Researchers documented a 105.7% increase in patients prescribed GLP-1 drugs between 2022 and 2023, and an 8.7% decrease in patients undergoingÂ ...\",\"url\":\"https://www.massgeneralbrigham.org/en/about/newsroom/press-releases/study-finds-bariatric-surgery-declined-with-rise-in-glp-1-drugs\",\"favicon\":\"\"},{\"id\":\"47\",\"title\":\"FDA Approves New Medication for Chronic Weight Management\",\"description\":\"Nov 8, 2023 Â· Those randomized to receive the highest approved dosage of Zepbound (15 mg once weekly) lost on average 12% of their body weight compared toÂ ...\u003c|separator|\u003e\",\"url\":\"https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management\",\"favicon\":\"\"},{\"id\":\"48\",\"title\":\"Tirzepatide Once Weekly for the Treatment of Obesity\",\"description\":\"Jun 4, 2022 Â· In this 72-week trial in participants with obesity, 5 mg, 10 mg, or 15 mg of tirzepatide once weekly provided substantial and sustained reductions in bodyÂ ...\",\"url\":\"https://www.nejm.org/doi/full/10.1056/NEJMoa2206038\",\"favicon\":\"\"},{\"id\":\"49\",\"title\":\"Tirzepatide as Compared with Semaglutide for the Treatment of ...\",\"description\":\"May 11, 2025 Â· In our trial, adults with obesity but without diabetes had a 20.2% reduction in weight at 72 weeks when receiving tirzepatide, as compared withÂ ...\",\"url\":\"https://www.nejm.org/doi/full/10.1056/NEJMoa2416394\",\"favicon\":\"\"},{\"id\":\"50\",\"title\":\"Zepbound (tirzepatide) showed superior weight loss over Wegovy ...\",\"description\":\"May 11, 2025 Â· Participants treated with Zepbound achieved an average weight reduction of 20.2% compared to 13.7% with Wegovy at 72 weeks using the treatment-regimen estimand.\",\"url\":\"https://www.prnewswire.com/news-releases/zepbound-tirzepatide-showed-superior-weight-loss-over-wegovy-semaglutide-in-complete-surmount-5-results-published-in-the-new-england-journal-of-medicine-302451241.html\",\"favicon\":\"\"},{\"id\":\"51\",\"title\":\"Novel GLP-1-based Medications for Type 2 Diabetes and Obesity\",\"description\":\"Oct 7, 2025 Â· GLP-1 receptor agonists have revolutionized treatment paradigms for type 2 diabetes and obesity, and next-generation agents are building on thisÂ ...\",\"url\":\"https://academic.oup.com/edrv/advance-article/doi/10.1210/endrev/bnaf036/8276515?searchresult=1\",\"favicon\":\"\"},{\"id\":\"52\",\"title\":\"GLP-1 receptor agonists, are we witnessing the emergence of a ...\",\"description\":\"A plethora of clinical trials have consistently validated the capacity of GLP-1RAs to improve glycemic control, promote weight loss, and mitigate cardiovascularÂ ...\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S0163725825000361\",\"favicon\":\"\"},{\"id\":\"53\",\"title\":\"Obesity Pathogenesis: An Endocrine Society Scientific Statement\",\"description\":\"Obesity pathogenesis involves two related but distinct processes: (1) sustained positive energy balance (energy intake \u003e energy expenditure) and (2) resettingÂ ...Abstract Â· Energy Homeostasis and the... Â· Mechanisms of Obesity... Â· Abbreviations\",\"url\":\"https://academic.oup.com/edrv/article/38/4/267/3892397\",\"favicon\":\"\"},{\"id\":\"54\",\"title\":\"Mechanisms, Pathophysiology, and Management of Obesity\",\"description\":\"Jan 19, 2017 Â· With weight gain over time, excess lipids are distributed to many body compartments. Subcutaneous adipose tissue holds most of the stored lipidÂ ...\",\"url\":\"https://www.nejm.org/doi/full/10.1056/NEJMra1514009\",\"favicon\":\"\"},{\"id\":\"55\",\"title\":\"Physiology, Obesity Neurohormonal Appetite And Satiety Control\",\"description\":\"Through the interactions of ghrelin and leptin, the hypothalamus can regulate the sensation of hunger and satiety, leading to energy homeostasis.\",\"url\":\"https://www.ncbi.nlm.nih.gov/books/NBK555906/\",\"favicon\":\"\"},{\"id\":\"56\",\"title\":\"Obesity: A Review of Pathophysiology and Classification - PMC\",\"description\":\"Dec 1, 2024 Â· A positive energy balance drives weight gain. Established genetic and environmental factors are associated with a positive energy balance andÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC10843116/\",\"favicon\":\"\"},{\"id\":\"57\",\"title\":\"The genetics of obesity: from discovery to biology - Nature\",\"description\":\"Sep 23, 2021 Â· Twin, family and adoption studies have estimated the heritability of obesity to be between 40% and 70%. As a consequence, genetic approaches canÂ ...\u003c|separator|\u003e\",\"url\":\"https://www.nature.com/articles/s41576-021-00414-z\",\"favicon\":\"\"},{\"id\":\"58\",\"title\":\"Genetics of Obesity in Humans: A Clinical Review - PMC\",\"description\":\"The melanocortin-4 receptor (MC4R) gene is now considered the most common associated gene for childhood obesity and found in about 4% of affected cases prior toÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC9569701/\",\"favicon\":\"\"},{\"id\":\"59\",\"title\":\"Association of FTO and near MC4R variants with obesity measures ...\",\"description\":\"FTO and near MC4R variants are associated with obesity ... The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylaseÂ ...\",\"url\":\"https://www.sciencedirect.com/science/article/abs/pii/S1871403X16000090\",\"favicon\":\"\"},{\"id\":\"60\",\"title\":\"Polygenic prediction of body mass index and obesity through the life ...\",\"description\":\"Jul 21, 2025 Â· Polygenic scores (PGSs) for body mass index (BMI) may guide early prevention and targeted treatment of obesity. Using genetic data from upÂ ...\",\"url\":\"https://www.nature.com/articles/s41591-025-03827-z\",\"favicon\":\"\"},{\"id\":\"61\",\"title\":\"The Genetic Blueprint of Obesity: From Pathogenesis to Novel ...\",\"description\":\"Jul 11, 2025 Â· The MC4R gene, located on chromosome 18, is recognized as the most frequent childhood obesity-associated gene [139]. The rs17782313 variant wasÂ ...\",\"url\":\"https://onlinelibrary.wiley.com/doi/10.1111/obr.13978\",\"favicon\":\"\"},{\"id\":\"62\",\"title\":\"Leptin physiology and pathophysiology: knowns and unknowns 30 ...\",\"description\":\"Jan 2, 2024 Â· Most individuals with obesity have high leptin levels to which they are partially resistant, causing them to be unresponsive to exogenous leptinÂ ...Discovery of leptin Â· Uncovering the role of leptin in... Â· Footnotes\",\"url\":\"https://www.jci.org/articles/view/174595\",\"favicon\":\"\"},{\"id\":\"63\",\"title\":\"Association of Leptin With Obesity and Insulin Resistance - PMC\",\"description\":\"Dec 19, 2020 Â· Studies have suggested that hyperinsulinemia can be a potential cause of leptin resistance and hence obesity, eventually leading to metabolicÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC7815269/\",\"favicon\":\"\"},{\"id\":\"64\",\"title\":\"Leptin and Obesity: Role and Clinical Implication - Frontiers\",\"description\":\"The blockade of glucose transports or glycolysis in the presence of high insulin levels inhibits the expression and secretion of leptin in adipocytes (51, 53).Abstract Â· Introduction Â· Leptin and Its Cognate Receptor Â· Leptin and Obesity\",\"url\":\"https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2021.585887/full\",\"favicon\":\"\"},{\"id\":\"65\",\"title\":\"Metabolic factors in obesity - PubMed\",\"description\":\"Metabolic factors in obesity ... The positive correlation of leptin with insulin resistance index may suggest a major role of leptin in insulin resistance.\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/20432812/\",\"favicon\":\"\"},{\"id\":\"66\",\"title\":\"Behavioral Determinants of Obesity: Research Findings and Policy ...\",\"description\":\"These obesity-promoting behaviours include frequent fast food consumption, eating occasions away from home, large portion sizes, high consumption of beveragesÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC3431098/\",\"favicon\":\"\"},{\"id\":\"67\",\"title\":\"Contribution of a sedentary lifestyle and inactivity to the ... - PubMed\",\"description\":\"This review provides clear evidence that low levels of physical activity are associated with an increased risk of weight gain and obesity.\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/10593524/\",\"favicon\":\"\"},{\"id\":\"68\",\"title\":\"New study blames diet, not physical inactivity, for obesity crisis\",\"description\":\"Jul 14, 2025 Â· A new study concludes diet is by far the most important driver of obesity in more economically developed countries.\",\"url\":\"https://www.science.org/content/article/new-study-blames-diet-not-physical-inactivity-obesity-crisis\",\"favicon\":\"\"},{\"id\":\"69\",\"title\":\"Obesity in children and adolescents: epidemiology, causes ...\",\"description\":\"Mar 3, 2022 Â· Other biobehavioural factors such as poor sleep quality, adversity, stress, and medications (causing iatrogenic weight gain) can also serve toÂ ...\",\"url\":\"https://www.thelancet.com/journals/landia/article/PIIS2213-8587%2822%2900047-X/fulltext\",\"favicon\":\"\"},{\"id\":\"70\",\"title\":\"Behavioral, contextual and biological factors associated with obesity ...\",\"description\":\"There was conflicting evidence for the contribution of dietary intake, physical activity, sedentary behavior, sleep, food store environment, school foodÂ ...\u003c|separator|\u003e\",\"url\":\"https://www.researchgate.net/publication/332286809_Behavioral_contextual_and_biological_factors_associated_with_obesity_during_adolescence_A_systematic_review\",\"favicon\":\"\"},{\"id\":\"71\",\"title\":\"Food environment and obesity: a systematic review and meta-analysis\",\"description\":\"Apr 22, 2024 Â· Background Obesity is influenced by a complex, multifaceted system of determinants, including the food environment.\",\"url\":\"https://nutrition.bmj.com/content/early/2024/04/21/bmjnph-2023-000663\",\"favicon\":\"\"},{\"id\":\"72\",\"title\":\"Outdoor environment and obesity: A review of current evidence\",\"description\":\"Most studies have shown an inverse association of obesity with the availability of safe outdoor green and open spaces, which favor physical activity. PhysicalÂ ...\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S258993682400063X\",\"favicon\":\"\"},{\"id\":\"73\",\"title\":\"Associations between the built environment and obesity\",\"description\":\"Feb 1, 2021 Â· A systematic review of environmental factors and obesogenic dietary intakes among adults: are we getting closer to understanding obesogenicÂ ...\",\"url\":\"https://ij-healthgeographics.biomedcentral.com/articles/10.1186/s12942-021-00260-6\",\"favicon\":\"\"},{\"id\":\"74\",\"title\":\"Social and Environmental Factors Influencing Obesity - NCBI - NIH\",\"description\":\"Oct 12, 2019 Â· Obesity prevalence is significantly associated with sex, racial ethnic identity, and socioeconomic status, which creates complex relationshipsÂ ...\",\"url\":\"https://www.ncbi.nlm.nih.gov/books/NBK278977/\",\"favicon\":\"\"},{\"id\":\"75\",\"title\":\"Is Metabolic and Bariatric Surgery Right for You? - asmbs\",\"description\":\"MBS is recommended for individuals with BMI â‰¥35 kg/m2, regardless of presence, absence, or severity of co-morbidities. Â· MBS is recommended in patients with T2DÂ ...\",\"url\":\"https://asmbs.org/patients/is-metabolic-and-bariatric-surgery-right-for-you/\",\"favicon\":\"\"},{\"id\":\"76\",\"title\":\"2022 American Society of Metabolic and Bariatric Surgery (ASMBS ...\",\"description\":\"Metabolic and bariatric surgery (MBS) is recommended for individuals with a body mass index (BMI) \u003e35 kg/m2, regardless of presence, absence, or severity ofÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC9834364/\",\"favicon\":\"\"},{\"id\":\"77\",\"title\":\"ASMBS/IFSO Guidelines for Metabolic and Bariatric Surgery\",\"description\":\"Mar 16, 2023 Â· MBS should be considered for individuals who have metabolic disease and a BMI between 30 and 34.9 kg/m2. In the Asian population, BMI thresholdsÂ ...Missing:  criteria | Show results with:criteria\",\"url\":\"https://emedicine.medscape.com/article/197081-guidelines\",\"favicon\":\"\"},{\"id\":\"78\",\"title\":\"Scientific Evidence for the Updated Guidelines on Indications for ...\",\"description\":\"Sep 25, 2024 Â· MBS should be considered in patients with a BMI of 30â€“34.9 kg/m2 who do not achieve substantial or durable weight loss or co-morbidityÂ ...Introduction Â· Bmi Criteria For Mbs Â· Mbs In The High-Risk...\",\"url\":\"https://link.springer.com/article/10.1007/s11695-024-07370-7\",\"favicon\":\"\"},{\"id\":\"79\",\"title\":\"Bariatric Surgery Guidelines and Recommendations - asmbs\",\"description\":\"Surgery should be an accepted option in people who have type 2 diabetes and a BMI of 35 or more. Surgery should be considered as an alternative treatment optionÂ ...Missing:  eligibility | Show results with:eligibility\",\"url\":\"https://asmbs.org/resources/bariatric-surgery-guidelines-and-recommendations/\",\"favicon\":\"\"},{\"id\":\"80\",\"title\":\"ASMBS pediatric metabolic and bariatric surgery guidelines, 2018\",\"description\":\"Overview of patient selection: A BMI â‰¥120% of the 95th percentile with a co-morbidity or a BMI â‰¥140% of the 95th percentile should be used whenÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC6097871/\",\"favicon\":\"\"},{\"id\":\"81\",\"title\":\"Perioperative Care for Metabolic and Bariatric Surgery - NCBI - NIH\",\"description\":\"Sep 2, 2025 Â· Updated eligibility criteria: BMI 35 kg/mÂ² and higher, regardless of comorbidities; BMI 30 to 34.9 kg/mÂ² with metabolic disease. SafetyÂ ...\u003c|control11|\u003e\u003c|separator|\u003e\",\"url\":\"https://www.ncbi.nlm.nih.gov/books/NBK546667/\",\"favicon\":\"\"},{\"id\":\"82\",\"title\":\"Pharmacologic Therapy for Obesity - StatPearls - NCBI Bookshelf\",\"description\":\"Feb 12, 2024 Â· They are approved for obesity treatment in adults with a BMI greater than or equal to 30 kg/m or with a BMI greater than or equal to 27 kg/mÂ ...Continuing Education Activity Â· Issues of Concern Â· Clinical Significance\",\"url\":\"https://www.ncbi.nlm.nih.gov/books/NBK562269/\",\"favicon\":\"\"},{\"id\":\"83\",\"title\":\"Pharmacotherapy for Obesity: Recent Updates - PMC\",\"description\":\"Sep 19, 2025 Â· In this narrative review we describe the recent updates regarding anti-obesity medications as of February 2025. We describe the physiologicÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC12456317/\",\"favicon\":\"\"},{\"id\":\"84\",\"title\":\"8. Obesity and Weight Management for the Prevention and ...\",\"description\":\"Dec 9, 2024 Â· This section aims to provide evidence-based recommendations for obesity management, including behavioral, pharmacologic, and surgical interventions,\",\"url\":\"https://diabetesjournals.org/care/article/48/Supplement_1/S167/157555/8-Obesity-and-Weight-Management-for-the-Prevention\",\"favicon\":\"\"},{\"id\":\"85\",\"title\":\"[PDF] Pharmacotherapy 2025 Update_FINAL_NORTH STAR Edited\",\"description\":\"Aug 11, 2025 Â· Obesity pharmacotherapy should be tailored to the individual, and medication should be titrated as tolerated to achieve the desired clinicalÂ ...\",\"url\":\"https://obesitycanada.ca/wp-content/uploads/2025/08/11-Canadian-Adult-Obesity-CPG-Pharmacotherapy-2025-update.pdf\",\"favicon\":\"\"},{\"id\":\"86\",\"title\":\"AGA Clinical Practice Guideline on Pharmacological Interventions ...\",\"description\":\"The panel strongly recommended the use of pharmacotherapy in addition to lifestyle intervention in adults with overweight and obesity (body mass index â‰¥30 kg/m2Â ...\",\"url\":\"https://www.gastrojournal.org/article/S0016-5085%2822%2901026-5/fulltext\",\"favicon\":\"\"},{\"id\":\"87\",\"title\":\"Pharmacotherapy for obesity: are we ready to select, tailor and ...\",\"description\":\"Comorbidities. BMI is currently the primary criterion for prescribing weight loss medications with thresholds of â‰¥30 kg/mÂ² for general obesity and â‰¥27 kg/mÂ²Â ...Abstract Â· Introduction Â· Combining lines of treatment Â· Developing an algorithm for...Missing:  eligibility | Show results with:eligibility\",\"url\":\"https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1569468/full\",\"favicon\":\"\"},{\"id\":\"88\",\"title\":\"Obesity and Its Comorbidities: Current Treatment Options, Emerging ...\",\"description\":\"Sep 12, 2025 Â· Defined by excessive fat accumulation, obesity significantly increases the risk of numerous diseases, including type 2 diabetes mellitus (T2DM),Â ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC12439710/\",\"favicon\":\"\"},{\"id\":\"89\",\"title\":\"Obesity, obstructive sleep apnea and type 2 diabetes mellitus\",\"description\":\"Even in people with pre-diabetes and morbid obesity, there is a twofold increased rate of OSA compared to morbid obese controls with normoglycemia.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC6112821/\",\"favicon\":\"\"},{\"id\":\"90\",\"title\":\"Bariatric Surgery Complications - StatPearls - NCBI - NIH\",\"description\":\"Feb 8, 2025 Â· Morbid obesity is associated with several significant comorbidities, including obstructive sleep apnea, hypertension, type 2 diabetes mellitus,Â ...\",\"url\":\"https://www.ncbi.nlm.nih.gov/books/NBK615299/\",\"favicon\":\"\"},{\"id\":\"91\",\"title\":\"Prevalence of obstructive sleep apnea in obese patients candidates ...\",\"description\":\"Obstructive sleep apnoea (OSA) is a highly prevalent disease in the obese population, and even higher in candidates for bariatric surgery, at between 63% and 83Â ...\",\"url\":\"https://www.sciencedirect.com/science/article/abs/pii/S2173573524000656\",\"favicon\":\"\"},{\"id\":\"92\",\"title\":\"Type 2 diabetes and pre-diabetes are associated with obstructive ...\",\"description\":\"In accordance with Foster et al, we have demonstrated a particularly high prevalence of OSA among severely obese patients with T2DM (78% in our study asÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC3206416/\",\"favicon\":\"\"},{\"id\":\"93\",\"title\":\"Biological effects of bariatric surgery on obesity-related comorbidities\",\"description\":\"The present paper reviews the types of bariatric surgical procedures and their impact on diabetes, sleep apnea, dyslipidemia and hypertension; 4 major obesity-Â ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC3569476/\",\"favicon\":\"\"},{\"id\":\"94\",\"title\":\"Systematic review of obesity surgery mortality risk score - PubMed\",\"description\":\"This systematic review analyses obesity surgery mortality risk score (OS-MRS) as a tool for pre-operative prediction of mortality risk in bariatric surgery.\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/22535443/\",\"favicon\":\"\"},{\"id\":\"95\",\"title\":\"Obesity Surgery Mortality Risk Score (OS-MRS) - MDCalc\",\"description\":\"The Obesity Surgery Mortality Risk Score evaluates mortality risk in patients undergoing gastric bypass surgery.\",\"url\":\"https://www.mdcalc.com/calc/10520/obesity-surgery-mortality-risk-score-os-mrs\",\"favicon\":\"\"},{\"id\":\"96\",\"title\":\"Usefulness of the Obesity Surgery Mortality Risk Score (OR-MRS) in ...\",\"description\":\"Jun 19, 2015 Â· The OS-MRS can be a useful clinical tool for choosing the appropriate laparoscopic bariatric procedure, depending on the risk of postoperativeÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC4520850/\",\"favicon\":\"\"},{\"id\":\"97\",\"title\":\"Risk stratification of serious adverse events after gastric bypass in ...\",\"description\":\"The purpose of this study was to develop and validate a risk stratification model of composite adverse events related to Roux-en-Y gastric bypass (RYGB) surgeryÂ ...\",\"url\":\"https://www.sciencedirect.com/science/article/abs/pii/S1550728912003292\",\"favicon\":\"\"},{\"id\":\"98\",\"title\":\"Metaâ€analysis of patient risk factors associated with postâ€bariatric ...\",\"description\":\"Jul 1, 2022 Â· The purpose of this study is to identify and determine the effect of modifiable risk factors on post-operative bariatric surgery leak, as pre-Â ...\",\"url\":\"https://onlinelibrary.wiley.com/doi/full/10.1002/osp4.628\",\"favicon\":\"\"},{\"id\":\"99\",\"title\":\"Lifestyle Modification Approaches for the Treatment of Obesity ... - NIH\",\"description\":\"This article reviews the principal components of comprehensive lifestyle modification, which include diet, physical activity, and behavior therapy.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC7027681/\",\"favicon\":\"\"},{\"id\":\"100\",\"title\":\"Long-term weight-loss maintenance: a meta-analysis of US studies\",\"description\":\"Five years after completing structured weight-loss programs, the average individual maintained a weight loss of \u003e3 kg and a reduced weight of \u003e3% of initialÂ ...\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S0002916523063748\",\"favicon\":\"\"},{\"id\":\"101\",\"title\":\"Maintenance of lost weight and long-term management of obesity\",\"description\":\"In contrast, numerous studies show that diet, exercise, and behavioral counseling, in the best of cases, only leads to 5â€“10% average weight loss, and fewÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC5764193/\",\"favicon\":\"\"},{\"id\":\"102\",\"title\":\"The Safety and Efficacy of a Controlled Low-Energy ('Very-Low ...\",\"description\":\"A highly supplemented controlled low-energy diet is a safe and efficacious treatment for diabetes and obesity, leading to significant decreases in weight,Â ...\u003c|separator|\u003e\",\"url\":\"https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/609705\",\"favicon\":\"\"},{\"id\":\"103\",\"title\":\"Efficacy and safety of very low calorie ketogenic diet (VLCKD) in ...\",\"description\":\"The present review supports the use of VLCKD as an effective strategy for the management of overweight and obesity.\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/31705259/\",\"favicon\":\"\"},{\"id\":\"104\",\"title\":\"Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 ...\",\"description\":\"Jun 24, 2013 Â· The control group had a gradual but consistent weight loss throughout the study, resulting in an average weight loss of 3.5% at the end of theÂ ...\",\"url\":\"https://www.nejm.org/doi/full/10.1056/NEJMoa1212914\",\"favicon\":\"\"},{\"id\":\"105\",\"title\":\"The Look AHEAD Trial: A Review and Discussion Of Its Outcomes\",\"description\":\"At 1 year, the severely obese lost 9.04% of initial body weight while the overweight lost 7.43% (32). â€œAll BMI groups had comparable improvements in fitness,Â ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC4339027/\",\"favicon\":\"\"},{\"id\":\"106\",\"title\":\"Behavioral Treatment of Obesity - PMC - NIH\",\"description\":\"Behavioral treatment is usually provided on a weekly basis for an initial period of 4 to 6 months. Programs that are focused on building weight loss maintenanceÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC3233993/\",\"favicon\":\"\"},{\"id\":\"107\",\"title\":\"Behavioral Approaches to Obesity Treatment - StatPearls - NCBI - NIH\",\"description\":\"Jan 31, 2024 Â· Successful behavioral approaches to treat obesity are based on counseling tools used in psychotherapy for conditions like smoking and alcohol abuse.\",\"url\":\"https://www.ncbi.nlm.nih.gov/books/NBK570565/\",\"favicon\":\"\"},{\"id\":\"108\",\"title\":\"Long-Term Effect of Weight Regain Following Behavioral Weight ...\",\"description\":\"Mar 28, 2023 Â· Despite weight regain, BWMPs reduce cardiometabolic risk factors with effects lasting at least 5 years after program end and dwindling with weight regain.\",\"url\":\"https://www.ahajournals.org/doi/10.1161/CIRCOUTCOMES.122.009348\",\"favicon\":\"\"},{\"id\":\"109\",\"title\":\"Pharmacotherapy for obesity management in adults: 2025 clinical ...\",\"description\":\"Aug 10, 2025 Â· Pharmacotherapy in obesity facilitates clinically meaningful weight loss and important improvements in obesity-related health complications.\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/40789597/\",\"favicon\":\"\"},{\"id\":\"110\",\"title\":\"Obesity Treatment With Bariatric Surgery vs GLP-1 Receptor Agonists\",\"description\":\"Sep 17, 2025 Â· The most effective treatment of class II and III obesity is metabolic bariatric surgery (MBS), which is usually considered a last resort.Missing:  pharmacological | Show results with:pharmacological\",\"url\":\"https://jamanetwork.com/journals/jamasurgery/fullarticle/2839126\",\"favicon\":\"\"},{\"id\":\"111\",\"title\":\"Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists ...\",\"description\":\"Jan 7, 2025 Â· GLP-1 RAs and co-agonists are efficacious for weight loss, with reported safety concerns predominantly gastrointestinal in nature, when used among adults withÂ ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/39761578/\",\"favicon\":\"\"},{\"id\":\"112\",\"title\":\"A systematic review and meta-analysis of the efficacy and safety of ...\",\"description\":\"Oct 2, 2025 Â· This systematic review and network meta-analysis evaluated the efficacy and safety of obesity management medications (OMMs) in terms ofÂ ...Missing:  eligibility | Show results with:eligibility\",\"url\":\"https://www.nature.com/articles/s41591-025-03978-z\",\"favicon\":\"\"},{\"id\":\"113\",\"title\":\"Weight loss outcomes, tolerability, side effects, and risks\",\"description\":\"GLP-1RAs are effective in managing obesity, their use is associated with gastrointestinal side effects and rare but serious adverse events.\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S2667368124000299\",\"favicon\":\"\"},{\"id\":\"114\",\"title\":\"Recent progress in the pharmacotherapy for obesity - ScienceDirect\",\"description\":\"Sep 5, 2025 Â· In this review, we explore current anti-obesity medications (AOMs) such as gastrointestinal lipase inhibitors, nutrient-stimulated hormone-based therapies, andÂ ...\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S0014299925006041\",\"favicon\":\"\"},{\"id\":\"115\",\"title\":\"ASMBS Endorsed Procedures and FDA Approved Devices\",\"description\":\"Jul 24, 2025 Â· ASMBS Endorsed Procedures Â· Adjustable Gastric Banding (FDA approved) Â· Sleeve Gastrectomy Â· Roux-en-Y Gastric Bypass Â· Biliopancreatic DiversionÂ ...\",\"url\":\"https://asmbs.org/resources/endorsed-procedures-and-devices/\",\"favicon\":\"\"},{\"id\":\"116\",\"title\":\"The advantages and disadvantages of sleeve gastrectomy - NIH\",\"description\":\"Feb 29, 2020 Â· The most common complications of sleeve gastrectomy are bleeding, nutrient deficiencies, and leakage.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC7052082/\",\"favicon\":\"\"},{\"id\":\"117\",\"title\":\"The use of adjustable gastric bands for management of severe ... - NIH\",\"description\":\"In summary, all of the studies with at least 10-year follow-up suggest that a clinically significant total body weight loss of 16â€“20% is maintained in the longÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC5127420/\",\"favicon\":\"\"},{\"id\":\"118\",\"title\":\"The Truth About Adjustable Gastric Banding Surgery\",\"description\":\"Jan 16, 2020 Â· Adjustable gastric banding is not as effective as other weight-loss surgeries. Studies have consistently shown other procedures are more effective than gastricÂ ...\",\"url\":\"https://www.templehealth.org/about/blog/truth-about-adjustable-gastric-banding-surgery\",\"favicon\":\"\"},{\"id\":\"119\",\"title\":\"\",\"description\":\"\",\"url\":\"https://asmbs.org/resources/estimate-of-bariatric-surgery-numbers\",\"favicon\":\"\"},{\"id\":\"120\",\"title\":\"Ten year comparative analysis of sleeve gastrectomy, Roux-en-Y ...\",\"description\":\"Nov 3, 2021 Â· Conclusions: Our study demonstrated that the BPD/DS is the most effective operation at long-term reduction of BMI and achieved highest %TWLÂ ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/34731300/\",\"favicon\":\"\"},{\"id\":\"121\",\"title\":\"About the ASMBS Integrated Health Section\",\"description\":\"Integrated Health professionals prepare, counsel and support in order to optimize the benefits of weight loss surgery. The Integrated Health professional isÂ ...Missing:  approaches | Show results with:approaches\",\"url\":\"https://asmbs.org/integrated-health/about-the-asmbs-integrated-health-section/\",\"favicon\":\"\"},{\"id\":\"122\",\"title\":\"an integrated interdisciplinary team approach pre- and post-bariatric ...\",\"description\":\"The integrated, interdisciplinary team approach to bariatric surgery patients using a hub-and-spokes model addresses several of the challenges inherent toÂ ...\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S1550728916308103\",\"favicon\":\"\"},{\"id\":\"123\",\"title\":\"Effectiveness of a Multidisciplinary Treatment Program for Severe ...\",\"description\":\"Jun 11, 2025 Â· Evidence supports the effectiveness of MIPs, even among patients with severe obesity [15,16,17].\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC12194354/\",\"favicon\":\"\"},{\"id\":\"124\",\"title\":\"Using multi-disciplinary teams to treat obese patients helps improve ...\",\"description\":\"In summary, for obese patients, MDTs from the GP's perspective are conducive to increasing the weight loss success rate, improving the blood glucose, bloodÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC8129361/\",\"favicon\":\"\"},{\"id\":\"125\",\"title\":\"Effectiveness of Combining Antiobesity Medication With an ...\",\"description\":\"Jul 13, 2021 Â· Clinically meaningful superior mean weight loss was achieved when access to AOMs was provided in the real-world setting of an employer-based WMP, compared withÂ ...\",\"url\":\"https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2781926\",\"favicon\":\"\"},{\"id\":\"126\",\"title\":\"Use of Weight Loss Drugs Before Bariatric Surgery Has Soared in ...\",\"description\":\"Oct 3, 2025 Â· New research findings show a significant increase in the use of weight loss drugs among patients undergoing metabolic and bariatric surgery,Â ...\",\"url\":\"https://www.facs.org/media-center/press-releases/2025/use-of-weight-loss-drugs-before-bariatric-surgery-has-soared-in-recent-years-study-finds/\",\"favicon\":\"\"},{\"id\":\"127\",\"title\":\"One in Seven Bariatric Surgery Patients Turn to New Weight Loss ...\",\"description\":\"Aug 27, 2025 Â· Several clinical trials and observational studies suggest that GLP-1 drugs are effective in causing weight loss and improved blood sugar controlÂ ...\",\"url\":\"https://publichealth.jhu.edu/2025/one-in-seven-bariatric-surgery-patients-turn-to-new-weight-loss-drugs\",\"favicon\":\"\"},{\"id\":\"128\",\"title\":\"Pharmacologic Disruption: How Emerging Weight Loss Therapies ...\",\"description\":\"Jul 18, 2025 Â· Recent advances in pharmacotherapyâ€”including GLP-1 receptor agonists, dual and triple incretin agonists, and amylin-based combination therapiesâ€”Â ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC12299311/\",\"favicon\":\"\"},{\"id\":\"129\",\"title\":\"\",\"description\":\"\",\"url\":\"https://www.goodrx.com/conditions/weight-loss/new-weight-loss-drugs\",\"favicon\":\"\"},{\"id\":\"130\",\"title\":\"Emerging Trends in Endoscopic Bariatric Therapies - PubMed\",\"description\":\"Jul 2, 2025 Â· This review examines established EBTs, including endoscopic sleeve gastroplasty (ESG), intragastric balloons (IGBs), and transoral outletÂ ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/40649055/\",\"favicon\":\"\"},{\"id\":\"131\",\"title\":\"Combining obesity pharmacotherapy with endoscopic bariatric and ...\",\"description\":\"This article will review available obesity pharmacotherapy options and describe current data on combining EBMT and pharmacotherapy.\",\"url\":\"https://www.sciencedirect.com/science/article/abs/pii/S2590030720300994\",\"favicon\":\"\"},{\"id\":\"132\",\"title\":\"Multi-modal neo-adjuvant anti-obesity medications may be ... - Nature\",\"description\":\"Jun 2, 2025 Â· Multi-modal anti-obesity medications (mmAOM) may enhance preoperative weight loss compared to non-pharmacologic medically supervised weight lossÂ ...\u003c|control11|\u003e\u003c|separator|\u003e\",\"url\":\"https://www.nature.com/articles/s41366-025-01798-2\",\"favicon\":\"\"},{\"id\":\"133\",\"title\":\"Bariatric Surgery vs. GLP-1 Medications: What the Latest Research ...\",\"description\":\"New Study Highlights Superiority of Bariatric Surgery Over GLP-1 Medications for Sustained Weight Loss. A new real-world study presented at the ASMBS 2025Â ...\",\"url\":\"https://asmbs.org/resources/glp-1-medications-vs-bariatric-surgery-what-the-latest-research-shows/\",\"favicon\":\"\"},{\"id\":\"134\",\"title\":\"Pharmacotherapy and metabolic/bariatric surgery: either or both?\",\"description\":\"Aug 30, 2025 Â· The potential for anti-obesity medications to replace or be an adjunct to bariatric surgery. Since the weight loss with some AOMs in randomisedÂ ...Missing:  pharmacological | Show results with:pharmacological\",\"url\":\"https://www.nature.com/articles/s41366-025-01897-0\",\"favicon\":\"\"},{\"id\":\"135\",\"title\":\"Long-term outcomes of bariatric surgery: An eight-year study at a ...\",\"description\":\"Excess Weight Loss (%EWL) peaked at 75.09 % by the third year, while Total Weight Loss (%TWL) sustained at 33.41 % after two years. ... bariatric surgeryÂ ...\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S2667008924000090\",\"favicon\":\"\"},{\"id\":\"136\",\"title\":\"Weight loss outcomes and associated factors after metabolic ...\",\"description\":\"At 2-years post-surgery, 43.6 â€‹% achieved â‰¥50 %EWL, and 44.1 â€‹% achieved â‰¥20%TWL, with 31.8 â€‹% maintaining this at 5-years. Depending on the definition used,Â ...\",\"url\":\"https://www.americanjournalofsurgery.com/article/S0002-9610%2824%2900703-7/fulltext\",\"favicon\":\"\"},{\"id\":\"137\",\"title\":\"Long-term outcomes of metabolic bariatric surgery: a 10-Year ...\",\"description\":\"Apr 23, 2025 Â· The median %EWL and %TWL were 59.2% and 22.8%, respectively. Revisional procedures were required in 23.9% of patients, most commonly after SG (Â ...\u003c|separator|\u003e\",\"url\":\"https://link.springer.com/article/10.1007/s00423-025-03713-9\",\"favicon\":\"\"},{\"id\":\"138\",\"title\":\"Long-Term Outcomes After Bariatric Surgery: a Systematic Review ...\",\"description\":\"All current procedures are associated with substantial and durable weight loss. More long-term data are needed for one-anastomosis gastric bypass and sleeveÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC6320354/\",\"favicon\":\"\"},{\"id\":\"139\",\"title\":\"Type 2 Diabetes Remission After Bariatric Surgery and Its Impact on ...\",\"description\":\"Oct 18, 2023 Â· At 1 year, remission of T2D was 58.8 percentage points higher among those who had bariatric surgery (73.1% vs 14.2%; RR = 5.13, 95% CI 4.81,Â ...\",\"url\":\"https://link.springer.com/article/10.1007/s11695-023-06856-0\",\"favicon\":\"\"},{\"id\":\"140\",\"title\":\"Weight loss specific to indication, remission of diabetes, and short ...\",\"description\":\"Overall diabetes remission was 53% (95% CI, 33%â€“72%), and the perioperative complication rate was 8.2% (95% CI, 7.6%â€“8.7%). Revisional SG conversion to RYGB forÂ ...\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S1550728922007572\",\"favicon\":\"\"},{\"id\":\"141\",\"title\":\"Diabetes Remission After Bariatric Surgery: A 10-Year Follow-Up ...\",\"description\":\"Dec 23, 2024 Â· Ten years after surgery, the rate of complete T2DM remission was 31%, partial remission was 15%, and late recurrence after initial remission wasÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC11717815/\",\"favicon\":\"\"},{\"id\":\"142\",\"title\":\"Metabolic surgery versus usual care effects on diabetes remission\",\"description\":\"Feb 24, 2023 Â· In the present meta-analysis, bariatric surgery achieved higher diabetes remission and prolonged remission rates, odd ratio, 0.06, 95 CI, 0.02â€“Â ...\",\"url\":\"https://dmsjournal.biomedcentral.com/articles/10.1186/s13098-023-01001-4\",\"favicon\":\"\"},{\"id\":\"143\",\"title\":\"Reconciliation of Type 2 Diabetes Remission Rates in Studies of ...\",\"description\":\"Oct 13, 2016 Â· However, estimates of remission of type 2 diabetes after bariatric surgery are highly variable (3â€“5), ranging from 25% (6) to 83% (7).\",\"url\":\"https://diabetesjournals.org/care/article/39/12/2247/31365/Reconciliation-of-Type-2-Diabetes-Remission-Rates\",\"favicon\":\"\"},{\"id\":\"144\",\"title\":\"Weight regain and cardiometabolic effects after withdrawal of ...\",\"description\":\"Apr 19, 2022 Â· Aim To explore changes in body weight and cardiometabolic risk factors after treatment withdrawal in the STEP 1 trial extension.INTRODUCTION Â· MATERIALS AND METHODS Â· RESULTS Â· DISCUSSION\",\"url\":\"https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.14725\",\"favicon\":\"\"},{\"id\":\"145\",\"title\":\"Semaglutide and Cardiovascular Outcomes in Obesity without ...\",\"description\":\"Semaglutide, a long-acting analogue of GLP-1, administered at a dose of 2.4 mg subcutaneously once weekly for 104 weeks, was found to reduce body weight by aÂ ...\",\"url\":\"https://www.nejm.org/doi/full/10.1056/NEJMoa2307563\",\"favicon\":\"\"},{\"id\":\"146\",\"title\":\"One-Year Weight Reduction With Semaglutide or Liraglutide in ...\",\"description\":\"Sep 13, 2024 Â· However, 61.0% of the patients who received semaglutide for obesity and with persistent coverage at 1 year achieved 10% or greater weight loss,Â ...\u003c|separator|\u003e\",\"url\":\"https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2823644\",\"favicon\":\"\"},{\"id\":\"147\",\"title\":\"Lifestyle interventions for weight loss among overweight and obese ...\",\"description\":\"To conduct a systematic review and meta-analysis to estimate effects of lifestyle intervention participation on weight reduction among overweight and obeseÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC5575752/\",\"favicon\":\"\"},{\"id\":\"148\",\"title\":\"Systematic review of lifestyle interventions to improve weight ...\",\"description\":\"Sep 9, 2022 Â· Meta-analysis of data indicated a positive effect of interventions to reduce BMI, with average BMI reduction across studies âˆ’0.48 units (95% CIÂ ...\",\"url\":\"https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-022-02067-3\",\"favicon\":\"\"},{\"id\":\"149\",\"title\":\"Intensity and duration of lifestyle interventions for long-term weight ...\",\"description\":\"The aim of this meta-analysis was to determine whether published randomised trials of lifestyle interventions for weight loss provide evidence\",\"url\":\"https://bmjopen.bmj.com/content/9/8/e029966\",\"favicon\":\"\"},{\"id\":\"150\",\"title\":\"Diabetes remission of bariatric surgery and nonsurgical treatments ...\",\"description\":\"Feb 22, 2023 Â· For our meta analysis, the overall T2DM remission rate for surgery group was 56.1% and conventional group was 7.0%. Our T2DM remission rate wereÂ ...\",\"url\":\"https://bmcendocrdisord.biomedcentral.com/articles/10.1186/s12902-023-01283-9\",\"favicon\":\"\"},{\"id\":\"151\",\"title\":\"Diabetes remission and diabetic complications of bariatric surgery ...\",\"description\":\"Sep 24, 2025 Â· Results: At 1 year follow-up, 53.1% of patients in the bariatric surgery group achieved diabetes remission, compared to only 5.4% in the medicalÂ ...Missing:  2020-2025 | Show results with:2020-2025\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/40988570/\",\"favicon\":\"\"},{\"id\":\"152\",\"title\":\"Effect of gastric bypass versus sleeve gastrectomy on the remission ...\",\"description\":\"Gastric bypass was superior to sleeve gastrectomy regarding long-term remission of type 2 diabetes, weight loss, and LDL cholesterol concentrations.\",\"url\":\"https://www.sciencedirect.com/science/article/abs/pii/S2213858724003966\",\"favicon\":\"\"},{\"id\":\"153\",\"title\":\"The role of bariatric surgery in hypertension control: a systematic ...\",\"description\":\"Mar 24, 2025 Â· Bariatric surgery is superior to non-surgical treatments in managing obesity-related hypertension and metabolic disorders.\",\"url\":\"https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-025-04640-9\",\"favicon\":\"\"},{\"id\":\"154\",\"title\":\"Reduced Risk of Cardiovascular Diseases After Bariatric Surgery ...\",\"description\":\"Mar 7, 2025 Â· Bariatric surgery significantly improves CKM health and reduces estimated CVD risk, particularly HF, by 47% to 56% within 1 to 2 years after surgery.\",\"url\":\"https://www.ahajournals.org/doi/10.1161/JAHA.124.038191\",\"favicon\":\"\"},{\"id\":\"155\",\"title\":\"Weight-loss Surgery Reduces Risk of Coronary Heart Disease By 40 ...\",\"description\":\"Nov 14, 2018 Â· Patients with severe obesity who get weight-loss surgery cut their risk of developing coronary heart disease by about 40 percent, according to a new study.Missing:  interventions evidence\",\"url\":\"https://asmbs.org/news_releases/weight-loss-surgery-reduces-risk-of-coronary-heart-disease-by-40-percent/\",\"favicon\":\"\"},{\"id\":\"156\",\"title\":\"Effects of Bariatric Surgery on Cardiovascular Disease - Frontiers\",\"description\":\"Overall, growing evidence supports that bariatric surgery is highly effective in preventing the development of new-onset hypertension, and is also a promisingÂ ...\",\"url\":\"https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2019.00094/full\",\"favicon\":\"\"},{\"id\":\"157\",\"title\":\"Life Expectancy after Bariatric Surgery in the Swedish Obese ...\",\"description\":\"the primary end point in the prospective, controlled Swedish ObeseÂ ...\",\"url\":\"https://www.nejm.org/doi/full/10.1056/NEJMoa2002449\",\"favicon\":\"\"},{\"id\":\"158\",\"title\":\"Bariatric surgery and cardiovascular disease: a systematic review ...\",\"description\":\"Mar 4, 2022 Â· The present systematic review and meta-analysis suggests that bariatric surgery is associated with reduced all-cause and CV mortality, and lowered incidence ofÂ ...Abstract Â· Introduction Â· Results Â· Discussion\",\"url\":\"https://academic.oup.com/eurheartj/article/43/20/1955/6542137\",\"favicon\":\"\"},{\"id\":\"159\",\"title\":\"Life expectancy after bariatric surgery or usual care in patients with ...\",\"description\":\"Jul 12, 2023 Â· Bariatric surgery is associated with similar reduction of overall and cardiovascular mortality and increased life expectancy regardless of baseline diabetesÂ ...\u003c|separator|\u003e\",\"url\":\"https://www.nature.com/articles/s41366-023-01332-2\",\"favicon\":\"\"},{\"id\":\"160\",\"title\":\"The Effect of Semaglutide on Mortality and COVID-19â€“Related Deaths\",\"description\":\"Compared to placebo, patients treated with semaglutide 2.4 mg had lower rates of all-cause death, driven similarly by CV and non-CV death.\",\"url\":\"https://www.jacc.org/doi/10.1016/j.jacc.2024.08.007\",\"favicon\":\"\"},{\"id\":\"161\",\"title\":\"Mortality and Serious Adverse Events Associated With Glucagon ...\",\"description\":\"Aug 2, 2024 Â· The GLP-1RAs with the highest percentage of AE reports associated with mortality were Victoza (3.4%), Byetta (3.2%), and Rybelsus (2.0%), andÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC11366408/\",\"favicon\":\"\"},{\"id\":\"162\",\"title\":\"Weight Regain After Bariatric Surgery: Scope of the Problem ... - NIH\",\"description\":\"Feb 15, 2023 Â· A systematic review revealed that up to 76% of SG patients had significant weight regain at 6-year follow-up [51]. In the largest prospectiveÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC9906605/\",\"favicon\":\"\"},{\"id\":\"163\",\"title\":\"Long-Term Effectiveness and Outcomes of Bariatric Surgery\",\"description\":\"Aug 9, 2024 Â· Achieving an initial weight loss of at least 20 kg during the preoperative program is strongly associated with better long-term maintenance.\",\"url\":\"https://www.cureus.com/articles/284070-long-term-effectiveness-and-outcomes-of-bariatric-surgery-a-comprehensive-review-of-current-evidence-and-emerging-trends\",\"favicon\":\"\"},{\"id\":\"164\",\"title\":\"Factors Associated With Weight Loss After Gastric Bypass\",\"description\":\"Sep 15, 2008 Â· Several factors thought to be associated with poor weight loss after GBP include older age,14,15 black race,16,17 male sex,18 being married,16Â ...Missing:  durability | Show results with:durability\",\"url\":\"https://jamanetwork.com/journals/jamasurgery/fullarticle/600864\",\"favicon\":\"\"},{\"id\":\"165\",\"title\":\"Are there really any predictive factors for a successful weight loss ...\",\"description\":\"Feb 5, 2020 Â· Unsuccessful surgery was associated with an older age, previous history of hypertension, abdominal surgery or depression/anxiety, also the number ofÂ ...\u003c|separator|\u003e\",\"url\":\"https://bmcendocrdisord.biomedcentral.com/articles/10.1186/s12902-020-0499-4\",\"favicon\":\"\"},{\"id\":\"166\",\"title\":\"Factors influencing bariatric surgery outcomes - ScienceDirect\",\"description\":\"Our analysis indicates that the choice of the surgical technique, age, initial BMI, ethnic origin, the presence of eating disorders and metabolic factors allÂ ...\",\"url\":\"https://www.sciencedirect.com/science/article/abs/pii/S1878788622001758\",\"favicon\":\"\"},{\"id\":\"167\",\"title\":\"Weight regain after bariatric surgery: A systematic review and meta ...\",\"description\":\"Weight regain (WR) is prevalent in 49% of bariatric surgery patients. RYGB has the highest prevalence of WR, occurring in 64% of cases. Europe sees the highestÂ ...\",\"url\":\"https://www.sciencedirect.com/science/article/abs/pii/S2451847623000520\",\"favicon\":\"\"},{\"id\":\"168\",\"title\":\"Post metabolic bariatric surgery weight regain: the importance of ...\",\"description\":\"Jan 15, 2024 Â· Studies and meta-analyses have revealed that postprandial GLP-1 levels increase after the Roux-en-Y gastric bypass and sleeve gastrectomy, but fasting GLP-1Â ...\",\"url\":\"https://www.nature.com/articles/s41366-024-01461-2\",\"favicon\":\"\"},{\"id\":\"169\",\"title\":\"Long-Term Follow-Up After Bariatric Surgery: Key to Successful ...\",\"description\":\"First, adequate energy and nutrients are needed to support post-BS tissue healing and promote the maintenance of lean body mass during extreme WL. Second, theÂ ...\",\"url\":\"https://www.mdpi.com/2072-6643/16/24/4399\",\"favicon\":\"\"},{\"id\":\"170\",\"title\":\"Understanding weight regain after a nutritional weight loss intervention\",\"description\":\"This systematic review and meta-analysis showed that lifestyle interventions remained effective in maintaining the mean weight (5% lower than baseline weight)Missing:  post- | Show results with:post-\",\"url\":\"https://www.sciencedirect.com/science/article/abs/pii/S2405457722002017\",\"favicon\":\"\"},{\"id\":\"171\",\"title\":\"Weight regain after bariatric surgery: Promoters and potential ...\",\"description\":\"Oct 28, 2021 Â· Several factors are proposed to influence weight regain as psychological, behavioral factors, hormonal, metabolic, anatomical lapses, as well as geneticÂ ...\",\"url\":\"https://www.wjgnet.com/2308-3840/full/v9/i5/438.htm\",\"favicon\":\"\"},{\"id\":\"172\",\"title\":\"Mortality risk higher with sleeve gastrectomy vs. gastric bypass for ...\",\"description\":\"Aug 22, 2022 Â· The all-cause mortality rate within 90 days of surgery was 0.04% with sleeve gastrectomy and 0.06% with gastric bypass. There was no differenceÂ ...\",\"url\":\"https://www.healio.com/news/endocrinology/20220822/mortality-risk-higher-with-sleeve-gastrectomy-vs-gastric-bypass-for-adults-with-diabetes\",\"favicon\":\"\"},{\"id\":\"173\",\"title\":\"Comparison of Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass\",\"description\":\"Jan 30, 2024 Â· The 30-day readmission rate was 3.1% after SG and 4.0% after RYGB (P = .33). There was no 90-day mortality. The 30-day incidence of any adverseÂ ...\",\"url\":\"https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2814336\",\"favicon\":\"\"},{\"id\":\"174\",\"title\":\"An Updated Systematic Review and Meta-analysis, 2013â€“2023 - NIH\",\"description\":\"The perioperative reoperation rates were low across all surgical treatments. Specific adverse events, such as intestinal obstruction and anastomosis siteÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC10771970/\",\"favicon\":\"\"},{\"id\":\"175\",\"title\":\"The Higher the Body Mass Index, the Higher the Risk for ... - asmbs\",\"description\":\"Jun 17, 2025 Â· The higher a person's body mass index (BMI), the higher their risk for complications after bariatric surgery, especially those with BMI of 50 or more.Missing:  perioperative systematic\",\"url\":\"https://asmbs.org/news_releases/the-higher-the-body-mass-index-the-higher-the-risk-for-complications-after-bariatric-surgery/\",\"favicon\":\"\"},{\"id\":\"176\",\"title\":\"Comparing Anastomotic Leak Rate Between Robotic and ... - PubMed\",\"description\":\"The overall incidence of anastomotic leaks was 0.21%. Robotic sleeve gastrectomy (SG) was associated with a significantly higher leak rate compared to theÂ ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/40526322/\",\"favicon\":\"\"},{\"id\":\"177\",\"title\":\"Gastrointestinal adverse events associated with GLP-1 RA in non ...\",\"description\":\"Aug 13, 2025 Â· Nausea, vomiting, diarrhea, and constipation were the most common gastrointestinal adverse effects. All evaluated GLP-1 RAs led to a significantÂ ...\",\"url\":\"https://www.nature.com/articles/s41366-025-01859-6\",\"favicon\":\"\"},{\"id\":\"178\",\"title\":\"Comparative gastrointestinal adverse effects of GLP-1 receptor ...\",\"description\":\"Tirzepatide had the highest risk of inducing nausea and diarrhea, while dulaglutide and lixisenatide had the lowest risks. Exenatide exhibited the highestÂ ...\",\"url\":\"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1613610/full\",\"favicon\":\"\"},{\"id\":\"179\",\"title\":\"Potentially fatal side effect of weight-loss drugs sparks new ...\",\"description\":\"Jul 6, 2025 Â· A 2024 analysis also found 6,751 reports of acute pancreatitis associated with GLP-1 drugs between 2005 to 2023. While US regulators like theÂ ...Fitness Â· Public Health Â· Ozempic Â· Diana Bruk\",\"url\":\"https://nypost.com/2025/07/06/health/potentially-fatal-side-effect-of-weight-loss-drugs-sparks-new-investigation/\",\"favicon\":\"\"},{\"id\":\"180\",\"title\":\"Glucagon-Like Peptide-1 Receptor Agonists and Gastrointestinal ...\",\"description\":\"CONCLUSIONS: GLP-1RAs are associated with an increased risk of cholelithiasis and GERD, but do not appear to increase the risk of other gastrointestinal orÂ ...\",\"url\":\"https://www.gastrojournal.org/article/S0016-5085%2825%2900845-5/abstract\",\"favicon\":\"\"},{\"id\":\"181\",\"title\":\"Eli Lilly and Company - 716485 - 09/09/2025 - FDA\",\"description\":\"Sep 9, 2025 Â· Specifically, serious risks pertaining to severe gastrointestinal disease, acute kidney injury, hypersensitivity reactions, hypoglycemia,Â ...Missing:  pharmacotherapies | Show results with:pharmacotherapies\",\"url\":\"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eli-lilly-and-company-716485-09092025\",\"favicon\":\"\"},{\"id\":\"182\",\"title\":\"FDA Side Effects Update: GLP-1 Drugs and Breathing Risks\",\"description\":\"Nov 22, 2024 Â· GLP-1 drugs like Ozempic, Wegovy and Mounjaro delay gastric emptying, increasing the risk for pulmonary aspiration.Missing:  pharmacotherapies | Show results with:pharmacotherapies\u003c|control11|\u003e\u003c|separator|\u003e\",\"url\":\"https://medshadow.org/fda-side-effects-update-glp1-drugs-pulmonary-aspiration/\",\"favicon\":\"\"},{\"id\":\"183\",\"title\":\"Novo Nordisk Inc. MARCS-CMS 716495 â€” September 09, 2025 - FDA\",\"description\":\"Sep 9, 2025 Â· In addition, the PI for Wegovy includes warnings and precautions regarding acute pancreatitis, acute gallbladder disease, hypoglycemia, acuteÂ ...Missing:  pharmacotherapies | Show results with:pharmacotherapies\",\"url\":\"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/novo-nordisk-inc-716495-09092025\",\"favicon\":\"\"},{\"id\":\"184\",\"title\":\"Phentermine and Topiramate: MedlinePlus Drug Information\",\"description\":\"Sep 15, 2023 Â· Phentermine and topiramate may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away: Â· headache Â· dizzinessÂ ...\",\"url\":\"https://medlineplus.gov/druginfo/meds/a612037.html\",\"favicon\":\"\"},{\"id\":\"185\",\"title\":\"Phentermine and topiramate (oral route) - Side effects \u0026 dosage\",\"description\":\"Chest discomfort Â· decreased urine Â· dry mouth Â· fast, irregular, pounding, or racing heartbeat or pulse Â· loss of appetite Â· mood changes Â· muscle pain or crampsÂ ...\",\"url\":\"https://www.mayoclinic.org/drugs-supplements/phentermine-and-topiramate-oral-route/description/drg-20075700\",\"favicon\":\"\"},{\"id\":\"186\",\"title\":\"Phentermine/Topiramate (Qsymia) for Chronic Weight Management\",\"description\":\"Oct 15, 2014 Â· Phentermine/topiramate is well tolerated by most patients. Common side effects are dose dependent and include dry mouth, constipationÂ ...\",\"url\":\"https://www.aafp.org/pubs/afp/issues/2014/1015/p576.html\",\"favicon\":\"\"},{\"id\":\"187\",\"title\":\"Anti-Obesity Drugs: Long-Term Efficacy and Safety - PubMed Central\",\"description\":\"Typical side effects include headache, dizziness, dry mouth, and gastrointestinal discomfort (i.e., nausea, vomiting, constipation, or diarrhea). AlthoughÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC7994651/\",\"favicon\":\"\"},{\"id\":\"188\",\"title\":\"Long-term effects of weight-reducing drugs in people with ... - PubMed\",\"description\":\"Mar 2, 2016 Â· The most frequent side effects were dry mouth, constipation, and headache with sibutramine, and dry mouth and paresthaesia with phentermine/Â ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/26934640/\",\"favicon\":\"\"},{\"id\":\"189\",\"title\":\"FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss\",\"description\":\"Sep 25, 2025 Â· FDA has warned companies that have illegally sold unapproved drugs containing semaglutide, tirzepatide or retatrutide that are falsely labeled â€œfor researchÂ ...FDA clarifies policies for... Â· FDA Roundup Â· Compounding and the FDA Â· BeSafeRx\",\"url\":\"https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss\",\"favicon\":\"\"},{\"id\":\"190\",\"title\":\"Real-World Safety Concerns of Tirzepatide - NIH\",\"description\":\"Sep 9, 2025 Â· Reviewing individual adverse events from 2022 to Q1 2025 showed that â€œIncorrect Dose Administeredâ€ was the most common, with 19,461 reports (Â ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC12469573/\",\"favicon\":\"\"},{\"id\":\"191\",\"title\":\"Semaglutide vs Tirzepatide for Weight Loss in Adults With ...\",\"description\":\"Although most adults with overweight or obesity experienced 5% or greater weight loss with treatment, the benefit was greater with tirzepatide.\",\"url\":\"https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2821080\",\"favicon\":\"\"},{\"id\":\"192\",\"title\":\"Medicalizing Obesity: Individual, Economic ... - AMA Journal of Ethics\",\"description\":\"While medicalization may bring benefits to obese individuals, it will also label all of them â€œsick,â€ regardless of the rest of their health status [5]. In thisÂ ...\",\"url\":\"https://journalofethics.ama-assn.org/article/medicalizing-obesity-individual-economic-and-medical-consequences/2011-12\",\"favicon\":\"\"},{\"id\":\"193\",\"title\":\"The Obesity Pandemicâ€”Whose Responsibility? No Blame, No ...\",\"description\":\"There are at least two sides to personal responsibility: medicalizing obesity, which reduces it, and parental supervision, which emphasizes it.\",\"url\":\"https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2020.00002/full\",\"favicon\":\"\"},{\"id\":\"194\",\"title\":\"Obesity and Responsibility for Health - Oxford Academic\",\"description\":\"May 7, 2024 Â· This chapter examines the case for health care policies aimed at holding obese individuals responsible for their weight and forÂ ...\",\"url\":\"https://academic.oup.com/book/56271/chapter/445196864\",\"favicon\":\"\"},{\"id\":\"195\",\"title\":\"Obesity and Responsibility - Hoover Institution\",\"description\":\"We need to usher in a new era of personal responsibility in health care, and obesity should be our highest priority.Missing:  debates | Show results with:debates\",\"url\":\"https://www.hoover.org/research/obesity-and-responsibility\",\"favicon\":\"\"},{\"id\":\"196\",\"title\":\"The medicalization of obesity, bariatric surgery, and population health\",\"description\":\"Aug 16, 2016 Â· This article examines how the medicalization of obesity validates the use of bariatric surgery to treat obesity in the United States and howÂ ...Missing:  criticisms | Show results with:criticisms\u003c|separator|\u003e\",\"url\":\"https://journals.sagepub.com/doi/abs/10.1177/1363459316660858\",\"favicon\":\"\"},{\"id\":\"197\",\"title\":\"Intensive Lifestyle Intervention for Obesity: Principles, Practices, and ...\",\"description\":\"The Guidelines recommend a minimum of 6 months of high-intensity, comprehensive lifestyle intervention, consisting of a reduced-calorie diet, increased physicalÂ ...\u003c|control11|\u003e\u003c|separator|\u003e\",\"url\":\"https://www.gastrojournal.org/article/S0016-5085%2817%2930139-7/fulltext\",\"favicon\":\"\"},{\"id\":\"198\",\"title\":\"Structured lifestyle modification as an adjunct to obesity ... - Nature\",\"description\":\"Mar 8, 2024 Â· There is strong evidence that structured lifestyle modification programmes improve health in patients with obesity and related disorders.\",\"url\":\"https://www.nature.com/articles/s41366-024-01499-2\",\"favicon\":\"\"},{\"id\":\"199\",\"title\":\"Personal responsibility and obesity: a constructive approach to a ...\",\"description\":\"The concept of personal responsibility has been central to social, legal, and political approaches to obesity. It evokes language of blame, weakness, and vice.\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/20194976/\",\"favicon\":\"\"},{\"id\":\"200\",\"title\":\"Behaviorâ€change lifestyle interventions for the treatment of obesity ...\",\"description\":\"Dec 23, 2024 Â· The authors concluded that there is low-certainty evidence that lifestyle and behavioral interventions are effective for obesity managementÂ ...\",\"url\":\"https://nyaspubs.onlinelibrary.wiley.com/doi/full/10.1111/nyas.15278\",\"favicon\":\"\"},{\"id\":\"201\",\"title\":\"Acknowledging Individual Responsibility while Emphasizing Social ...\",\"description\":\"This study tests whether policy narratives designed to increase support for obesity-reducing public policies should explicitly acknowledge individualÂ ...Missing:  treatment | Show results with:treatment\",\"url\":\"https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0117565\",\"favicon\":\"\"},{\"id\":\"202\",\"title\":\"Obesity and overweight - World Health Organization (WHO)\",\"description\":\"May 7, 2025 Â· In 2024, 35 million children under the age of 5 were overweight. Over 390 million children and adolescents aged 5â€“19 years were overweight inÂ ...One in eight people are now... Â· Global nutrition targets 2025\",\"url\":\"https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight\",\"favicon\":\"\"},{\"id\":\"203\",\"title\":\"Global, regional, and national prevalence of adult overweight and ...\",\"description\":\"Mar 3, 2025 Â· The age-standardised prevalence of overweight and obesity is forecasted to increase by 30Â·7% (95% UI 17Â·8â€“36Â·3) globally over the next 30 years,Â ...\",\"url\":\"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2825%2900355-1/fulltext\",\"favicon\":\"\"},{\"id\":\"204\",\"title\":\"Obesity and Severe Obesity Prevalence in Adults - CDC\",\"description\":\"Sep 24, 2024 Â· The prevalence of obesity among adults was 40.3% during August 2021â€“August 2023 (Figure 1, Table 1). The prevalence was 39.2% in men and 41.3% in women.\",\"url\":\"https://www.cdc.gov/nchs/products/databriefs/db508.htm\",\"favicon\":\"\"},{\"id\":\"205\",\"title\":\"Obesity and Cancer Fact Sheet - NCI\",\"description\":\"Jan 28, 2025 Â· Those with overweight or obesity are at greater risk for many diseases, including diabetes, high blood pressure, cardiovascular disease, stroke, and at leastÂ ...\",\"url\":\"https://www.cancer.gov/about-cancer/causes-prevention/risk/obesity/obesity-fact-sheet\",\"favicon\":\"\"},{\"id\":\"206\",\"title\":\"Fast Facts â€“ Obesity-Related Chronic Disease | STOP Obesity Alliance\",\"description\":\"According to the CDC, approximately 55% of cancer diagnoses for women and 24% of cancer diagnoses for men are associated with overweight and obesity.10; In 2014Â ...\",\"url\":\"https://stop.publichealth.gwu.edu/fast-facts/obesity-related-chronic-disease\",\"favicon\":\"\"},{\"id\":\"207\",\"title\":\"Worldwide burden of cancer attributable to diabetes and high body ...\",\"description\":\"Oct 10, 2024 Â· We estimated that 5Â·6% of all incident cancers in 2012 were attributable to the combined effects of diabetes and high BMI as independent risk factors.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC5805864/\",\"favicon\":\"\"},{\"id\":\"208\",\"title\":\"Prevalence of complications and comorbidities associated with obesity\",\"description\":\"Jan 22, 2025 Â· In this claims study, hypertension and dyslipidemia were the leading comorbidities in people with obesity, with an increasing prevalence with age.\",\"url\":\"https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-024-21061-z\",\"favicon\":\"\"},{\"id\":\"209\",\"title\":\"An overview of obesityâ€related complications: The epidemiological ...\",\"description\":\"Mar 11, 2025 Â· Obesity is a risk factor for heart failure even if disease risk was adjusted for type 2 diabetes, hypertension, age, smoking, physical activityÂ ...\",\"url\":\"https://dom-pubs.onlinelibrary.wiley.com/doi/full/10.1111/dom.16263\",\"favicon\":\"\"},{\"id\":\"210\",\"title\":\"How Much Does Obesity Cost the U.S?\",\"description\":\"Jul 25, 2023 Â· The annual cost of obesity in the U.S. exceeds $1.4 trillion, including treatment, related conditions, and work productivity. Medical costs forÂ ...\",\"url\":\"https://obesitymedicine.org/blog/health-economic-impact-of-obesity/\",\"favicon\":\"\"},{\"id\":\"211\",\"title\":\"Consequences of Obesity | Overweight \u0026 Obesity - CDC\",\"description\":\"Jul 15, 2022 Â· Annual nationwide productivity costs of obesity-related absenteeism range between $3.38 billion ($79 per individual with obesity) and $6.38Â ...\",\"url\":\"https://www.cdc.gov/obesity/basics/consequences.html\",\"favicon\":\"\"},{\"id\":\"212\",\"title\":\"Report: Obesity could cost the world over $4 trillion a year by 2035\",\"description\":\"Mar 2, 2023 Â· A recent Milken Institute study put the total annual cost of chronic diseases caused by obesity and excess weight at $1.72 trillion in the U.S.Â ...\u003c|separator|\u003e\",\"url\":\"https://www.statnews.com/2023/03/02/obesity-costs-4-trillion-2035/\",\"favicon\":\"\"},{\"id\":\"213\",\"title\":\"[PDF] The Economic Impact of Overweight \u0026 Obesity in 2020 and 2060\",\"description\":\"Global economic costs of overweight and obesity are predicted to rise from under $2 trillion in 2020 to over $3 trillion by 2030 and over $18 trillion by 2060.\",\"url\":\"https://data.worldobesity.org/publications/WOF-Economic-Impacts-2-V2.pdf\",\"favicon\":\"\"},{\"id\":\"214\",\"title\":\"Worldwide trends in underweight and obesity from 1990 to 2022\",\"description\":\"Feb 29, 2024 Â· In 25 countries (13%) for girls and 17 countries (9%) for boys, more than 90% of double burden consisted of obesity in 2022, whereas the shareÂ ...\",\"url\":\"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2823%2902750-2/fulltext\",\"favicon\":\"\"},{\"id\":\"215\",\"title\":\"than half of adults and a third of children and adolescents predicted ...\",\"description\":\"Mar 3, 2025 Â· Over half the world's adult population (3.8 billion) and a third of all children and adolescents (746 million) are forecast to be living with overweight orÂ ...\",\"url\":\"https://www.healthdata.org/news-events/newsroom/news-releases/lancet-more-half-adults-and-third-children-and-adolescents\",\"favicon\":\"\"},{\"id\":\"216\",\"title\":\"A cost comparison of GLP-1 receptor agonists and bariatric surgery\",\"description\":\"Sep 16, 2024 Â· This study examines the initial and long-term costs of GLP-1 s compared to bariatric surgery. Study design: We compared average 2023 national retail prices forÂ ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/39285034/\",\"favicon\":\"\"},{\"id\":\"217\",\"title\":\"Long term cost outcomes among commercially insured patients ...\",\"description\":\"Jan 1, 2024 Â· In our study, with 10â€year followâ€up data, we find that bariatric surgery (BS) is associated with lower followâ€up cost from Year 2 to Year 9Â ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC10766043/\",\"favicon\":\"\"},{\"id\":\"218\",\"title\":\"Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s\",\"description\":\"Sep 18, 2025 Â· The mean total costs over 2 years were $63,483 for treatment with a GLP-1 and $51,794 for bariatric surgery (P \u003c 0.001).\",\"url\":\"https://www.tctmd.com/news/better-outcomes-and-lower-cost-bariatric-surgery-over-glp-1s\",\"favicon\":\"\"},{\"id\":\"219\",\"title\":\"Impact of metabolic surgery on cost and long-term health outcome\",\"description\":\"A systematic review and meta-analysis have reported a weighted mean of excess weight loss (EWL) between 50.9% and 80.9% for different bariatric procedures [7].\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S1550728921004950\",\"favicon\":\"\"},{\"id\":\"220\",\"title\":\"Cost-effectiveness of Medical Therapy, Sleeve Gastrectomy, and ...\",\"description\":\"Feb 14, 2022 Â· Overall, the cost-effectiveness of RYGB compared with medical therapy improved to $17 497 per QALY gained when projected over a longer 10-yearÂ ...\",\"url\":\"https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2789003\",\"favicon\":\"\"},{\"id\":\"221\",\"title\":\"Cost-Effectiveness Analysis of Endoscopic Sleeve Gastroplasty\",\"description\":\"This cost-effectiveness analysis suggests that ESG is cost effective in 5 years and cost saving over a lifetime for patients with obesity and type 2 diabetes.\u003c|separator|\u003e\",\"url\":\"https://www.sciencedirect.com/science/article/abs/pii/S2590030724000357\",\"favicon\":\"\"},{\"id\":\"222\",\"title\":\"Evaluating the Economic Impact of Bariatric Surgery: A Multi-year ...\",\"description\":\"Oct 10, 2025 Â· Conclusions. Bariatric surgery patients had higher post-operative costs through four years after surgery compared to non-operative controls,Â ...\",\"url\":\"https://www.americanjournalofsurgery.com/article/S0002-9610%2825%2900488-X/abstract\",\"favicon\":\"\"},{\"id\":\"223\",\"title\":\"Bariatric Surgery Is More Cost Effective Than Newer Weight Loss ...\",\"description\":\"Oct 18, 2024 Â· Newer weight loss drugs are cost effective in the long term only when combined with bariatric weight loss surgery, according to a studyÂ ...\",\"url\":\"https://www.facs.org/media-center/press-releases/2024/bariatric-surgery-is-more-cost-effective-than-newer-weight-loss-drugs-alone/\",\"favicon\":\"\"},{\"id\":\"224\",\"title\":\"Assessing the economic impact of obesity and overweight ... - Nature\",\"description\":\"Dec 4, 2024 Â· In conclusion, the economic burden of obesity and overweight on employers and employees is staggering, amounting to $425.5 billion in 2023 aloneÂ ...\",\"url\":\"https://www.nature.com/articles/s41387-024-00352-9\",\"favicon\":\"\"},{\"id\":\"225\",\"title\":\"Long-Term Effectiveness and Outcomes of Bariatric Surgery\",\"description\":\"Aug 9, 2024 Â· Bariatric surgery has demonstrated substantial and sustained weight loss over the long term, with varying degrees of effectiveness among different procedures.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC11381104/\",\"favicon\":\"\"},{\"id\":\"226\",\"title\":\"Popular Weight-Loss Drugs Prove More Costly Than Metabolic and ...\",\"description\":\"Oct 7, 2024 Â· â€œBariatric surgery offers a more permanent and rapid resolution to obesity and metabolic syndrome, with cost-saving benefits in the long-term,â€Â ...\",\"url\":\"https://asmbs.org/news_releases/popular-weight-loss-drugs-prove-more-costly-than-metabolic-and-bariatric-surgery-within-one-year/\",\"favicon\":\"\"}],\"images\":[],\"fixedIssues\":[],\"slug\":\"Bariatrics\",\"title\":\"Bariatrics\",\"content\":\"$1f\",\"description\":\"Bariatrics\\n\\nBariatrics is the branch of medicine dedicated to the prevention, diagnosis, treatment, and management of obesity and its associated comorbidities, encompassing both nonsurgical...\",\"metadata\":{\"categories\":[],\"lastModified\":\"1761584245\",\"contentLength\":\"90608\",\"version\":\"1.0\",\"lastEditor\":\"system\",\"language\":\"en\",\"isRedirect\":false,\"redirectTarget\":\"\",\"isWithheld\":false},\"stats\":{\"totalViews\":\"30832\",\"recentViews\":\"30832\",\"dailyAvgViews\":1027.7332763671875,\"qualityScore\":1,\"lastViewed\":\"1761884348\"},\"linkedPages\":null},\"found\":true},\"dataUpdateCount\":1,\"dataUpdatedAt\":1761884348377,\"error\":null,\"errorUpdateCount\":0,\"errorUpdatedAt\":0,\"fetchFailureCount\":0,\"fetchFailureReason\":null,\"fetchMeta\":null,\"isInvalidated\":false,\"status\":\"success\",\"fetchStatus\":\"idle\"},\"queryKey\":[\"page\",\"Bariatrics\"],\"queryHash\":\"[\\\"page\\\",\\\"Bariatrics\\\"]\"}]},\"children\":\"$L20\"}]\n"])</script><script nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh">self.__next_f.push([1,"c:{\"metadata\":[[\"$\",\"title\",\"0\",{\"children\":\"Bariatrics\"}],[\"$\",\"meta\",\"1\",{\"name\":\"description\",\"content\":\"Bariatrics is the branch of medicine dedicated to the prevention, diagnosis, treatment, and management of obesity and its associated comorbidities, encompassing both nonsurgical interventions and surgical procedures aimed at inducing sustained weight loss through alterations in gastrointestinal anatomy or function. The field addresses obesity primarily as a chronic condition driven by caloric surplus relative to expenditure, with treatments prioritizing empirical evidence of efficacy over...\"}],[\"$\",\"meta\",\"2\",{\"name\":\"author\",\"content\":\"system\"}],[\"$\",\"link\",\"3\",{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\",\"crossOrigin\":\"$undefined\"}],[\"$\",\"meta\",\"4\",{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",\"5\",{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"link\",\"6\",{\"rel\":\"canonical\",\"href\":\"https://grokipedia.com/page/Bariatrics\"}],[\"$\",\"meta\",\"7\",{\"property\":\"og:title\",\"content\":\"Bariatrics\"}],[\"$\",\"meta\",\"8\",{\"property\":\"og:description\",\"content\":\"Bariatrics is the branch of medicine dedicated to the prevention, diagnosis, treatment, and management of obesity and its associated comorbidities, encompassing both nonsurgical interventions and surgical procedures aimed at inducing sustained weight loss through alterations in gastrointestinal anatomy or function. The field addresses obesity primarily as a chronic condition driven by caloric surplus relative to expenditure, with treatments prioritizing empirical evidence of efficacy over...\"}],[\"$\",\"meta\",\"9\",{\"property\":\"og:url\",\"content\":\"https://grokipedia.com/page/Bariatrics\"}],[\"$\",\"meta\",\"10\",{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",\"11\",{\"property\":\"og:locale\",\"content\":\"en\"}],[\"$\",\"meta\",\"12\",{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",\"13\",{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",\"14\",{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",\"15\",{\"property\":\"og:image:alt\",\"content\":\"Bariatrics\"}],[\"$\",\"meta\",\"16\",{\"property\":\"og:type\",\"content\":\"article\"}],[\"$\",\"meta\",\"17\",{\"property\":\"article:modified_time\",\"content\":\"1970-01-21T09:19:44.245Z\"}],[\"$\",\"meta\",\"18\",{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",\"19\",{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",\"20\",{\"name\":\"twitter:title\",\"content\":\"Bariatrics\"}],[\"$\",\"meta\",\"21\",{\"name\":\"twitter:description\",\"content\":\"Bariatrics is the branch of medicine dedicated to the prevention, diagnosis, treatment, and management of obesity and its associated comorbidities, encompassing both nonsurgical interventions and surgical procedures aimed at inducing sustained weight loss through alterations in gastrointestinal anatomy or function. The field addresses obesity primarily as a chronic condition driven by caloric surplus relative to expenditure, with treatments prioritizing empirical evidence of efficacy over...\"}],[\"$\",\"meta\",\"22\",{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"link\",\"23\",{\"rel\":\"icon\",\"href\":\"/favicon.ico\",\"type\":\"image/x-icon\",\"sizes\":\"16x16\"}],[\"$\",\"$L21\",\"24\",{}]],\"error\":null,\"digest\":\"$undefined\"}\n"])</script><script nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh">self.__next_f.push([1,"11:\"$c:metadata\"\n"])</script><script nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh">self.__next_f.push([1,"22:I[61172,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"PageEditorProvider\"]\n"])</script><script nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh">self.__next_f.push([1,"23:I[63493,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="NDVhMGZiYWItMTM3ZS00NGQ3LWIzZmEtMGMyMGU5OThjZGVh">self.__next_f.push([1,"20:[\"$\",\"$L22\",null,{\"children\":[\"$\",\"$L23\",null,{\"slug\":\"Bariatrics\"}]}]\n"])</script></body></html>